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Exposure to solar ultraviolet (UV) radiation causes induction of skin cancers.
Previous experiments using mice have demonstrated that the majority of these skin
tumours are antigenic, and are rejected upon transplantation into immunocompetent,
syngeneic recipients. However, prior irradiation of the recipients with sub-
carcinogenic doses ofUV renders them susceptible to progressive tumour outgrowth,
suggesting a role for UV in suppression of immune responses to skin tumours. Using
a moderately immunogenic fibrosarcoma (FSA) cell line, the present study examines
which UV wavebands are most effective in increasing susceptibility to tumour cell
outgrowth; it also investigates the mechanisms by which UV exposure affects
immune responses to injected tumour cells.
To establish the most important wavebands for affecting the immunity to
tumours, three different lamps were used: a broad-band UVB source (TL12), a
narrow-band UVB source (TL01, 311-313 nm) and a UVA-I source (340-400 nm). A
three week irradiation protocol was chosen as this has previously been shown to
result in increased outgrowth of implanted tumours. The immunosuppressive
properties of these lamps were assessed by irradiating mice twice a week for three
weeks. All three sources were shown to reduce the number of epidermal Langerhans
cells and the contact hypersensitivity response. Additionally, the numbers of
dendritic cells in the draining lymph nodes ofmice irradiated over 3 weeks with the
broad-band UVB source were counted; a significant reduction in lymph node
dendritic cell numbers was observed in irradiated mice compared with unirradiated
viii
controls, although the expression ofMHC Class II and CD86 antigens on these cells
was unaffected.
The effects of the different lamps on tumour outgrowth were assessed by
irradiating mice twice a week for three weeks on their shaved backs; the FSA cells
were then injected subcutaneously into the irradiated site. Prior exposure of mice to
2 2doses of 1200 J/m , but not 1000 J/m broad-band UVB resulted in increased growth
of the injected cells, indicating a dose dependency ofUVB-enhanced tumour
outgrowth. No increase in tumour size was seen following injection of FSA cells into
an unirradiated site on UV-irradiated mice, demonstrating that the effect of the UVB
was a local one. Prior exposure ofmice to narrow-band UVB or UVA-I did not result
in increased tumour cell outgrowth.
In unirradiated tumour-bearing mice, it was found that the in vitro
spontaneous proliferation of cells from lymph nodes draining the sites of tumour cell
injection was increased compared with the proliferation of cells from tumour-free
mice. Taking lymph nodes at various time points after tumour cell inoculation
showed that UVB-exposure prior to FSA cell injection resulted in a delay in the time
at which an increase in the in vitro proliferation became apparent. Using flow
cytometry, the expression of various cell surface markers on lymph node cells from
tumour-bearing mice was assessed. Additionally, an attempt was made to identify
any infiltrating host cells in the tumours using immunohistochemistry.
CA-urocanic acid (UCA), formed from the naturally occurring tra«s-isomer
on UVB-irradiation of skin, is a recognised initiator ofUVB-induced
immunosuppression, and has previously been implicated in photocarcinogenesis. In
the present study, mice were treated twice a week for 3 weeks with cA-UCA prior to
ix
FSA cell injection; this treatment did not result in increased outgrowth of the
resulting tumours. Similarly, injection of a monoclonal antibody with specificity for
cA-UCA prior to each irradiation with broad-band UVB did not reverse the UV-
induced increase in tumour growth. Thus no role for cA-UCA in UV-enhanced
tumour outgrowth was established.
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1.1.1 - Environmental exposure
The ultraviolet (UV) spectrum is divided into UVC (200-280 nm), UVB (280-
315 nm) and UVA (315-400 nm). The UVA waveband is further sub-divided into
UVA-II (315-340 nm) and UVA-I (340-400 nm). The major source ofUV exposure of
humans is sunlight. Of the UV that reaches the earth's surface the majority is UVA, with
some UVB. All of the wavelengths in the UVC range, and some UVB is absorbed by
ozone, which forms a thin layer in the stratosphere. In the early 1980s a hole in the
ozone layer was discovered above the Antarctic, which is present each year from spring
to autumn. This, along with thinning of the ozone layer globally, raised concerns that
increasing amounts ofUVB, which are the most biologically active wavelengths, would
reach the earth's surface. A long-term study in Poland found that between 1976 tol997,
there was an increase in UV intensity, capable of causing sunburn at the terrestrial
surface, of approximately 6% per decade. This was attributed mainly to ozone change
(Borkowski, 2000). In the Antarctic, the increase was 130% (Madronich et al, 1998).
Ozone depletion is primarily due to release of chlorofluorocarbons (CFCs) and
the Montreal Protocol of 1987 limits the use and manufacture ofCFCs. Although it is
likely that it will be some years before the full benefits of these measures will be seen,
modelling studies have demonstrated that ozone column amounts in the Southern
hemisphere are 5% more than they would otherwise have been; it is expected that it will
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be 50 years until the ozone layer is repaired, with a probable delay due to global
warming (McKenzie et al, 2003).
1.1.2 - Artificial sources
Other sources of human UV exposure include UV lamps used in the treatment of
medical conditions such as psoriasis, and lamps used for cosmetic tanning.
Additionally, there may be some accidental exposure to industrial UV sources, such as
welding arcs.
1.1.3 - Biological effects
One benefit ofUV exposure is the production of vitamin D3 by
photoisomerisation of 7-dihydrocholesterol. Studies have also found an association of
UV exposure with reduced incidence of some internal cancers, such as prostate cancer
(Luscombe et al, 2001). Damaging effects ofUV exposure include sunburn,
photoageing of the skin, immune suppression, ocular effects and skin cancer. Increasing
UV exposure of humans is due to a number of factors, including longer life expectancy
and changes in lifestyles and attitudes, such as increased leisure time, changes in
clothing and the desire for tanned skin. In many countries, the rising popularity of
sunshine holidays is the most important factor in causing increased UV exposure;
estimates of the UV dose received during a 3 week summer holiday in the USA
demonstrated that this can increase the annual UV dose of an average American by
around 30% (Godar et al, 2001). This increase in sun exposure is mirrored by an
increased incidence of skin cancer, as discussed in the next section.
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1.2 - Skin Cancer
1.2.1 - Incidence worldwide
Non-melanoma skin cancers (NMSC) are the most common malignant neoplasms
in humans. These include squamous cell carcinoma (SCC, Figure 1.1), a malignant
neoplasm derived from keratinocytes of the squamous epithelium, and basal cell
carcinoma (BCC, Figure 1.2), derived from the cells of the basal lamina. Numerous
studies have shown that cases ofNMSC in Caucasian populations continue to increase.
A study in south Wales found that from 1988-1998 the number of total cases ofNMSC
rose from 173.4 to 265.4 per 100,000 population (Holme et al, 2000).
Figure 1.1. Squamous cell carcinoma
In Australia, the current figures for NMSC are extremely high; a study in Queensland
between 1997-1999 found that the yearly age-standardised incidence of BCC per
100,000 population was 1444.8 for men and 942.7 for women. For SCC the rates were
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805 for men and 423.6 for women (Raasch and Buettner, 2002). Other studies in
Sweden and the USA have demonstrated that the incidence ofNMSC has greatly
increased over the last 30 years (Dahl et al, 1992, Karagas et al, 1999).
Figure 1.2. Basal cell carcinoma
Melanoma (Figure 1.3), although less prevalent than the NMSC, is the most
common fatal malignancy in young adults; many studies have shown that the incidence
ofmelanoma has also increased, for example in Norway (Moan and Dahlback, 1992)
and the USA (Elder, 1995). A Scottish study (MacKie et al, 2002) found that from 1979
to 1998 melanoma incidence per 100,000 increased from 3.5 to 10.6 for men, and from
7.0 to 13.1 for women.
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1.2.2 - Sunlight exposure and skin cancer
The risk factors for skin cancer point to a role for sunlight exposure. The
incidence ofNMSC is higher in areas of high ambient solar irradiance, such as
Australia, related to occupational exposure to sunlight, and increased on sun-exposed
parts of the body (Kricker et al, 1994). Skin cancer is more prevalent in Caucasian
populations, compared with those with more pigmented skin. In a Califomian study, the
incidence ofmelanoma in Blacks was 1.0 (female) and 0.7 (male) per 100,000
population, whereas the incidence in non-Hispanic whites was 17.2 (female) and 11.3
(male) (Cress and Holly, 1997).
Figure 1.3. Melanoma
The most important risk factor for SCC is thought to be cumulative lifetime
sunlight exposure (Vitasa et al, 1990; English et al, 1998). SCC is found mostly on the
5
most sun exposed sites, such as the upper face, neck, ears and hands, and can progress
by stages; sun-damaged epithelium, actinic keratosis, carcinoma in situ and SCC.
The role of sunlight exposure in BCC is less clear. Sun exposure appears to
induce BCC at lower levels; this is thought to be due to a lower dose of radiation being
required for transformation of the highly mitotic cells of the basal lamina, compared
with the keratinocytes that give rise to SCC (Rosso et al, 1996). One study found that
the incidence ofBCC in Norway increased with decreasing latitude (Moan and
Dahlback, 1992); however, this has not been seen in other studies (Kricker et al, 1994).
BCC are commonly found on sun exposed sites, including the head and neck. However,
BCC is increasingly found on sites, such as the trunk, that are exposed less frequently to
the sun (Kricker et al, 1994). A study in western Australia suggested that intermittent
exposure to sunlight caused increased risk of BCC compared with a more continual
exposure (Kricker et al, 1995).
Like BCC, the incidence of cutaneous malignant melanoma is not linked to
cumulative lifetime sunlight exposure; melanoma is more common in indoor, rather
than outdoor workers, and as well as being found on the face and neck, it is found on
less frequently exposed areas such as the trunk (males) and lower limbs (females)
(Elder, 1995). Studies in humans have suggested that melanoma may arise as a result of
high dose, intermittent sun exposure, particularly during childhood (Holman et al, 1983;
Whiteman et al, 2001). Two animal studies have substantiated this observation. Using
transgenic mice that have melanocytes in a similar distribution to human skin, Noonan
et al (2001) demonstrated that a single dose ofUVR (23 minimal erythemal doses,
MED) of neonatal (3.5 days) but not adult (6 weeks) mice was sufficient to induce
melanoma later in life. In a model using the opossom Monodelphis domestica, 3 weeks
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exposure of sucklings to moderate doses ofUVB resulted in the development of
cutaneous melanoma (Robinson et al, 1998).
1.2.3 - UV and induction of skin cancer
In a study of photocarcinogenesis in hairless mice, it was demonstrated that the
wavelength ofmaximum effectiveness for tumour induction was 293 nm (in the UVB
range); there was also a shoulder ofmaximum effectiveness above 340 nm (UVA) (de
Gruijl et al, 1993). UVB induces characteristic lesions in cellular DNA, in the form of
pyrimidine dimers. Mutations arise during DNA replication, when DNA polymerase
incorporates an adenine residue (A) opposite the pyrimidine photoproducts; the
resulting C—»T (and less commonly CC—»TT) transitions are signature mutations of
UVB-induced DNA damage, and are detectable in human NMSC (Brash et al, 1991;
Ziegler et al, 1993). UVA wavelengths are thought to indirectly damage DNA through
the formation of reactive oxygen species, which cause oxidative damage, including
single-strand breaks (Kielbassa et al, 1997). Mutations in genes that code for regulators
of the cell cycle, including tumour suppressor genes, and oncogenes, have been shown
to be important in the pathogenesis of skin cancer.
DNA damage by UV induces expression of the tumour suppressor gene p53,
leading either to transient cell cycle arrest (Fisher, 1994) or apoptotic cell death (Clarke
et al, 1993), which helps to prevent survival of cells containing DNA damage.
Mutations in the p53 gene are thought to be an early event in the pathogenesis of skin
cancer (Berg et al, 1996; Ziegler et al, 1994), and occur in over 90 % of human SCC,
with 58 % being C->T or CC->TT (Brash et al, 1991); p53 mutations are also seen in
human BCC (Rady et al, 1992). p53 mutations are also present in 20-100 % tumours in
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UV-irradiated mice, the majority having C—>T or CC-»TT mutations (Kress et al, 1992;
Kanjilal et al, 1993). UV radiation also induces expression of another tumour
suppressor gene, pl6INI<4, which binds to cyclin-dependent kinases to block cell cycle
progression (Pavey et al, 1999). Inactivated pi 6 is seen in the majority of melanoma
cell lines (Rizos et al, 1999); and UV-induced C->T mutations in the pl6 gene have
been seen in melanoma in vivo (Herbst et al, 1997).
In mice, the proto-oncogene ras appears to be essential for melanoma
development (Chin et al, 1999); around 70 % of human melanomas display aberrant
activation of the gene that codes for BRAF, a protein which is activated by ras,
although they do not show a signature UVB mutation (Davies et al, 2002). UV-induced
SCC ofmice display increased ras gene expression (Flusain et al, 1990). However, the
role of ras mutations in development of human NMSC is less clear (Campbell et al,
1993).
1.2.4 Sunscreens and skin cancer
Until recently, there was little evidence that sunscreen use prevents skin cancer.
Two short-term studies had shown that sunscreen application over 7 (Thompson et al,
1993) or 24 (Naylor et al, 1995) months reduced the appearance of solar keratoses.
Protection from skin cancer by sunscreen use was shown in a recent study by Green et
al (1999), in which adults in Queensland, Australia applied sunscreen daily on the head,
neck, arms and hands for a period of 4.5 years. Compared to the non-sunscreen group
(who applied sunscreen at their own discretion) the incidence of SCC in those that
applied sunscreen daily was significantly reduced from 1832 to 1115 per 100,000.
Sunscreen application had no significant effect on BCC however, possibly because SCC
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induction is related to long-term sunlight exposure, whereas BCC is thought to be
related to intermittent sun exposure. Evidence that sunscreen protects against melanoma
and BCC is lacking; however, when considering the possible link between early
incidences of sunburn and melanoma, and intermittent sun exposure and BCC, it might
be speculated that use of sunscreen earlier in life, reducing incidences of sunburn, may
protect against the induction of these skin cancers.
1.3 - Cutaneous immunity
1.3.1 - Skin physiology
The skin is the largest organ of the body and is exposed to a wide variety of
exogenous influences including UV radiation, microorganisms, chemicals and physical
damage. It is relatively impermeable to water and has an important barrier function. The
structural integrity of the skin is provided mostly by the dermis, which consists of
connective tissue of collagen and elastin fibres, into which capillaries and lymphatics
intertwine. Outside the dermis is the epidermis, made up of keratinocytes
predominantly, the outermost layer ofwhich is the stratum corneum, comprising dead
cells which then slough off.
The skin is the first point of defence against many microorganisms, and provides
both a physical barrier and protection through inhibitory substances, such as
antimicrobial peptides. In addition, the skin has a number of cells that can lead to
specific, protective immune responses (Figure 1.4); these cells make up the skin
immune system (SIS; Bos and Kapsenberg, 1986). Leukocytes in the blood extravasate
through the blood vessel wall to populate the tissue of the skin. Cells migrating out of
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the skin do so via the afferent lymphatics, which carry leukocytes from the tissues to the















Figure 1.4. Cellular components of the skin immune system.
1.3.2 - Keratinocytes
The majority of skin cells are keratinocytes, which make up the growing
component of the epidermis. In addition to this role, keratinocytes can express/release
numerous molecules involved in induction of immune responses. Human and murine
keratinocytes express the major histocompatibility complex (MHC) class II surface
antigen, involved in presentation of antigen to T cells (Section 1.3.6), upon exposure to
IFN-y (Wilkner et al, 1986). IFN-y is produced by activated T cells and natural killer
(NK) cells, and its main actions include activation ofmacrophages, upregulation of
MHC class I and II expression, and promotion of the differentiation ofCD4f T cells
towards the Thl subset (section 1.3.6). IFN-y exposure also upregulates keratinocyte
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expression of intercellular adhesion molecule (ICAM) -1 (Dustin et al, 1985), a ligand
for T cell binding.
Keratinocytes release a number of cytokines, such as the inflammatory cytokines
tumour necrosis factor (TNF)-a and interleukin (IL) -1 (Kutsch et al, 1993; Kock et al,
1990). The main actions ofTNF-a include induction of adhesion molecule expression
on vascular endothelial cells and activation ofmacrophages; IL-1 has similar
inflammatory actions to TNF-a. Murine keratinocytes have also been demonstrated to
produce the anti-inflammatory IL-10 (Enk et al, 1992), although studies have failed to
observe IL-10 production by human keratinocytes (Teunissen et al, 1997; Jackson et al,
1996). IL-10 is also produced by Th2 T cells, and inhibits the effector functions of Thl
cells; IL-10 acts to reduce production ofpro-inflammatory cytokines such as IFNy and
TNF-a, and decrease expression of co-stimulatory molecules on antigen presenting cells
(APC).
The expression of surface receptors, including MHC class II, that are important in
T cell recognition of antigen would suggest that keratinocytes could act as APC to
induce T cell responses; however, there is no definitive evidence that keratinocytes can
initiate immune responses in this way.
1.3.3 - Langerhans cells
Langerhans cells (LC) are members of the bone-marrow derived dendritic cell
lineage, and constitute around 1 % of the cells of the epidermis. They have long
dendritic processes that extend through the epidermis to form a meshwork. LC are
professional antigen presenting cells (APC) and express high levels ofMHC class II;
other surface molecules expressed on LC, that are used in combination for detection of
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these cells, include CD la (human LC), and the enzyme adenosine triphosphatase
(ATPase). LC also contain unique intracellular rod-shaped organelles known as Birbeck
granules (Birbeck et al, 1961), the function ofwhich is unclear.
LC are potent APC, capable of internalising antigen, processing it and presenting
it to T cells. Following application of antigen to the skin, LC phagocytose the antigen
and migrate to the afferent lymphatics, where they are known as veiled cells. They are
carried in the lymph to the DLN, and differentiate into interdigitating cells, expressing
high levels ofMHC Class II, enabling efficient antigen presentation to T cells in the
paracortex of the DLN. For T cell activation, both antigen presented by MHC class II
molecules and a second, co-stimulatory signal is required. LC can be induced to express
molecules involved in interaction with T cells, such as ICAM-1 (Teunissen et al, 1994),
and B7.1 and B7.2, which bind to CD28 on T cells to provide a co-stimulatory signal.
LC also release T cell activating cytokines, including IL-1 and IL-12. The principal
sources of IL-12 are macrophages and dendritic cells; IL-12 causes T cells to produce
IFN-y, promotes differentiation of Thl-type CD4+ cells, and enhances the cytotoxic
activities of CD8+ T cells and NK cells.
1.3.4 - Dermal APC
Some of the DC found in the dermis are LC precursors that are migrating from
the blood vessels towards the epidermis, or are LC moving from the epidermis to the
afferent lymphatics. There is also a distinct subset of DC resident in the dermis, that
lack CDla, BG, and ATPase; the majority of these cells appear to be more related to
macrophages, expressing CD68 and CD1 lb (Narvaez et al, 1995). In addition, cells
expressing macrophage markers such as CD14 are present (Nestle et al, 1993). The
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antigen presenting ability of dermal cells has been shown by Tse and Cooper (1990),
who demonstrated that dermal cells taken from mice and exposed to antigen in vitro are
capable of induction of an immune response upon injection into naive syngeneic mice.
1.3.5 - Mast cells
Mast cells contain numerous secretory granules, and degranulation results in
release of various preformed mediators, including histamine and TNF-a. Activation of
mast cells can occur following exposure to a number of stimuli, such as IgE and
neuropeptides. Release ofhistamine causes smooth muscle contraction and increased
vascular permeability, resulting in an influx of cells and fluid into the tissues. Dermal
mast cells have been implicated in UV-induced immunosuppression, as will be
discussed in section 1.5.5 below.
1.3.6 - T cells
T lymphocytes express a unique T cell receptor (TCR) which is antigen-specific,
and which requires antigen presentation in conjunction with MHC molecules. There are
two main subsets of T cells, CD4+ and CD8+. CD8+T cells recognise antigen presented
by MHC class I molecules, which are present on all nucleated cells, and which generally
present antigens that have originated from within the cell, such as viruses, or tumour
cell antigens. Following antigen recognition and activation of specifc CD8+ cells, these
cells then lyse the affected cell. CD4+ T cells (T helper [Th] cells) require antigen
presentation by professional APC that process and present antigen via the MHC class II
pathway; antigens presented in this way are mostly exogenous, that have been
phagoctyosed by the APC. Activation of CD4+ T cells results in release of cytokines,
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and CD4+ T cells have been further sub-divided into Thl and Th2 cells, based on the
repertoire of cytokines that they release. For example, Thl cells release IFNy, which
stimulates phagocytes, and IL-2, which is an autocrine T cell growth factor, and
stimulates CD8+ T cells. Characteristic cytokines produced by Th2 cells include IL-4,
IL-5 and IL-10; as well as being involved in some protective immune responses such as
antibody production, some Th2 cytokines can suppress the production of Thl cytokines.
The majority of skin associated T cells are found in the dermis, with a few
detectable in the epidermis. Most of these are memory T cells, that have previously been
exposed to antigen, and many of these express the homing receptor cutaneous
lymphocyte-associated antigen (CLA), that binds to E-selectin, which is expressed on
blood vessels within the skin (Berg et al, 1991). Both CD8+ and CD4+ T cells are
represented in the skin. Humans and mice differ in that the majority of T cells in human
skin express the a.p form of the TCR, while in murine skin, a significant population of
dendritic epidermal y5-TCR T cells is present.
1.3.6 - Hypersensitivity responses
Contact hypersensitivity (CH) responses are induced following application of a
chemical to the skin, and are characterised by redness and swelling in the sensitised site.
Extensive experimental evidence indicates that during the sensitisation stage of CH,
epidermal LC internalise the antigen and migrate to the draining lymph nodes (DLN),
where they stimulate differentiation and proliferation of na'ive T cells (Kimber et al,
1990; Kripke et al, 1990); these T cells then migrate back to the site of skin
sensitisation. Elicitation of CH occurs following challenge of previously sensitised
animals, with a peak response at around 24 h after exposure; migration of the already
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expanded T cells into the challenge site results in a much increased hypersensitivity
response and leukocyte recruitment than that seen after a single application. Thl cells
are thought to be the most important cells in mediating CH, promoting increased release
of proinflammatory cytokines, including IL-1, IFN-y and TNF-a (reviewed in Ullrich,
1995).
Delayed type hypersensitivity reactions are mounted following subcutaneous
exposure to more complex antigens such as allogeneic cells, or infection with a
microorganism.
1.4- Immunity to cutaneous tumours
1.4.1 - Skin cancer and immunosurveillance
The theory of immunosurveillance states that the immune system protects against
the development of cancers, by recognition and elimination of transformed cells
(Burnet, 1970). Control of tumour outgrowth by the immune system is thought to be
particularly important in skin cancers. Histological examination of skin cancers in
humans reveals a mononuclear inflammatory infiltrate around almost all SCC
(Kohchiyama et al, 1986) and over 60% of BCC (Habets et al, 1988), with a few cells
infiltrating the tumour nests. Immunohistochemical analysis of human BCC found that
the majority of infiltrating cells were T cells (50-75%); the remaining cells included
macrophages (16%), LC (4-15%) and NK cells (4%) (Habets et al, 1988; Kohchiyama
et al, 1986; Synkowski et al, 1985). Additionally, a proportion ofmelanomas and BCC
undergo spontaneous regression, accompanied by increased numbers of infiltrating T
cells compared with non-regressing lesions (Hunt et al, 1994; Tefany et al, 1991).
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Actinic keratoses, the pre-malignant stage of SCC, can also undergo spontaneous
regression, which is thought to be due to a host immune response (Marks et al, 1986).
The incidence of skin cancer in patients who are being treated with
immunosuppressive agents has been found to be greater than that in the general
population. Numerous studies have found increased incidences ofNMSC in renal
allograft patients (Boyle et al, 1984; Hartevelt et al, 1990); in Australia the incidence
was found to exceed 40%, 9 years post-transplant (Hardie et al, 1980). Studies of heart
transplant patients have found that 15% of patients developed at least one cutaneous
neoplasm (BCC or SCC), within 5 years of transplantation (Espana et al, 1995; Caforio
et al, 2001). The incidence ofmelanoma in renal transplant patients is also increased
(Greene et al, 1981). Patients receiving immunosuppressive agents for reasons other
than transplantation also show higher incidences of pre-malignant and malignant skin
lesions (Marshall, 1974). Anecdotal evidence also suggests that NMSC in
immunosuppressed patients behave more aggressively (Weimar et al, 1979), implying
that the immune system, as well as preventing the appearance of neoplastic lesions, also
controls the outgrowth of existing tumours.
The immune system also appears to be important in experimentally UV-induced
skin cancer in mice; a study of photocarcinogensis in hairless mice demonstrated that
treatment with the immunosuppressive drug azothioprine resulted in enhanced tumour
induction (Koranda et al, 1975).
1.4.2 - Antigenicity of UV-induced tumours
Many skin tumours induced experimentally in mice by chronic UV exposure are
antigenic, such that if these tumours are transplanted into normal mice, they are
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rejected; however, the tumours grow progressively if they are transplanted into
thymectomised, x-irradiated mice (Kripke, 1974). Mice immunised with tumour
fragments were resistant to subsequent challenge with the same tumour, whereas mice
immunised with a different tumour from that used for challenge were equally
susceptible to challenge as unimmunised mice (Kripke, 1974). Thus, tumours induced
by UV exposure express tumour-specific antigens (TSA), which are not found on other
UV-induced tumours, or on normal cells. In vitro UV irradiation of a weakly antigenic
melanoma cell line generated antigenic variants; an in vivo immunisation and challenge
assay demonstrated that the immunity generated against one variant failed to protect
against challenge with other antigenic variants (Hostetler et al, 1989). CD8+ cytotoxic
clones generated by immunisation with UV-induced tumours, and maintained in culture,
were found to be uniquely specific for the particular tumour used for immunisation, as
measured by their in vitro cytotoxicity (Ward et al, 1989).
UV-induced tumours also express tumour-associated antigens (TAA); these are
proteins that may be found on normal cells, but which are over-expressed on tumour
cells. In humans, a number ofmelanoma antigens have been described, the majority of
which appear to be either developmental antigens, or differentiation antigens of
melanocytes (Pardoll, 1994).
1.4.3 - Antigen presenting cells
LC, by nature of their professional antigen presentation ability, and location in
the epidermis, are the most likely cells involved in induction of immune responses to
UV-induced skin tumours. The number of tumour infiltrating LC does not appear to
indicate the effectiveness of the anti-tumour immune response (Srnolle et al, 1986). An
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increase in the number of LC in the epidermis overlying BCC has been observed
(Yamaji et al, 1987); however, a decrease in epidermal LC in BCC has also been
reported (Bergfelt et al, 1992). The morphology of LC near BCC is altered, showing
thicker and fewer dendrites (Bergfelt et al, 1994). Presentation of tumour antigens by
APC in humans was investigated in a study by Nestle et al (1998), where DC were
generated from peripheral blood of melanoma patients and then pulsed with tumour
antigen. Vaccination of the patients with these DC resulted in regression or partial
regression in 5 out of 16 patients.
The majority of evidence for the role of antigen presentation in tumour immunity
has come from animal models. Grabbe et al (1991) immunised mice 3 times at weekly
intervals with Thy-1 depleted epidermal cells (EC) pulsed with tumour fragments of a
chemically induced fibrosarcoma. Mice receiving tumour antigen-pulsed syngeneic EC
demonstrated protective immunity to subsequent challenge with live tumour cells, and
were also able to mount a DTH response to killed tumour cells; induction of immunity
required culture of the EC in granulocyte-macrophage colony stimulating factor (GM-
CSF) prior to antigen pulsing. Further studies demonstrated that this ability of epidermal
LC to induce tumour immunity could be abrogated by culture of the cells in IFN-y or
IL-10, but not TNF-a (Grabbe et al, 1994; Beissert et al, 1995; Grabbe et al, 1992).
Using this model, the ability of antigen-pulsed LC to elicit a DTH response in mice that
had been immunised with whole tumour cells was also shown; this was inhibited by
culture of the LC in IFN-y or IL-10, but augmented by culture of the cells in TNF-a.
The ability of APC to elicit a response to tumour antigen in vitro was demonstrated by
Cohen et al (1994), where T cells from hyperimmune mice proliferated in response to
tumour antigen-pulsed epidermal LC or splenic DC from nai've mice.
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Dermal I-A+ cells pulsed with tumour-antigen in a similar system to that used by
Grabbe et al (1991) were also able to induce tumour immunity when used to immunise
mice; as seen with epidermal cells, these dermal APC could also elicit DTH responses
in mice immunised with killed tumour cells (Campton et al, 2000).
Sluyter et al (2001) transplanted skin overlying subcutaneous tumours (resulting
from injection of cells from a UV-induced fibrosarcoma) onto nai've mice. This resulted
in induction of tumour immunity in the nai've mice, suggesting that APC in the
epidermis and dermis of the tumour-bearing mice contained sufficient levels of antigen
to induce an immune response in the recipient mice. Lucas and Halliday (1999) found
that FITC-induced migration of LC from the epidermis overlying progressor tumours to
the draining lymph nodes (DLN) was inhibited by a factor released by the tumours. LC
migration was not inhibited from epidermis overlying regressor tumours however,
implying that induction of an effective immune response to tumours requires migration
of LC to DLN.
The y§+ DETC population resident in murine epidermis may also be important in
tumour immunity. yS+ "transgenic mice show increased susceptibility to an injected
SCC line (Girardi et al, 2001). When mixed with murine melanoma cells, DETC have
been shown to prevent tumour growth after intradermal injection (Love-Schimenti and
Kripke, 1994). Following culture in IL-2, DETC cell lines show in vitro cytotoxicity
towards a range of skin tumour cell lines, including melanomas (Kaminski et al, 1993)
and UV-induced fibrosarcomas (Okamoto et al, 1988) but not normal keratinocytes.
This effect is thought to be mediated by a surface glycoprotein, 2B4, which is also
found on natural killer (NK) cells (Schuhmachers et al, 1995). DETC have also been
implicated in induction of protective T cell immunity. Cavanagh et al (1997)
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demonstrated that a single immunisation with tumour antigen-pulsed DETC, followed
by a single immunisation with a low dose of live tumour cells induced protective, long-
term tumour immunity.
1.4.4 - T cells
Studies of human BCC have found that the majority of tumour infiltrating T cells
express markers of activated T cells (Synkowski et al, 1985; Habets et al, 1988).
Almost all of the T cells infiltrating human SCC were found to bear the ap TCR and
these were demonstrated to be cytotoxic towards autologous tumour cells in vitro
(Haeffner et al, 1997). Analysis of the variable p chain usage of infiltrating T cells
from human BCC and SCC demonstrated that certain variable P chain families were
overrepresented in tumour-infiltrating lymphocytes, compared with T cells from the
blood of the same patient, suggesting that clonally expanded T cells may contribute to a
specific immune response to NMSC (Ohmen et al, 1994).
Both CD4+ and CD8+ T cells are thought to be involved in the specific immune
response to skin tumours. In vitro experiments have demonstrated that lysis of SCC
cells by cell lines derived from autologous tumour-infiltrating lymphocytes is dependent
on MHC class I expression (Chikamatsu et al, 1994), indicating that the cytotoxic
immune response requires CD8+ T cells. Expansion in vitro of cells from LN draining
melanomas in mice resulted in a population of predominantly CD8+ T cells, which
showed specific cytolytic activity in a MHC class I restricted manner; adoptive transfer
of these cells, with co-injection of IL-2, showed a significant anti-tumour effect against
metastatic melanoma in mice (Harada et al, 1996).
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Studies have found that, in regressing human BCC and melanomas, the number
of infiltrating CD4+ cells was increased, whereas there was no difference in the number
of infiltrating CD8+ and macrophages compared with progressing tumours (Hunt et al,
1994; Tefany et al, 1991), suggesting that CD4+cells are most important in mediating
skin tumour destruction.
Animal studies have also demonstrated the central role of CD4+ cells in immune
responses to skin tumours. Regression of a UV-induced tumour cell line in mice was
associated with an increase in helper T cell activity, which was detectable in the
environment of the regressing tumour (Romerdahl and Kripke, 1988). Hung et al (1998)
immunised wild-type, CD8_/" and CD4"/_ mice with B16 melanoma cells, then assessed
induction ofprotective tumour immunity by challenge with the melanoma cells. The
majority ofwild-type mice were able to mount a protective immune response; however,
whereas none of the CD4mice were protected from tumour challenge; a significant
proportion of the CD8' " mice were able to mount tumour rejection. It has also been
demonstrated that transfer ofCD4+ tumour-specific T cells into SCID mice can cause
rejection ofUV-induced tumour cells, and that this effect is dependent on IFN-y;
additionally, the IFN-y did not act directly on the tumour cells themselves, suggesting
that tumour immunity by CD4+ T cells may be mediated by activation of effector cells
such as macrophages (Mumberg et al, 1999).
1.4.5 - Other effector cells
NK cells are thought to play a role in tumour immunosurveillance by recognition
and destruction of cells with decreased MHC class I expression, such as transformed
cells. A decrease in MHC class I expression in BCC has been reported (Hua et al,
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1985). Kohchiyama et al (1986) observed numerous NK cells in close contact with
tumour cells in human SCC. Human BCC could be successfully transplanted into
athymic mice with impaired NK cell function (nude mice), without the need for the
further immunosuppression that is required in mice with intact NK cells (Grimwood et
al, 1988). Additionally, transfer of human NK cells into NK cell-depleted SCID mice
provided some protection against two human melanoma cell lines when co-injected with
IL-2 (Hill etal, 1994).
Macrophages are also present in substantial numbers in the tumour infdtrate of
human and murine skin tumours (Habets et al, 1988; McBride et al, 1992). They may
contribute to cytotoxic killing of tumour cells, following activation by cytokines
expressed by T cells; alternatively they may be involved in presentation of tumour
antigens.
1.4.6 - Alteration of immune responses by tumours
A number of studies have found that tumours can cause suppression of immune
responses, which may aid their escape from immunosurveillance mechanisms. Tumour
infdtrating lymphocytes from melanoma and BCC patients demonstrated suppressed
proliferative responses following in vitro mitogenic stimulation (Miescher et al, 1986).
In the same study, it was seen that normal peripheral blood lymphocytes exposed in
vitro to tumour cells or their supernatants also lost their ability to respond to mitogenic
stimulation.
Measurement of cytokine levels following culture ofwhole blood from skin
cancer patients found no alterations in cytokine production by cells from BCC patients;
however, melanoma patients demonstrated decreased levels of IL-2, IFN-y and TNF-a
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(Elasser-Beile et al, 1993). It is possible that this may be a result of the tumours, or it
may be that alterations in cytokines in these patients has allowed the outgrowth of the
melanomas. Melanoma cell lines have been shown to produce certain cytokines in
culture, such as IL-10 and TGF-P, which could have immunosuppressive activities
(Bennicelli and Guerry, 1993).
Tumour cells may also interfere with antigen presentation; incubation of
monocyte-derived DC in the culture supernatant from a melanoma cell line resulted in
altered maturation of these cells, such that they were unable to produce IL-12; these
cells then rapidly underwent apoptosis (Kiertscher et al, 2000).
1.5 - UV-induced immunosuppression
1.5.1 - Suppression of immune responses
A large number of human and animal studies have demonstrated the suppressive
effects ofUV exposure on immune responses, particularly cell-mediated immune
responses. UV irradiation suppresses the induction of hypersensitivity responses in
humans and mice (Yoshikawa et al, 1990; Noonan et al, 1981). Animal studies have
shown that UVB exposure enhances susceptibility to infectious diseases, as determined
by microbial load or mortality; decreased resistance to bacteria, fungi, parasites and
viruses has been observed in irradiated animals. As will be discussed in section 1.6,
UVB-induced immunosuppression also plays a role in outgrowth of skin tumours.
1.5.2 - Initiators of immunosuppression
UV exposure can cause local suppression of responses, when antigen is applied to
the irradiated skin, or systemic suppression of responses to an antigen applied to a site
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distant from the irradiated skin. Wavelengths within the UVB range do not penetrate
past the upper layer of the dermis; therefore it is thought that to initiate systemic
suppression, UV acts via a photoreceptor in the skin. Two skin chromophores that
absorb UVB, and that have been shown to have a role in UV-induced immune
modulation, are urocanic acid (UCA) and DNA, both ofwhich are discussed below.
The trans isomer ofUCA is formed by the deamination of histidine by the
enzyme histidase (Figure 1.5). During keratinisation, the histidine-rich proteins of
keratohyalin granules break down, and, once the cells become impermeable, the
histidase enzyme becomes activated, converting histidine to UCA (Scott et al, 1982).
The enzymes required for the metabolism ofUCA are present in the liver, however they
are absent from the skin, resulting in the accumulation of trans-UCA in the stratum
corneum (Scott, 1981), such that it represents up to 0.7% of the dry weight of the
epidermis.
The first evidence for UCA as a photoreceptor for UV-induced
immunosuppression came from experiments by De Fabo and Noonan (1983), who
demonstrated that the action spectrum ofUV-induced suppression of CH matched the
absorption spectrum of UCA, and that tape-stripping ofmurine skin to remove the
stratum corneum prior to irradiation reversed UV-induced systemic suppression of CFI.
On exposure of trans-UCA to UV, it is photoisomerised to form cA-UCA (Figure
1.5), in a dose-dependent fashion, until a photostationary state is reached, when the two
isomers are present in approximately equal quantities. The most effective wavelengths
for cis- to trans-UCA isomerisation in human skin were shown to lie between 280-310
nm (Gibbs et al, 1997), while the action spectrum for isomerisation in mouse skin has











Figure 1.5. Biochemical formation and photoisomerisation of UCA isomers
Once formed cA-UCA persists in the skin for up to two weeks, and is shed along
with dead keratinocytes and sweat. CA-UCA has also been detected in the serum for at
least two days after UVB-irradiation ofmice (Moodycliffe et al, 1993) and in the urine
ofUVB-exposed human volunteers for up to 12 days after exposure (Kammeyer et al,
1997); thus, after UV exposure, cA-UCA is present systemically, and may act at sites
distant from the skin.
A large number of studies in animal models have demonstrated the ability of cis-
UCA to suppress immune responses. For example, treatment ofmice topically with cis-
UCA prior to contact sensitisation suppressed the CH response to oxazalone (Lauerma
et al, 1995). Topical cA-UCA treatment also suppressed DTH responses to herpes
simplex virus (HSV, Ross et al, 1986). Multiple subcutaneous injections of cA-UCA
before and after oral infection of rats with the parasitic worm Trichinella spiralis
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resulted in increased numbers of T. spiralis larvae in the muscle tissue of infected rats,
and a significantly impaired DTH response to T. spiralis antigen (Garssen et al, 1999).
Additionally, the development of a monoclonal antibody specific for cA-UCA
(Moodycliffe et al, 1993) has permitted investigation of the role of cA-UCA in UV-
induced immunosuppression. Injection of cA-UCA antibody prior to UVB exposure
abrogated the UV-induced suppression ofDTH to alloantigen (Moodycliffe et al, 1996),
and UV-induced suppression of immune responses to T. spiralis in rats (Garssen et al,
1999). Injection of cA-UCA antibody prior to UV exposure did not reverse UV-induced
suppression of CH however (El-Ghorr and Norval, 1995; Moodycliffe et al, 1996),
suggesting that cA-UCA mediates some, but not all of the immunosuppressive effects of
UV.
CA-UCA may cause immune suppression via effects on antigen presenting cells.
Application of cA-UCA to the skin caused a significant decrease in the number of
epidermal LC (Norval et al, 1990), while injection of cA-UCA antibody prior to UV
exposure prevented the UV-induced reduction in epidermal LC numbers (El-Ghorr and
Norval, 1995). Dendritic cells taken from cA-UCA treated mice demonstrated
significantly impaired APC ability in vitro (Noonan et al, 1988); however, addition of
cA-UCA to LC or cultured DC in vitro failed to affect their allostimulatory funtion
(Rattis et al, 1995; Lappin et al, 1997), suggesting that in vivo, cA-UCA influences
APC function indirectly, through induction of secondary mediators. It has been
suggested that cA-UCA may act through induction of cytokine release, however, studies
to examine the in vitro effects of cA-UCA on cytokine release by keratinocytes (Zak-
Prelich et al, 2001; Redondo et al, 1996) and monocytes (Laihia et al, 1994) have failed
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to demonstrate alterations in release of cytokines, including IL-1, IL-10, TGF-P and
TNF-a, following cA-UCA treatment.
The effects ofUCA on other cells include suppression of human neutrophil
activation in vitro by treatment with cis- or trans-UCA (Kivisto et al, 1996), and
degranulation ofmast cells by cA-UCA treatment of human skin organ cultures (Wille
et al, 1999). In one study, cis- but not trans-UCA inhibited human in vitro NK cell
activity in a dose-dependent manner (Gilmour et al, 1993); however another study
showed that trans-UCA suppressed human NK cell function, while cA-UCA had no
effect (Uksila et al, 1994).
It was originally thought that, as cA-UCA and histamine are structurally related,
cA-UCA could act via histamine receptors, and it was demonstrated that treatment of
mice with histamine receptor antagonists blocked the suppression ofDTH by cA-UCA
(Norval et al, 1990); however, cA-UCA does not bind to histamine receptors (Laihia et
al, 1998). More recently, Flart et al (1997) demonstrated that the suppressive effects of
cA-UCA and histamine on CH responses were not cumulative, suggesting that cA-UCA
and histamine signalled through the same pathway. CA-UCA does not act directly on
mast cells to cause degranulation and histamine release, but is thought to mediate this
effect via neuropeptides released from sensory nerve fibres, such as calcitonin gene-
related peptide (CGRP) and substance P (Khalil et al, 2001). CA-UCA is structurally
related to serotonin, and recent evidence suggests that cA-UCA may act via the
serotonin receptor (S. Ullrich, personal communication).
As discussed in section 1.2.3, UV is strongly absorbed by DNA, leading to the
induction ofmany genes, such as the p53 tumour suppressor gene. UV absorption by
DNA is also involved in suppression of immune responses. Induction ofDNA strand
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breaks by topical application of restriction endonucleases to mouse skin impaired the
induction of CH and DTH responses (O'Connor et al, 1996; Nishigori et al, 1998);
treatment with restriction endonucleases also induced TNF-a and IL-10 in murine
epidermis, and in vitro production of IL-10 and TNF-a by a murine keratinocyte cell
line.
Application of the DNA excision repair enzyme T4 endonuclease V, which
increases repair of cyclobutyl pyrimidine dimers (CPD), following UV exposure
partially protected against UV-induced suppression ofCH, and UV-induced
morphological effects on epidermal LC (Wolf et al, 1995). Treatment of irradiated mice
with T4 endonuclease also reduced the number of CPD+ cells in the DLN, and restored
the antigen presenting activity of these cells, suggesting a role for DNA damage to APC
in UV-induced immunosuppression (Vink et al, 1996). This was further substantiated
by the isolation of APC from the DLN of UV-irradiated, FITC-sensitised mice, which
were treated with liposomes containing a photolyase enzyme, followed by
photoreactivating light. This treatment decreased the number of cells containing CPD,
and restored their antigen presenting ability upon injection into naive recipients,
preventing the induction of transferable regulatory cells in these mice (Vink et al,
1997).
Recently, Cruz et al (2000) demonstrated that topical application of thymidine
dinucleotides to mouse skin caused suppression of CH, and that intradermal injection
resulted in activation of the TNF-a gene. These studies imply that UV-induced DNA
damage of skin APC may act to alter their ability to present antigen. At the same time,
DNA damage by UV in keratinocytes leads to the production of cytokines such as IL-
10, IL-6 and TNF-a, which may influence antigen presentation by APC.
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1.5.3 - Effects of UVR on APC
It has been suggested by Bacci et al (2001) that irradiation of skin transiently
inhibits the migration of LC out of the epidermis, thus preventing antigen presentation
by these cells in the DLN. However, the majority of studies have demonstrated that UV
exposure of skin causes a reduction in the number of human and murine LC, and
alterations in the morphology of the remaining LC (Aberer et al, 1981; Duthie et al,
2000; Kolgen et al, 2002). Although in vitro UV exposure causes apoptosis of LC
(Rattis et al, 1998), experiments in mice and sheep indicate that loss of LC from the
epidermis following skin irradiation is due to enhanced migration of LC out of the skin,
to the DLN (Moodycliffe et al, 1992; Dandie et al, 2001). Loss of epidermal LC was
reversed by antibodies to IL-1 and TNF-a (Duthie et al, 2000). Suppression of CH
following UV exposure may be related to loss of available APC in the skin at the time
of antigen application, however, Noonan et al (1984) demonstrated that the waveband
dependencies differ for alteration in LC and suppression of CH, implying that the
relationship between UV-induced suppression and APC is more complex than this.
UV-induced immunosuppression may arise from alterations in the antigen-
presenting function of epidermal cells. T lymphocytes cultured with autologous EC
from irradiated human skin showed decreased antigen-induced proliferation compared
with EC taken from unirradiated skin (Rasanen et al, 1989); the skin was taken 2 h after
UV exposure, therefore there was no significant decrease in epidermal LC numbers
compared with unirradiated skin. Similarly, in vitro exposure ofmurine epidermal cells
to UV prior to antigen-pulsing caused a reduction in their ability to stimulate
proliferation of syngeneic immune T cells (Stingl et al, 1983). The decrease in antigen
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presenting ability of irradiated EC may result from the reduced expression of the co-
stimulatory molecules required for T cell activation, leading to anergy of the T cells. In
vitro UV exposure has been observed to result in decreased upregulation ofB7.2
expression by human LC (Rattis et al, 1998) and decreased upregulation of B7.1 and
B7.2 by murine LC (Denfeld et al, 1998). ICAM-1 expression by LC has also been
shown to be subject to modulation by UV (Tang and Udey, 1991).
Alternatively, UV-induced suppression ofCH responses may result from
alteration in the immune responses generated by the irradiated APC. CH is primarily
driven by Thl cells, requiring IL-12 from APC. Simon et al (1990) demonstrated that
irradiated, antigen-pulsed murine LC were capable of stimulating antigen-specific Th2
cell lines, but not Thl cell lines. Analysis of DC from lymphoid organs of irradiated
mice indicated that following antigen-pulsing these cells produced significantly less IL-
12 than DC from unirradiated mice. Incubation of these cells with antigen-specific T
cells caused T cell proliferation. However, supernatants from the irradiated-DC cultures
contained markedly less IFN-y (Kitazawa and Streilein, 2000).
Loss of epidermal LC following skin irradiation is accompanied by an influx of
inflammatory cells, including neutrophils, macrophages, and monocyte-derived APC
(Cooper et al, 1993). In vivo administration of irradiated mice with CD1 lb antibody
blocked infiltration of the monocyte/macrophage cells into the irradiated skin, and
completely restored CH responses (Hammerberg et al, 1996); thus, alternative antigen
presentation by infiltrating monocyte-derived APC may represent another mechanism
by which UV induces suppression in place of an active immune response. These
CD1 lb+ infiltrating macrophages have been shown to be potent producers of IL-10
(Kang et al, 1994). In addition, a recent study has shown that a high number of the
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neutrophils infiltrating irradiated dermis and epidermis stain positive for intracellular
IL-4, which may affect the Thl/Th2 balance (Teunissen et al, 2002).
1.5.4 - Effects of UVR on keratinocytes
UV exposure of the skin can induce the formation of 'sunburn cells' in the
epidermis; these cells are keratinocytes undergoing apoptosis as a result ofDNA
damage by UV. Irradiation of keratinocytes has also been shown to induce a variety of
cytokines, including TNF-a, IL-6 and IL-10; production of these cytokines is thought to
result from UV-induced DNA damage (Kibitel et al, 1998; Petit-Frere et al, 1998;
Nishigori et al, 1996). Rivas and Ullrich (1992) demonstrated that injection of
supernatants from irradiated keratinocytes resulted in suppression ofDTH responses in
mice; this effect was blocked by anti-IL-10 antibody. Thus, keratinocytes may
contribute to UV-induced immunosuppression through production of cytokines that
down-regulate immune responses, such as IL-10.
1.5.5 - Effects ofUVR on mast cells
Subcutaneous injection of histamine prior to sensitisation suppressed systemic
CH responses in mice, and administration of histamine antagonists approximately
halved UVB-induced immunosuppression ofCH (Hart et al, 1997). Treatment with
indomethacin partly blocked histamine-induced suppression, suggesting that histamine
could suppress immune responses via prostaglandin production. The most likely source
of histamine in irradiated mice is mast cells, which also release TNF-a and IL-4. Using
mast cell-depleted mice, Hart et al (1998) demonstrated the critical role of dermal mast
cells in UV-induced immunosuppression. Unlike wild type mice, exposure of these
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mice to UVB did not result in systemic suppression of CH responses, nor were these
mice susceptible to UV-induced suppression of DTH responses to allogeneic spleen
cells. These mice did remain susceptible to local suppression of CH responses by UVR
however. Reconstitution of the skin ofmast cell-depleted mice with bone marrow-
derived mast cell precursors from wild type mice, prior to UV exposure, restored
susceptibility to UV-induced suppression of systemic CH responses in these mice.
Mast cells did not degranulate following direct UVB exposure (Danno et al,
1988), suggesting that UV causes mast cell degranulation via release of mediators, such
as neuropeptides. In sensory-nerve depleted mice, UV exposure failed to induce
systemic suppression of a CH response; treatment of wild type mice with a CGRP
antagonist reversed UV-induced immune suppression (Garssen et al, 1998). As
discussed in section 1.5.2, cis-UCA may cause mast cell degranulation following UV
exposure by causing release of substance P and CGRP from sensory nerves. There is
also evidence that release of nerve growth factor (NGF) by keratinocytes in irradiated
skin results in neuropeptide release by sensory nerves, leading to mast cell
degranulation (Townley et al, 2002).
1.5.6 - Effects of UVR on T cells
UV exposure prior to contact sensitisation induces transferable antigen-specific
regulatory (also known as suppressor) T cells to haptens applied to the irradiated site
(Toews et al, 1980; Glass et al, 1990). Transfer ofDLN cells from UV-irradiated,
fluorescein isothiocyanate (FITC)-sensitised mice to naive recipients, followed by
challenge of the recipients with FITC, resulted in the induction of transferable
regulatory cells in the spleens of these mice, which was dependent on the presence of
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Thyl.2+ and CD4+ cells in the DLN cell suspensions (Saijo et al, 1995). Injection of
FITC-bearing DLN cells from unirradiated mice into UV-irradiated recipients, followed
by challenge of the recipients with FITC, failed to induce a CH response, and resulted in
fonnation of regulatory T cells; this effect was blocked by treatment of the UV-
irradiated recipients with anti-TNF-a (Saijo et al, 1995). Thus, UV-induced transferable
regulatory T cells can occur in the absence of altered antigen presentation, and may
depend on TNF-a.
To further characterise these UV-induced regulatory cells, hapten-specific cell
lines and clones were established from the LN of irradiated and unirradiated FITC-
sensitised mice. These cells were CD4+ and TCRa.p+, and proliferated in response to
APC taken from sensitised animals; however, whereas cell lines from unirradiated mice
were Thl like, producing large amounts of IFN-y, but little IL-4 or IL-10, cloned cells
from irradiated mice produced IL-10, but no IL-4 or IFN-y, and blocked APC functions
and IL-12 production in vitro (Shreedhar et al, 1998).
More recently, Schwarz et al (2000) demonstrated that depletion ofCTLA-4+
cells prior to injection of LN cells from irradiated, dinitrofluorobenzene (DNFB) mice
into nai've recipients prevented the transfer of suppression to these mice. Additionally,
UV-induced tolerance and transfer of suppression of CH could be prevented by in vivo
injection of anti-CTLA-4. CTLA-4 is able to ligate B7.1 and B7.2, but unlike CD28,
CTLA-4 is thought to provide a regulatory, rather than a co-stimulatory signal, blocking
T cell activation (Walunas et al, 1996). In vitro stimulation ofCTLA-4+ cells from
irradiated, sensitised mice results in secretion of high levels of IL-10, TGF-P and IFN-y,
with low level of IL-2, and no IL-4 (Schwarz et al, 2000). Additionally, treatment of
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UV-CTLA-4+ cell recipients with anti-IL-10 prevented transfer of tolerance to these
mice.
Moodycliffe et al (2000) investigated the role ofNKT cells in UV-induced
suppression ofDTH responses to Candida albicans. NKT cells express intermediate
amounts ofT cell receptor molecules, coexpress surface antigens normally found on NK
cells, have a restricted T cell receptor usage, are CD4+, restricted by CD1, and secrete
IL-4. While transfer of T cells from irradiated, C. albicans immunised mice to C.
albicans-sensitised syngeneic recipients resulted in suppression of the DTH response,
removal ofNKT cells from the T cell suspension abrogated the suppression.
The results of Schwarz et al (2000) and Moodycliffe et al (2000) indicate that
different types of regulatory T cells are involved in UV-induced suppression ofCH and
DTH responses. The cytokines produced by these regulatory cells point to a general
shift away from Thl responses towards the production of Th2 cytokines following UV
exposure.
1.6 - UV-induced suppression of tumour immunity
1.6.1 - UV exposure and growth of UV-induced tumours
As described in section 1.4.1, the majority ofUV-induced tumours in mice are
rejected upon transplantation to immunocompetent hosts. Kripke and Fisher (1976)
demonstrated that a short course ofUV irradiation, as little as two weeks, made mice
susceptible to challenge with a UV-induced tumour, which grew progressively in these
mice. This result was confirmed by Daynes et al (1977). UV exposure did not affect
established anti-tumour responses however, such that irradiation of mice previously
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immunised against a UV-induced tumour did not alter their ability to reject tumour
challenge (Kripke and Fisher, 1976). Parabiosis of two mice, one UV-irradiated and one
untreated, followed by tumour implantation, resulted in progressive tumour outgrowth
in both the irradiated and unirradiated mice; this suggested that prior UV exposure
resulted in an active, systemic suppression (Fisher and Kripke, 1977). Splenic
lymphocytes from tumour-bearing mice exhibited tumour-specific cytotoxicity in vitro\
irradiation prior to tumour-implantation abrogated this in vitro cytotoxicity. Transfer of
lymphoid (spleen and lymph node) cells from UV-irradiated to x-irradiated mice
resulted in progressive growth of implanted tumours in the recipient mice, indicating the
immunological nature of this suppression. (Fisher and Kripke, 1977).
The role ofUV-induced immunosuppression in photocarcinogensis in humans is
less easy to establish. The increased incidence of skin cancer in transplant patients
taking immunosuppressive drugs, that have high levels of sun exposure, may result
from the greater sun exposure causing more mutagenic events. However, it has been
suggested that in those patients with high sun exposure, UV-induced
immunosuppression may exert an additive effect on their already immunosuppressed
state (Boyle et al, 1984; Caforio et al, 2001). Yoshikawa et al (1990) tested the effect of
low dose UVB exposure on CH responses in NMSC patients and healthy controls; more
than 90% of skin cancer patients demonstrated susceptibility to UVB-induced
suppression, compared with only 40% of controls. This implied that skin cancer patients
are more susceptible to UV-induced immunosuppression, which may allow outgrowth
of antigenic UV-induced tumours.
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1.6.2 - Regulatory cells and UV-induced suppression of anti-tumour responses
The role of T 'suppressor' cells in outgrowth ofprimary UV-induced tumours
was shown by injection of T-cell enriched lymphoid cells to mice during
photocarcinogenesis; mice receiving T cell from UV-irradiated donors developed more
tumours than mice receiving T cells from normal mice (Fisher and Kripke, 1982).
Whereas immune responses mounted against UV-induced antigenic tumours
showed tumour specificity, UV-induced 'suppressor' cells conferred suppression
against more than one UV-induced tumour (Kripke and Fisher, 1976). This, along with
the establishment of a cloned UV-induced suppressor T cell line that could inhibit
immune responses against a variety ofUV-induced tumours (Roberts, 1986), suggested
that UV-induced 'suppressor' cells recognise a common antigen found on UV-induced
tumours.
More recently, attempts to characterise the UV-induced T regulatory cells that
control outgrowth of tumours in irradiated mice have shown two types of T cell to be
important. Beissert et al (1999) used transgenic mice that were unable to signal via the
B7/CD28-CTLA-4 co-stimulatory pathways; chronic UV exposure of these mice
resulted in the development of fewer tumours than arose in control wild-type mice. T
cells isolated from these transgenic mice and stimulated in vitro produced significantly
less IL-4, but more IFNy than wild-type mice, suggesting that these mice have an
impaired Th2 response, and increased Thl immunity. Thus, UV-induced alteration of
the Thl/Th2 balance may be responsible for suppression of anti-tumour responses seen
following UV exposure.
In a different approach, Moodycliffe et al (2000) examined the role ofNKT cells
(described in section 1.5.6) in UV-induced suppression of anti-tumour responses.
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Reconstitution of x-irradiated mice with NKT cells from irradiated, but not unirradiated
mice resulted in progressive outgrowth of a regressor UV-induced tumour in these mice.
However, reconstitution with NKT cells failed to suppress the rejection of a regressor
chemically-induced tumour, suggesting that UV-induced NKT cells recognise UV-
induced tumours as a class, perhaps by the common antigen previously shown to be
recognised by UV-induced 'suppressor' cells (Kripke and Fisher, 1976; Roberts, 1986).
1.6.3 - Antigen presentation and UV-induced suppression of anti-tumour
responses
As discussed in section 1.5.3, UV exposure has numerous effects on epidermal
APC, including a reduction of their numbers and antigen presenting activity. As
described in section 1.4.3, mice immunised with tumour antigen-pulsed syngeneic EC
demonstrated protective immunity to subsequent challenge with live tumour cells, and
were also able to mount a DTH response to killed tumour cells. UV irradiation of the
EC prior to injection into mice abrogated their ability to induce protective tumour
immunity, and to elicit a DTH response to tumour cells (Grabbe et al, 1992). Use of
anti-TNF-a antibodies suggested that this effect ofUV was not dependent on TNF-a.
Studies of chemicals that cause promotion of tumour outgrowth have shown that
these chemicals can cause depletion of LC from the epidermis (Muller et al, 1985;
Halliday et al, 1987); therefore, loss of LC from the skin following UVB may affect the
induction of anti-tumour responses. A study by Sluyter and Halliday (2000) found that
following exposure ofmice to a single high dose ofUV, reduction in epidermal LC did
not occur until at least 4 days after irradiation, whereas increased outgrowth of
implanted tumours only occurred if the tumours were inoculated less than 4 days after
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irradiation. Although they failed to find a correlation between LC number and enhanced
tumour outgrowth, this study indicated that UV effects on tumour outgrowth were
associated with infiltration of inflammatory cells, including macrophages, into the
epidermis. As discussed in section 1.5.3 MHC class II+, CD1 lb+ macrophages present
in UV-irradiated epidermis are known to produce IL-10, and can induce tolerance to a
contact sensitiser (Kang et al, 1994; Hammerberg et al, 1996). It is possible that
alternative antigen presentation by these cells leads to the induction of regulatory cells;
alternatively, production of IL-10 by these cells may affect the induction of an effective
anti-tumour immune response.
1.6.4 - NK cells and UV-induced suppression of anti-tumour responses
One study assessed the activity ofNK cells during photocarcinogenesis of nude
mice (Toda et al, 1986). Chronic UV exposure resulted in significantly suppressed
activity, measured in vitro, of splenic NK cells from irradiated mice; this was apparent
from week 15 ofUV exposure, and continued to decrease. Tumours first appeared at 19
weeks. It is not clear whether suppression ofNK activity was important for tumour
appearance in these mice; additionally, while NK cells may have a role in protection
from photocarcinogenesis in nude mice, which lack T cells, suppression ofNK cell
activity by UV might not be an important mechanism of suppression in
immunocompetent mice.
1.6.5 - Mast cells and UV-induced suppression of anti-tumour responses
Two studies using hairless mouse models suggested that the mast cell product
histamine is involved in photocarcinogenesis. Feeding mice cimetidine, a histamine
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type 2 receptor antagonist, during chronic UV exposure reduced the number of tumours
that appeared (Matheson and Reeve, 1991). Feeding mice indomethacin, which blocks
prostaglandin production, during chronic UV exposure, also protected against later
tumour development (Reeve et al, 1995).
A recent human study found that BCC patients had a higher median dermal mast
cell prevalence than healthy controls (Grimbaldeston et al, 2000). The authors
suggested that UV exposure initiates immunosuppression through these dermal mast
cells, resulting in a permissive environment for BCC development.
1.6.6 - CA-UCA and UV-induced suppression of anti-tumour responses
Evidence from a small number of animal studies has pointed to a role for cis-
UCA in outgrowth ofUV-induced tumours. During photocarcinogenesis of hairless
mice by daily exposure to a MED ofUV, Reeve et al (1989) demonstrated that topical
application ofUCA prior to each irradiation increased both the number of tumours
produced, and the degree ofmalignancy of those tumours. In mice exposed to UV for
10 weeks, and later treated with the tumour promoter croton oil to reveal latent tumours,
mice that had received UCA topically prior to each irradiation were found to have an
increased number of latent tumours. Thus, UCA treatment appeared to promote the
survival ofUV-initiated cells, perhaps by cA-UCA-induced suppression of local
immune responses to the altered cells.
More recently, Beissert et al (2001) chronically exposed mice to UV three times
a week for 6 months; before each UV treatment, mice were injected with a monoclonal
antibody specific for cA-UCA, or an irrelevant control antibody. The probability of
development of cutaneous malignancies was significantly reduced in the mice treated
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with the anti-cA-UCA antibody, suggesting that cA-UCA formed following UV
exposure has a role in photocarcinogenesis.
CA-UCA may be important during photocarcinogenesis due to effects on
presentation of tumour antigens. As described in section 1.4.3, mice immunised with
tumour antigen-pulsed syngeneic EC demonstrated protective immunity to subsequent
challenge with live tumour cells, and were also able to mount a DTH response to killed
tumour cells. Incubation of EC in cA-UCA prior to tumour antigen pulsing abrogated
their ability to induce protective tumour immunity and to elicit a DTEI response in
tumour immune mice; incubation with trans-UCA had no effect (Beissert et al, 1997).
The effect of cA-UCA on tumour immunity could not be reversed by addition of a
histamine antagonist, or indomethacin, which blocks prostaglandin production, to the
incubation medium (Beissert et al, 1997). Elowever, addition of IL-12 to the cA-UCA
incubated EC restored their ability to induce protective tumour immunity, and to elicit a
DTH response in tumour immune mice (Beissert et al, 2001).
Attempts to investigate the role ofUCA in human skin cancers have focussed on
comparing the amounts ofUCA in the skin of cancer patients and controls. A Danish
study measured the UCA concentration in skin that is regularly exposed to UV
(forehead) or not exposed to UV (buttock); no difference in total UCA or cA-UCA
concentration in the skin of patients with a past history of BCC or malignant melanoma
compared with healthy controls was found (de Fine Olivarius et al, 1998). In a similar
study conducted in Italy, the concentration ofUCA in the skin ofNMSC patients was
measured during the summer and winter months. No difference in the concentration of
UCA or percentage of cA-UCA in the buttock skin ofNMSC patients compared with
healthy controls was seen; however, the percentage of cA-UCA in arm skin was lower
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in NMSC patients than healthy controls during the summer months, possibly due to the
patients avoiding sun exposure (de Simone et al, 2001). Additionally, the production of
cA-UCA in skin following UV irradiation has been measured. In one study, a slight
increase in cA-UCA production was seen in the skin ofBCC and melanoma patients
compared with healthy controls (de Fine Olivarius et al, 1998). A second study showed
no difference in cA-UCA production between controls and BCC patients, and a slight
decrease in cA-UCA production in the skin of melanoma patients (Snellman et al,
1999).
1.6.7 - UV-induced immunosuppression in melanoma
Evidence of the immunogencity ofmelanomas, and the development of a murine
model ofmelanoma, has led to investigations of the role ofUV-induced
immunosuppression in melanoma outgrowth in mice. As seen with other UV-induced
tumours, UV exposure ofmice prior to injection with melanoma cells resulted in an
increased incidence and size of tumours compared with those in mice not irradiated
prior to melanoma cell injection (Romerdahl et al, 1988). Injection ofmelanoma cell
into the unirradiated skin of irradiated mice had no effect on tumour outgrowth
however, indicating that UV exposure acted locally to alter tumour outgrowth in
irradiated skin. UV irradiation of x-irradiated, athymic or Thyl+ cell-depleted mice
prior to injection ofmelanoma cells had no effect on tumour outgrowth in these mice,
suggesting that immunological mechanisms have a role in UV-enhanced melanoma cell
outgrowth (Donawho and Kripke, 1991). Donawho et al (1996) demonstrated that
tumour rejection in melanoma-immune mice is suppressed when they are challenged in
a UV-irradiated site, but not in unirradiated skin following UV-exposure. Melanoma
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growth could be inhibited in normal mice ifmelanoma cells were mixed with lymphoid
cells from tumour-immune mice prior to injection; however, injection of this mixture
into previously irradiated skin resulted in tumour outgrowth. Analysis of tumour
infiltrating lymphocytes demonstrated a significant decrease in numbers of CD8+ cells
in tumours growing in a UV-irradiated site. From these experiments, UV exposure
appears to suppress the number and activity of effector cells in the irradiated site.
1.6.8 - Sunscreens and UV-induced suppression of anti-tumour responses
A study by Roberts and Beasley (1997) found that application of high sun
protection factor sunscreens prior to each irradiation protected against enhanced tumour
outgrowth seen in mice exposed to solar-simulating UV for 6 weeks prior to tumour
transplantation ofNMSC. In this and other studies (Morison, 1984; Gurish et al, 1981),
sunscreen application also prevented the induction of transferable tumour-specific
regulatory T cells in UV-irradiated mice. In contrast, Wolf et al (1994) demonstrated
that application of low sun protection factor sunscreens, which blocked UV-induced
oedema, did not protect against UV enhanced outgrowth ofmelanoma cells. Flowever, it
may that that while the sunscreens protected the mice from oedema-inducing UV doses,
the mice still received sufficient UV to cause suppression of anti-tumour responses.
1.7 - Hypotheses tested in this investigation
1.7.1 - Multiple exposures of UVB or UVA irradiation suppress immune
responses
Use of an experimental protocol with multiple UV exposures bears more
resemblance to the sunlight exposure patterns of humans, than the single, often high
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dose of UV that the majority of studies on UV-induced immunosuppression have used.
In the present study, the effect of exposure ofmice to a 3 week suberythemal UV
protocol on various immune parameters was assessed. CH responses, epidermal LC
number and dendritic cell numbers in LN draining the irradiated sites were measured
following broad-band UVB exposure ofmice, to determine whether multiple UV
exposures have similar effects to a single exposure on these immune responses. The
effects ofUVA and narrow band UVB (TL01) exposure over the 3 week period on CH
and epidermal LC number were compared with that of broad-band UVB exposure, to
assess the waveband dependence of immunosuppression following repeated UV
exposure.
1.7.2 - UVA-I irradiation can contribute to tumour outgrowth by suppressing
immune responses to tumours
UVB exposure is thought to have a dual role in photocarcinogenesis, inducing
DNA damage that gives rise to neoplastic cells, and suppressing immune responses
that might otherwise destroy these transfonned cells. Although less effective than
wavelengths within the UVB range, wavelengths above 340 nm (UVA) cause
carcinogenesis in the hairless mouse. In the present study, the hypothesis that UVA can
suppress immune responses to skin tumours was tested using a mouse fibrosarcoma
(FSA) model. Mice were irradiated for a period of 3 weeks, and FSA cells were then
injected subcutaneously. The effect ofUVA, and broad-band and narrow-band UVB
on tumour cell outgrowth was measured. The dose dependency of UV-enhanced
tumour outgrowth was also assessed.
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1.7.3 - UVB exposure suppresses systemic immune responses in tumour-bearing
mice
Regulatory T cells are present in the lymphoid organs of irradiated, tumour-
bearing mice. Therefore these mice are likely to have suppressed immune responses to
the tumour, such that control of tumour growth by the immune system is lost. An
attempt was made to develop in vivo and in vitro assays to measure tumour immunity
in tumour-bearing mice. Tumours were induced by subcutaneous injection of FSA
cells. Changes in proliferation and surface maker expression of LN cells from
irradiated and unirrradiated tumour-bearing mice were assessed to try to understand the
mechanisms by which UV exposure ofmice results in increased tumour outgrowth.
1.7.4 - CA-UCA is the chromophore that initiates UV-induced suppression of
immune responses to tumour cells.
The hypothesis that cA-UCA is involved in UV-induced suppression of anti-
tumour responses was tested in two ways. First, mice were treated for a period of 3
weeks with cis-UCA prior to injection of FSA cells, and the growth of the resulting
tumour measured. Second, mice exposed to UVB for 3 weeks were injected with anti-
cA-UCA antibody prior to each irradiation; these mice were then injected with FSA






C3H/HeN (H-2k) mice were obtained from the Medical Faculty Animal Area,
University of Edinburgh; they were housed in a room where ambient light was
regulated on a 12 h light/dark cycle and had free access to food and water. Room
lights were shielded such that any contaminating UV wavelengths were fdtered out.
Female mice aged 6-10 weeks were used unless otherwise stated.
2.1.2 - Growth medium and supplements
RPMI-1640 (Gibco, BRL) was supplemented with 100 I.U./ml penicillin, 200 mg/ml
streptomycin, 2 mM L-glutamine, 100 pg/ml gentamicin, 1.5 pg/ml fungizone and
10% heat-inactivated foetal calf serum (FCS; Gibco, BRL) designated RPMI-FCS
throughout. In some experiments RPMI-FCS was supplemented with 10 mM HEPES
(Sigma, Poole, Dorset) and 2xlO~5M (3-mercaptoethanol (RPMI-HEPES).
2.1.3 - Cells
Fibrosarcoma (FSA) cells were obtained from Professor William McBride
(University of California, Los Angeles); they are moderately immunogenic and are
derived from a fibrosarcoma that was induced in C3H mice by methylcholanthrene
treatment (Suit and Kastellan, 1970). Cells were cultured in RPMI-FCS; they were
harvested using a 0.1% (v/v) trypsin/ 0.04% (w/v) versene solution and the number
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of viable cells determined by trypan blue exclusion. For injection into mice, cells
were washed once in RPMI-FCS, then resuspended in Hanks' balanced salt solution
(HBSS), supplemented with 20 pg/ml deoxyribonuclease I (Sigma) (HBSS-DNAse).
2.1.4 - UV sources and exposure
Mice were shaved on the back at least 24 h before the first irradiation and again 24 h
before the final irradiation. Control mice were shaved but not irradiated. Mice were
placed in a Perspex box with no more than 4 mice per box to avoid shielding by
littermates. Mice were irradiated twice a week for 3 weeks, unless otherwise stated.
Three UV sources with different emission spectra were used (Figure 2.1) and their
outputs determined using a filtered photodiode meter, calibrated against
measurements made with aUV-visible spectroradiometer (model 742, Optronic
laboratories) across the spectral range 250-400 nm. The broad-band UVB source was
provided by two Philips TL-20W/12 bulbs with an output range of 270-350 nm, peak
305 nm, emitting 80 mW/cm2. The tube to target distance was 16 cm. One minimal
erythemal dose (MED) for C3H/HeN mice under these conditions was 1500 J/m2.
The narrow-band UVB source was a Philips TL01 lamp, which emitted
predominantly (51%) at 310-312nm; the total irradiance was 200 pW/cm2. One MED
for C3H/HeN mice was 10,000 J/m . For UVA exposure, a Dr. Hoenle Bluelight
lamp was used. This had an output range 315-400 nm, emitting 3.3 mW/cm2; for
UVA-I exposure, contaminating UVB was filtered out using Cation X (provided by
Dr. F de Gruijl, Utrecht) at 0.1 mg/ml in distilled water, at a depth of 1cm in a tray
made using window glass 2 mm deep. One MED for C3H/HeN mice under these
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2.1.5 - Urocanic acid isomers
Trans-urocanic acid {trans-UCA; 4-imidazoleacrylic acid) was purchased from
Sigma. CA-UCA was prepared by irradiation of trans-UCA, followed by purification
by thin-layer chromatography to give a greater than 99% pure preparation, as
described previously (Norval et al, 1989). CA-UCA was provided by Dr. J Crosby,
University of Bristol.
2.1.6 - Recombinant IL-12 injection
Recombinant mouse IL-12 (rIL-12) was purchased from Serotec (Oxford, UK).
Mice received 50 ng of rIL-12 in 200 pi sterile, endotoxin-free PBS, by
intraperitoneal injection, 4 h after each irradiation.
2.2 Hypersensitivity responses
2.2.1 - Contact Hypersensitivity response to oxazalone
Oxazolone (50 pi of a 1% (w/v) solution in 4:1 acetone:olive oil; 4-
ethoxymethylene-2-phenyl-2-oxazolin-5-one, Sigma) was applied to the shaved
dorsal skin; 50 pi vehicle only was applied for negative controls. Mice were
tailmarked 8 days later; they were then anaesthetised with halothane and the
thickness of their ears measured using an engineer's micrometer (Mitutoyo
Corporation, Japan). A challenge dose of 0.5% oxazolone in 25 pi vehicle was
applied to both ears of all mice. Ear swelling was measured 24 h later, and the mean
ear swelling and standard error of the mean (SEM) calculated for each group.
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2.2.2 - Delayed hypersensitivity response to FSA cells
FSA cells (104 in 100 pi HBSS-DNAse) were injected either subcutaneously in 4
dorsal sites, or intravenously into the tail vein of normal mice. Control mice received
100 pi HBSS only, either subcutaneously or intravenously. Mice were tailmarked 14
days later and ear thickness measured with an engineer's micrometer. They were
then challenged intrapinnally with FSA cells (105 in 10 pi FIBSS) which had been
inactivated by exposure to 18,000 J/m2 broad-band UVB (TL20W/12) directly prior
to injection. Ear swelling was measured 24 h later and the mean ear swelling and
SEM calculated for each group.
2.3 - Langerhans cell counts
The number of Langerhans cells in the epidermis ofUV-irradiated and control mice
was determined by staining for adenine triphospatase (ATPase) using adenine
diphosphate as a substrate (Chaker et al, 1984). Mice were killed by cervical
dislocation 24 h after the final irradiation, and their ears removed into ice-cold PBS.
The dorsal surface was separated from the lower surface using forceps, and floated
epidermal side down for 2 h at 37°C in 0.76% (w/v) tetrasodium ethylenediamine
tetraacetic acid (EDTA; Sigma). After washing 3 times in PBS, epidermal sheets
were removed using a scalpel blade, and fixed by floating in sodium
cacodylate/formaldehyde buffer [6.85% (w/v) sucrose, 1.6% (w/v) sodium
cacodylate, in distilled water, with 10% (v/v) formaldehyde solution (Merck Eurolab
Etd, Lutterworth, Leic.)] for 1 h at 4°C. Sheets were washed in PBS again, then
stained with ADP-lead [0.12% (w/v) MgS04, 5% (w/v) D-glucose, 0.06% (w/v)
ADP (Sigma), 0.12% (w/v) Pb(NCE)2] in Tris/Mal buffer [3.025% (w/v) Tris buffer
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salt, 2.9% (w/v) maleic acid, 1% (w/v) NaOH; pH 7.3] for 70 min at 37°C. Sheets
were then rinsed 3 times in Tris/mal buffer:distilled water 2:3. The stain was
developed in 2% (w/v) ammonium polysulfide (20 min at room temperature); sheets
were then rinsed in tap water and mounted onto a glass slide under a cover slip in
50% (v/v) glycerol. The number of ATPase+ cells in 10 fields per epidermal sheet
was counted (1 field = 0.1 mm ), with a minimum of 4 sheets per group.
2.4 Injection of tumour cells
2.4.1 - Injection of FSA cells in UV exposed skin
Mice were anaesthetised with halothane 24 h after the final irradiation and 7.5x104
fibrosarcoma (FSA) cells in 100 pi HBSS-DNAse were injected subcutaneously into
4 sites in the irradiated back skin. Mice were monitored daily for the appearance of
tumours; once the tumours were a measurable size two bisecting diameters were
measured using a ruler. The tumours were not a uniform shape, therefore an arbitrary
measurement of tumour size was calculated by multiplying together the values for
the two bisecting diameters; the sum of the tumour sizes for a single mouse was
calculated to give the total tumour area for that mouse. The tumour growth was
measured for a period of 4 weeks, or until the tumours either showed ulceration or
reached a diameter of 10 mm, at which point the mice were killed by cervical
dislocation.
2.4.2 - Injection of FSA cells in unirradiated skin of irradiated mice
Mice were anaesthetised 24 h prior to the final irradiation and their ventral hair
shaved; 24 h after the final irradiation they were anaesthetised again and 7.5x104
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FSA cells injected subcutaneously into 4 ventral sites. The resulting tumours were
measured as already described.
2.4.3 - Intravenous injection of FSA cells
FSA cells were resuspended to 106 cells/ml in HBSS-DNAse and 100 pi injected
intravenously into the tail vein. Mice were killed 14 days later and their lungs
removed into Bouin's fluid; following fixation for 24 h the number of lung colonies
was counted by eye.
2.5 Proliferation and phenotyping of draining lymph node cells
2.5.1 - Collection and preparation of draining lymph node (DLN) cells
Lymph nodes draining the dorsal skin (unless otherwise stated) were collected and
pooled in RPMI-HEPES. Single cell suspensions were prepared by mechanical
disaggregation through a nylon cell strainer (Becton Dickinson, Bedford, USA) and
washed once in RPMI-HEPES. Viable cells were counted by trypan blue exclusion.
The number of cells per lymph node for a single group ofmice was calculated using
the following formula:
Cell count per ml x Total volume of cell suspension
Number of LN collected
2.5.2 - Spontaneous proliferation of DLN cells
Cells were resuspended to 2 x 106 cells/ml, and 200 pi seeded into wells of a 96-well
round-bottom culture plate (Iwaki, Asahi Techno Glass, Japan). Cells were
.3 . . .
radioactively pulsed by adding 0.7 pCi H-methyl thymidine (specific activity 2.0
Ci/mmol; Amersham Life Science, UK) in 10 pi RPMI-HEPES per well and
incubated for 24 h at 37°C in a humid atmosphere of 5% CO2 in air. Cells were
harvested onto filter mats and "H-thymidme incorporation measured in counts per
minute using a scintillation counter (Canberra Packard, Zurich, Switzerland).
2.5.3 - Proliferation of DLN cells in response to mitogens
Cell suspensions were prepared as described in section 2.4.1 and 100 pi (2 x 105
cells) seeded into a 96-well round bottom plate. The mitogens concanavalin A (Con
A; Sigma) or phytohaemagglutinin (PHA; Sigma), were dissolved in RPMI-HEPES
and added to the cells in 100 pi volumes to give a final concentration of 2.5 pg/ml.
Alternatively, an antibody to murine CD3 (Serotec) was dissolved similarly and
added to the cells at a final concentration of 1 pg/ml. The cultures were incubated as
previously described for 48 h or 72 h; cells were pulsed with 0.7 pCi/well 3H-methyl
thymidine 8 h prior to harvesting.
2.5.4 - Proliferation of DLN cells in response to tumour antigens
Confluent monolayers of FSA cells in 75 cm tissue culture flasks were rinsed in
PBS and harvested using a sterile cell scraper (Merck Eurolab Ltd.). Glycine extracts
of tumour cell antigens (TA) were prepared from FSA cells using the method of
Booth et al (1979). Briefly, cells were washed once in PBS and resuspended in
glycine buffer, prepared from five parts 0.1 M aqueous solution of glycine and three
parts 0.1 M aqueous sodium hydroxide (equivalent to 0.5 ml ofbuffer per culture
flask of cells). The cells were disrupted by three freeze/thaw cycles, with vigorous
agitation and ultrasonication (1 min) between each cycle. The cellular debris was
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removed by centrifugation at 800 g for 10 min, and the final supernatant stored in
small aliquots at -70°C. The protein concentration of the extract was determined by
the Lowry method (Lowry et al, 1951).
Lymph node and spleen cell suspensions were prepared as described in section 2.5.1
and 100 pi (2 x 105 cells) seeded into a 96-well round bottom plate. Glycine
extracted TA were diluted in RPMI-HEPES and 100 pi added to the cells, to give
final concentrations of 0.2-200 pg protein/ml. Cells were incubated for 24-96 h, and
proliferation measured by thymidine incorporation as described in section 2.5.3. To
test whether the glycine extraction buffer affected proliferation of the cells, LN and
spleen cells from a tumour-bearing mouse were cultured for 96 h in the presence of
TA-free glycine buffer diluted in RPMI-HEPES (Figure 2.2). The glycine extract
was toxic at the highest concentration used, but otherwise had little effect on the
proliferation of the cells.
2.5.5 - Measurement of IL-10 production by ELISA
Lymph node cell suspensions were prepared (section 2.5.1) to a concentration of 107
cells/ml and 1 ml seeded into the wells of a 24-well tissue culture plate (Iwaki).
Supernatants were collected at 24, 48 and 120 h of culture and stored at -70°C until
assayed for IL-10 content. IL-10 was assayed using a Quantikine mouse IL-10
immunoassay kit (R&D Systems) according to the manufacturer's instructions. For
each assay a standard curve was created by addition of standards to a row ofwells;
these ranged from 0-1000 pg/ml. Standards and samples were diluted 1/2 in diluent
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Figure 2.2. Proliferation of immune cells cultured in varying concentrations of
glycine buffer. Cells from LN draining the tumour site (clear columns) or the spleen
(filled columns) were cultured for 96 h in medium alone (0), or with varying
concentrations of glycine buffer (0.05-50 % in medium); 3H-Thymidine was added
for the final 8 h of culture. The cells were taken from tumour-bearing mice that had
received 7.5 x 104 FSA cells in 4 dorsal sites 20 days previously. Error bars show
the SEM of 3 replicate wells (only shown for cells incubated in medium alone).
diluent buffer only. After washing 4 times in wash buffer, 100 pi of horse radish
peroxidase (HRP)-conjugated anti-mouse IL-10 antibody was added to each well for
a further 2 h at RT. Following a further wash, 100 pi stabilized chromagen was
added to each well for 20 min in the dark, before the addition of stop solution.
Absorbance at 450 nm of each well was read on a plate reader (MR 700 Plate
Reader, Dynatech) blanked against the control wells. The minimum detectable dose
ofmouse IL-10 was 4.0 pg/ml, according to the manufacturers.
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2.5.6 - Phenotyping of DLN cells by flow cytometry
Monoclonal antibodies raised in rat, recognising Thyl.2, CD8, CD4, CDllb, la and
CD86 (B7.2), and negative control antibodies (isotypes IgG2a and IgG2b) were all
purchased from Serotec and titrated to determine the optimal concentration (shown in
Table 2.1). Lymph node cell suspensions were prepared as described in section 2.4.1
and 5 x 105 cells incubated on ice for 45 min with 500 pi control antibody or the
primary monoclonals listed in Table 2.1. The cells were washed once with 1 ml
RPMI-HEPES, resuspended in RPMI-HEPES and incubated with an affinity purified
F(ab')2 goat anti-rat IgG-FITC conjugate (100 pi of 1/100 dilution; Serotec) for 45
min on ice. Cells were washed again, resuspended and fixed in 1 ml 10% formol
saline and analysed using a Coulter XL Flow cytometer. Cells were identified first
Specificity Clone Isotype Concentration
Human CD8 (control) YTH862.2 IgG2b 1/500
Serotec negative control Not known IgG2a 1/200
Murine Thyl.2 FF-10 IgGl 1/1000
Murine CD4 YTS191.1 IgG2b 1/1000
Murine CD8 YTS105.18 IgG2a 1/500
Murine CDllb(CR3) 5C6 IgG2b 1/500
Murine CD86 (B7.2) RMMP-2 IgG2a 1/200
Murine la Ye2/36hlk IgG2a Neat (30 pi)
Table 2.1. Rat Monoclonal antibodies to mouse lymphocyte cell surface
markers.
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using forward scatter and side angle light scatter to quantify their size and
granularity. Gates were placed around the entire cell population and around cells
with low side scatter and forward scatter (lymphocytes) and around larger, more
granular cells (Figure 2.3a). The events within each region were displayed on
histograms of log fluorescence intensity (x-axis) against cell count (y-axis). Isotype
controls were routinely set at 1 % and a minimum of 20,000 events was accumulated
in the region around the entire cell population.
2.5.7 - DC enrichment and phenotyping
Mice were killed by cervical dislocation 48 h after the final UV irradiation or were
unirradiated (8 mice per group). Their auricular, axillary and inguinal LN were
collected and pooled in RPMI-HEPES. Single cell suspensions were prepared as
described in section 2.4.1. The LN cell suspensions were enriched for DC using the
method ofMacatonia et al (1989). Briefly, 4 x 107 LN cells in 8 ml medium were
underlaid with 2 ml metrizamide (14.5 % in RPMI-HEPES, Sigma, UK). Following
a 15 rnin centrifugation at 600g, the interface layer was collected, washed and
resuspended in a minimal amount ofmedium. The number ofDC was assessed by
morphological examination by light microscopy; at least 5 counts for each group
were made, and the mean number of DC per LN was calculated. Using this method,
55-70% of the cells in the DC-enriched suspension were DC. Expression of the
surface markers la and CD86 was detennined by flow cytometry (104 cells per
antibody) as described in section 2.4.6. The scatter profile of the DC enriched
population is shown in Figure 2.3b.
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Figure 2.3. Scatter profile of mouse lymph node cells, a) the size and granularity
of cells from lymph nodes draining the skin of an untreated mouse. Gates were
placed around the lymphocyte region (A), the larger, more granular cells (B), and
around the total cell population (C). b) profile of cells from lymph nodes draining the
skin of an untreated mouse, that have been enriched for DC. Gates were placed
around the lymphocyte region (A) and the larger, more granular cells (B).
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2.5.8 - Annexin V staining of total and DC-enriched DLN cells
In the early stages of apoptosis, changes in the plasma membrane result in the
exposure of phosphatidylserine on the outer layer of the membrane. This can be
detected by flow cytometry using FITC-conjugated annexin V, which is a
phospholipid binding protein with a high affinity for phosphatidylserine (Vermes et
al, 1995). Freshly isolated or DC enriched cells (2 x 105) from lymph nodes draining
the dorsal skin were incubated for 3 min at RT with FITC-conjugated annexin V
(Boehringer) diluted 1/500 in annexin V binding buffer (HBSS, containing 5pM
CaCb). Control cells were incubated in annexin V binding buffer only. Cells were
then analysed immediately by flow cytometry as described in section 2.5.6.
2.6 - Detection of tumour infiltrating cells
2.6.1 - Disaggregation of tumours for flow cytometry
Mice were killed by cervical dislocation and all the tumours from one mouse were
excised and pooled in 3 ml PBS containing 0.4% w/v Dispase (Dispase solution;
Boehringer Mannheim, Mannheim, Germany). The tumours were cut into small
fragments (approximately 2 mm ) using a scalpel, and shaken gently in Dispase
solution for 45 min at RT. The fragments were then washed twice with PBS by
centrifugation, resuspended in 3 ml Dispase solution, and shaken gently for 30 min at
RT (McBride, 1986). Single cell suspensions were prepared by mechanical
disaggregation through a nylon cell strainer, washed twice and counted. Expression
of the surface markers Thy 1.2, CD4, CD8 and CD1 lb was determined by flow
cytometry (105 cells per antibody) as described in section 2.5.6.
58
2.6.2 - Immunoperoxidase staining of tumours
Mice were killed by cervical dislocation, whole tumours removed and snap frozen in
cryomatrix (Life Sciences International, Runcom, UK). Sections were prepared using
a cryostat and allowed to dry for 1 h at RT. After fixing in ice-cold acetone for 5
min, sections were stored frozen at -20°C until use. For immunoperoxidase staining,
slides were brought to RT and endogenous peroxidase blocked by incubation for 10
min in 1 % hydrogen peroxide in methanol. Slides were then washed in tap water,
and blocked for 20 min at RT in 20 % (v/v) goat serum in PBS. Monoclonal rat anti-
mouse antibodies (Serotec) were titrated using mouse tumour and LN sections to
determine the optimal concentration; these were: CD4 (1/2000) and CD8 (1/800).
The antibodies were diluted in PBS (containing 20 % v/v goat serum) and the slides
incubated overnight at 4°C. Control slides were incubated in an irrelevant isotype
control antibody (anti-human CD8, Serotec). After washing 3 times in PBS, slides
were incubated for 30 min at RT with biotinylated goat anti-rat IgG (Serotec) diluted
1/200 (PBS, containing 20 % v/v goat serum). Slides were washed 3 times in PBS
and incubated for 30 min at RT with a commercial avidin/biotinylated-HRP complex
(Dako, Ely, Cambridgeshire, UK). After washing, slides were developed by the
addition of diaminobenzidine (liquid DAB, Dako) for 4-7 min; slides were monitored
microscopically for the appearance of staining and the reaction stopped by washing
in water. Slides were counterstained with haematoxylin and mounted in DPX under a
glass cover slip.
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2.7 In vivo and in vitro effects of c/s-UCA
2.7.1 - Topical application ofUCA isomers
The UCA isomers were dissolved in dimethyl sulfoxide (10 mg/ml); this was diluted
to 2 mg/ml in ethanol, and mice received 50 pi of this on shaved back skin twice a
week for 3 weeks prior to tumour cell injection.
2.7.2 - Intradermal injection of c/s-UCA
In one experiment, cA-UCA was dissolved in PBS to a concentration of 1 mg/ml; 20
pi of this was injected subcutaneously in 5 dorsal sites to give a final dose of lOOpg
per mouse. This was repeated twice a week for 3 weeks prior to tumour cell
injection.
2.7.3 - Antibody to c/s-UCA
A monoclonal antibody with specificity for c/s-UCA (Moodycliffe et al, 1993) has
been shown previously to abrogate some of the immunosuppressive effects ofUVB,
such as suppression of the DTH response to herpes simplex virus (El-Ghorr and
Norval, 1995). This was diluted in PBS and 300 pi injected intraperitoneally 2 h
prior to each irradiation. Control mice received an isotype control antibody (anti-
Border disease virus) at the same concentration. Unirradiated controls received either
cA-UCA antibody or control antibody.
2.7.4 - Proliferative responses to CD3 antibody
The method ofHolan et al (1998) was used to determine the effect of cA-UCA on
the in vitro proliferation of spleen cells from C3H/HeN mice in response to CD3
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antibody. Spleens from normal mice were removed into ice-cold RPMI-HEPES and
cell suspensions prepared by mechanical disaggregation through a nylon cell strainer.
Cells were washed once, counted by trypan blue exclusion, resuspended to 3 x 106
cells/ml, and 3 ml seeded into the wells of a 6-well culture plate (Iwaki). UCA
isomers were dissolved in PBS to a concentration of 2 mg/ml; these were added to
the cells in varying amounts. Control cells received equal volumes of PBS.
Following an incubation of 2-24 h at 37°C, cells were washed in RPMI-EIEPES and
resuspended to 1 x 106 cells/ml. CD3 antibody (see section 2.4.3) was added at a
concentration of 2 pg/ml; 200 pi per well was seeded into a 96-well round bottomed
tissue culture plate and incubated for 72 h at 37°C. 3H-methyl thymidine was added
8h prior to the cells being harvested onto filter mats; incorporation of the radioactive
thymidine was quantified as described in section 2.4.2 above.
2.7.5 - Isolation ofRNA
Spleen cells were resuspended to 2 x 106 cells/ml and 1 ml seeded into the wells of
24-well tissue culture plates. The cells were incubated for 20 h in the presence of 200
pg/ml cis or trans-UCA, in the presence or absence of 2 pg/ml CD3 antibody. Cells
were collected with the aid of a cell scraper (Costar, Corning, NY, USA), centrifuged
for 5 min at 300 x g, and the supernatant completely removed. Total RNA was
extracted using the Qiagen RNeasy mini kit according to the manufacturer's
instructions. Cell pellets were resuspended in Qiagen lysis buffer; a 700 pi volume
was transferred to a QIAshredder column and homogenised by centrifugation for 2
min at maximum speed. The lysate was removed and added to an equal volume of
70% ethanol. Up to 700 pi of this mixture was transferred to a spin column,
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centrifuged for 15 sec and the eluate discarded. The RNA was washed by
centrifugation with 700 pi Qiagen wash buffer for 15 sec and washed twice more by
centrifugation with 500 gtl Qiagen wash buffer for 15 sec and 2 min. The RNA was
eluted by centrifugation for 1 min in 50 jliI RNase-free water and stored at -70°C.
Purity and concentration was detennined by optical density at 260 nm and 280 nm.
2.7.6 - Reverse transcription of RNA
RNA was diluted in RNase-free water to a concentration of 2 pg in 10 pi, and
denatured by heating to 65°C for 2 min. After quenching on ice, 10 pi of a reverse
transcription (RT) mix was added to each sample; 1 pi RNA guard (Pharmacia
Biotech), 1 pg oligo dT, 4 pi 1st strand buffer, 0.01 M dithiothreitol (Gibco, BRL), 2
units Moloney murine leukaemia virus reverse transcriptase (MMLV RT; Gibco,
BRL), 1.6 pi dNTPs (25 mM mix of dATP, dCTP, dGTP, dTTP; Pharmacia
Biotech). Following a 1 h incubation at 37°C, the reaction was stopped by heating to
95°C for 5 mins.
2.7.7 - Amplification of cDNA by PCR
A 2 pi volume of the RT-reaction was heated to 85°C for 5 min with 2 pi lOx PCR
buffer, 3.5 mM MgCb, 0.2 pi Taq DNA polymerase, 1.3 pi dNTPs (1.2 mM mix of
dATP, dCTP, dGTP, dTTP) and 7.3 pi distilled water. Primers (IL-10 or P-actin,
Table 2.2) were added in a 1.5 pi mix and the products amplified at 95°C for 1 min
(denaturing), 65°C for 1 min (annealing) and 72°C for 1 min (polymerisation), for 40
cycles, with a final extension for 7 min at 72°C.
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2.7.8 - Visualisation of PCR products
Products were run on a 1 % agarose (Gibco, BRL) gel with 10 mg/ml ethidium












Table 2.2. Primer sequences used for polymerase chain reactions, and
expected product size.
2.8 - Statistics




Effect of UV irradiation with broad-band UVB, narrow-band TL01
or UVA on antigen presenting cells and contact hypersensitivity
3.1 - Introduction
Mice irradiated with FS40 sunlamps (87% ofUV radiation lies between 255-
340 nm, with a peak at 313 nm) for 3 weeks prior to tumour implantation show
enhanced growth of tumours compared with unirradiated controls; this increased
tumour outgrowth is the result ofUV-induced modulation of immune responses
(Donawho and Kripke, 1991).
In the present study, as will be described in Chapter 4, an attempt has been
made to determine the most effective UV wavelengths for increased outgrowth of
FSA tumour cells by irradiating mice with UV lamps with different spectral outputs:
broad-band UVB (TL20W/12), narrow-band UVB (TL01) and UVA-I. Prior to this,
it was decided to investigate the immune status of C3H/HeN mice after 3 weeks
exposure to these lamps, which was the point at which they were injected with the
FSA cells (see Chapter 4).
Immune unresponsiveness following UV exposure has been attributed partly to
effects on epidermal antigen presenting cells. A single exposure ofmice to broad¬
band UVB or UVA-I decreases the number of epidennal Langerhans cells (LC)
(Duthie et al, 2000). In vitro exposure of LC to UVB affects the expression of co-
stimulatory molecules such as CD86 and ICAM-1 (Rattis et al, 1998; Tang and
Udey, 1992). In the current study, irradiating mice over a 3 week period with broad-
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band UVB was compared with UVA to determine whether there was any correlation
between changes in epidermal LC numbers and enhanced tumour outgrowth.
The decrease in epidermal LC following a single UVB exposure is
accompanied by an increase in the number of dendritic cells (DC) in the lymph nodes
draining the irradiated skin (Moodycliffe et al, 1992). UVB also causes an increase in
the number of LC in the afferent lymph draining the skin of irradiated sheep (Dandie
et al, 2001); therefore it is thought that the decrease in epidermal LC may be due to
migration of the LC out of the skin to the draining lymph nodes (DLN). In the present
study, the number ofDC in the DLN of mice that had been irradiated for 3 weeks
with broad-band UVB was assessed, to determine whether chronic UVB exposure
has similar effects to a single UVB dose on antigen presenting cells. In addition, the
DC were tested for expression of la and CD86.
The contact hypersensitivity (CH) response has often been used as an indicator
of the effect ofUV on cell-mediated immune responses; all 3 lamps used in this
study suppress the CH response after a single exposure (El-Ghorr and Norval, 1999).
The CH response is suppressed following chronic (6 weeks) exposure to broad-band
UVB, but not TL01 (El-Ghorr et al, 1995), suggesting that there are differences in the
effects of these lamps on T-cell mediated immune responses.
The suppression of CH responses following UV irradiation has been attributed
partly to changes in cytokine profiles in irradiated mice. One important mediator in
CH responses is IL-12; injection of anti-IL-12 antibody reduces the CH response in
normal mice by 85% (Midler et al, 1995). IL-12 is a heterodimeric molecule
composed of two covalently linked chains, p40 and p35, and is a potent inducer of
Thl responses and interferon-y (IFN-y) production (Manetti et al, 1993; Trinchieri et
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al, 1993). Previous reports have demonstrated that exogenous IL-12 can overcome
UV-induced suppression of CH responses (Schwarz et al, 1996), probably by
reducing the DNA damage resulting from the irradiation (Schwarz et al, 2002). The
effect of exogenous IL-12 on suppression of CH responses by the broad-band UVB
protocol was examined in the current study.
LN cells from normal mice demonstrate a low level of spontaneous
proliferation in vitro; levels ofproliferation are increased in mice that have been
contact sensitised (Kimber et al, 1986). It is not known whether UVB exposure
affects the in vitro spontaneous proliferation of cells from LN draining the UV
irradiated site. In the present study, the spontaneous and mitogen-induced
proliferation of LN cells from naive, irradiated mice was measured. The effect of
broad-band UVB and exogenous IL-12 on the spontaneous proliferation of LN cells
from oxazalone-challenged mice was also determined.
3.2 - Results
3.2.1 - Effect of broad-band UVB and UVA exposure on numbers of
epidermal Langerhans cells
In the epidermis only LC express the ATPase enzyme on their cell surface.
Mice were irradiated twice a week for 3 weeks with 1000 J/m2 broad-band UVB or
10,000 J/m UVA on the ears and shaved back. These sub-erythemal doses were
chosen because 3 weeks of exposure ofC3H/HeN mice to these doses has previously
been shown to affect epidermal LC numbers (El-Ghorr et al, 1995). Ears were
removed 24 h after the final exposure and stained for the presence of ATPase+
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dendritic cells, as described in section 2.3. The number of LC was significantly














Figure 3.1. Effect of 3 week UV on epidermal LC numbers. Mice were irradiated twice a
week for 3 weeks and epidermal sheets from the ears stained for ATPase+ LC 24 h after the
final exposure. Control mice were not irradiated. Error bars show the standard error of the
mean of 40 fields (SEM). * indicates a significant difference (p<0.05) between the control
group and the irradiated groups.
3.2.2 - Effect of 3 week broad-band UVB exposure on DC in the DLN
In a study by Moodycliffe et al (1992), the number of DC was increased in the
auricular LN following UVB irradiation of unshaved mice with a single dose, and
peaked 42 h after the exposure. In the present study, mice were irradiated with a
single dose of 1500 J/m2 UVB on their shaved dorsal skin; this resulted in an
increase in the number ofDC in the LN draining the irradiated dorsal surface from
4575 to 6595 per LN. To determine whether the same effect was seen in mice
following multiple UV exposures, mice were exposed to 1500 J/m2 UVB twice a
week for 3 weeks, and LN draining both the ears and back were pooled and enriched
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for DC, as described in section 2.5.7. The results of 4 separate experiments are
shown in Table 3.1. The number ofDC in the LN from irradiated mice was
consistently less than the number in the LN from control mice. The mean DC count
for each group was calculated, and a t-test of the pooled data showed that exposure of
mice to broad-band UVB for 3 weeks significantly (p<0.05) decreased the number of
DC in the DLN.
DC count/lymph node
Experiment Control UV % decrease
1 11101 9009 19
2 7888 4776 39
3 12295 7096 42
4 10425 7997 16
Mean 10427 (930) 7219 (903)* 29
Table 3.1. Effect of 3 week UVB irradiation on DC numbers in LN draining the
irradiated site. Mice were irradiated on their shaved backs (1500 J/m2 broad-band UVB
twice a week for 3 weeks) and the number of DC in the DLN counted 42 h after the final
exposure. Numbers in brackets show the standard deviation (SD). * shows a significant
difference (p<0.05) between the control and the irradiated groups.
To assess whether chronic UV exposure affected the expression of cell
surface markers involved in antigen presentation in unsensitised mice, DLN cells
from unirradiated mice, and from mice that had been irradiated over a 3 week period,
were enriched for DC, and the expression of la and CD86 determined by flow
cytometry (as described in section 2.5.7). No difference was seen in the expression of
either la Figure 3.2a) or CD86 (Figure 3.2b) between mice exposed to multiple doses
ofUV and unirradiated controls. This experiment was repeated twice with similar
results.
68
Figure 3.2. Effect of 3 week UVB exposure on DC expression of cell surface markers.
Groups of 8 mice were irradiated twice a week for 3 weeks and their LN removed 42 h after
the final exposure. Control mice were not irradiated. Following DC enrichment of DLN cells,
the enriched populations were stained for the presence of (a) la and (b) CD86, and analysed
by flow cytometry. The fluorescence intensity of the gated DC population is shown for control
(blue line) and irradiated mice (orange line). The fluorescence intensity of DC from
unirradiated mice stained with a control antibody is also shown (grey line).
To determine whether the decrease in DC number in the DLN of irradiated mice was
due to increased apoptosis of these cells, DLN from unirradiated mice, and from
mice that had been irradiated over a 3 week period, were enriched for DC, and the
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level of annexin V binding assessed by flow cytometry (section 2.5.8). DC from
control and irradiated mice demonstrated similar levels of annexin V binding, with
an average (from two experiments) of 72 % positive cells for control DC and 74% for
DC from irradiated mice (Figure 3.3).
Figure 3.3. Effect of 3 week UVB exposure on annexin V binding to DC. Groups of 8
mice were irradiated twice a week for 3 weeks and their LN removed 42 h after the final
exposure. Control mice were not irradiated. Following DC enrichment of DLN cells, the
enriched populations were stained with FITC-conjugated annexin V, which binds to
phospatidylserine present on the surface of apoptotic cells. The fluorescence intensity of the
gated DC population is shown for control (blue line) and irradiated mice (orange line). The
fluorescence intensity of DC from unirradiated mice stained with a control antibody is also
shown (grey line).
Additionally, the level of annexin V binding by DC in DLN cell populations that had
not been enriched for DC was assessed by flow cytometry. The levels of annexin
binding by DC from the total cell population were lower than the levels of binding by
DC enriched populations. The average of 3 experiments was 58 % and 52 % annexin
V positive cells for control DC and DC from irradiated mice respectively (not
significantly different).
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3.2.3 - Effect of 3 week UV exposure on the CH response to oxazalone
Mice were irradiated twice a week for 3 weeks with 1000 J/m2 broad-band
UVB, 10,000 J/m2 TL01 or 10,000 J/m2 UVA. In single exposure experiments (El-
Ghorr and Norval, 1999) higher doses of these wavebands (5000 J/m2, 50,000 J/m2
and 500,000 J/m2 respectively) were required to suppress the CH response. In the
present study, sub-erythemal doses were used to determine whether multiple
exposures reduced the dose required for suppression ofCH. Mice were sensitised
with oxazalone on the irradiated back skin 3 days after the final UV irradiation
(Chapter 2, section 2.2.1). All 3 UV sources significantly (p<0.05) suppressed the
CH response to oxazalone (Figure 3.4); the response was suppressed by 56%, 38% or
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Figure 3.4. Effect of 3 week UV exposure on the contact hypersensitivity response to
oxazalone. Mice (4-6 per group) were sensitised with oxazalone 3 days after the final
irradiation, and challenged 8 days later. Negative controls (Neg) were not sensitised prior to
challenge with oxazalone. Positive controls (Pos) were sensitised and challenged with
oxazalone, but not irradiated. Error bars show the SEM. * indicates a significant difference
(p<0.05) between the unirradiated positive control group and the irradiated groups.
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3.2.4 - IL-12 and broad-band UVB-induced suppression of the CH response
The effect of exogenous IL-12 (rIL-12) on suppression of the CH response by 3
weeks exposure to broad-band UVB was determined by irradiating mice twice a
week for 3 weeks with 1500 J/m" broad-band UVB; rIL-12 was injected
intraperitoneally 4 h after each irradiation (Chapter 2, section 2.1.6). Control groups
received UVB only, IL-12 only, or no treatment. Mice were contact sensitised 3 days
after the final irradiation as described in section 2.2.1. Once the ear swelling response
after challenge had been measured, mice were re-challenged with oxazalone, and any
further increase in ear swelling was measured 24 h later. This was done to assess
whether a second challenge would overcome the UVB-induced suppression.
Mice receiving rIL-12 only showed no difference in their CH response
compared with untreated controls (Figure 3.5a); in mice irradiated with 1500 J/m2
UVB the CH response was significantly (p<0.05) suppressed (40% suppression)
compared with the positive controls. Mice that received rIL-12 following each
irradiation also had significantly (p<0.005) suppressed responses to oxazalone (70%
suppression) compared with control mice which were either untreated or received
rIL-12 only.
Following a second challenge with oxazalone, all groups showed a slight
increase in ear swelling compared to that seen after a single challenge (Figure 3.5b);
however, both the irradiated mice and the mice that received rIL-12 following
irradiation still showed significantly (p<0.05) suppressed responses (22%
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Figure 3.5. Effect of exogenous IL-12 on UVB-induced suppression of the CH response
to oxazalone. Mice (6-8 per group) were irradiated for 3 weeks, and received rlL-12 4 h after
each irradiation (UVB+IL-12). Control mice received either broad-band UVB only (UVB), rlL-
12 only (IL-12), or no treatment prior to sensitisation (Pos). Mice were challenged 7 days after
sensitisation (a) and re-challenged 24 h later (b). Negative control mice (Neg) were not
irradiated and not sensitised prior to challenge with oxazalone. * indicates a significant
difference between the unirradiated positive control group and the irradiated groups. Error
bars show the SEM.
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3.2.5 - Effect of UVB exposure on the in vitro proliferation of LN cells from
naive and challenged mice
To assess whether UV irradiation had any effect on the spontaneous
proliferation ofDLN cells from unchallenged mice, mice were irradiated twice a
week for 3 weeks with broad-band UVB and their LN removed 24 h after the final
irradiation (sections 2.5.1 and 2.5.2). No difference was seen in spontaneous
proliferation of cells from UV-irradiated mice compared with unirradiated controls
(Figure 3.6). This experiment was repeated 3 times with similar results.
T
Cbntrd LN/
Figure 3.6. Effect of UVB exposure on
proliferation of DLN cells from unsensitised
mice. Groups of 8 mice were irradiated twice a
week for 3 weeks and LN draining the irradiated
sites removed 42 h after the final exposure.
Control mice were not irradiated. Cells were
cultured for 24 h and the level of proliferation
was assessed using 3H-thymidine incorporation.
The average cpm for 3 separate experiments is
shown. Error bars show the standard deviation
(SD).
In one experiment, proliferation ofLN cells stimulated with the mitogen
concanavalin A (2.5 pg/ml for 48 h) was measured, as described in section 2.5.3.
Figure 3.7 demonstrates that the mitogen-stimulated proliferation of LN cells from
mice irradiated with UVB for 3 weeks was increased compared to controls, however
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Figure 3.7. Effect of UVB exposure on
Concanavalin A stimulated proliferation of
DLN cells from unsensitised mice. Groups of 8
mice were irradiated twice a week for 3 weeks
and LN draining the irradiated sites removed 42 h
after the final exposure. Control mice were not
irradiated. Cells were cultured in medium only
(Neg) or in the presence of the mitogen
concanavalin A (Con A) for 48 h. The level of
proliferation of cells from control (white) and
irradiated (grey) mice was assessed using 3H-
thymidine incorporation. Error bars show the SD
of 5 replicate wells. The stimulation index (SI) is
the cpm of stimulated cells divided by the cpm of
unstimulated cells.
The in vitro spontaneous proliferation ofDLN cells (Chapter 2, section 2.5.2)
from oxazalone-sensitised mice that had been challenged twice with oxazalone is
shown in Figure 3.8. The unsensitised mice receiving 2 challenges with oxazalone
showed significantly (p<0.05) higher spontaneous proliferation compared with all of
the sensitised groups. The spontaneous proliferation ofDLN cells from rIL-12 treated
mice (irradiated or unirradiated) was significantly higher (p<0.05) than that of the
unirradiated positive controls. There was no difference in spontaneous proliferation
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Figure 3.8. Effect of UVB and exogenous IL-12 on spontaneous proliferation of DLN
cells from oxazalone-challenged mice. Mice were treated as described in Figure 3.4.
Lymph nodes draining the challenge site were taken 24 h after the second challenge and
cultured overnight in the presence of 3H-thymidine; the average of 5 replicate wells is shown.
Error bars show the SD. * indicates a significant difference (p<0.05) between the negative or
rlL-12 treated groups and the positive control group.
3.3 - Discussion
3.3.1 - Effect of broad-band UVB and UVA on numbers of epidermal LC
Exposure of mice for twice a week for 3 weeks to sub-erythemal doses of
broad-band UVB (1000 J/m2) and UVA (10,000 J/m2) resulted in a decrease in the
number of LC in the UV-irradiated site. This is in agreement with previous studies
where epidermal LC numbers were reduced following multiple exposures ofmice to
sub-erythemal doses ofbroad-band UVB (500 J/m2, El-Ghorr et al, 1995) or UVA
(19320 to 42446 J/m2, Bestak and Halliday, 1996). In the study by El-Ghorr et al,
irradiation of mice 3 times a week for 3 weeks with 1000 J/m2 UVB (TL20/12)
resulted in a decrease in epidermal LC numbers at a greater magnitude (70%) than






study also showed a decrease in LC numbers following 3000 J/m TL01 3 times a
week for 3 weeks; determination of LC numbers following TL01 exposure in this
system would have made the data more complete.
The decrease in LC numbers (-50%) following a 3 week exposure to UVA was
unexpected because in a previous study, although a single MED ofbroad-band UVB
(5000 J/m2 in that study) was sufficient to deplete epidermal LC numbers, no
decrease was seen following a single MED ofUVA-1 (500,000 J/m2) (Duthie et al,
2000). The use of a chronic low-dose UVA regimen may be responsible for the
differential effects on LC numbers. Contaminating UVB wavelengths (0.5% of total
emission ofUVA lamp) were not removed with Cation X in the current study, such
that mice received a very low dose ofUVB (50 J/m2 UVB per 10,000 J/m2 UVA).
The decrease in epidermal LC following UVA irradiation may have been due to the
UVB wavelengths; however, in single exposure experiments, at least 2500 J/m2
broad-band UVB (TL20W/12) was required to cause significant depletion of
epidermal LC (Duthie et al, 2000). In the present study, UVA irradiated mice
received a total dose of only 300 J/m UVB; however it could be that multiple
exposures to very small amounts ofUVB reduces the total dose required to affect
epidermal LC numbers. In determining an action spectrum for UV-induced LC
depletion, Obata and Tagami (1985) demonstrated that a single exposure to
wavelengths of 320 nm and below reduced LC numbers, while wavelengths of 340
nm and above (UVA-I) had no effect. To rule out the possible contribution of the
contaminating UVB wavelengths to LC loss following UVA irradiation, this
experiment could be repeated using the Cation X filter such that mice are exposed
only to UVA-I.
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3.3.2 - Effect of 3 week broad-band UVB on DC in DLN
A number of studies have provided evidence that the decrease in LC numbers
following UV exposure is due to the migration of LC from the skin. Experiments
involving cannulation of draining afferent lymph vessels have demonstrated an
increase in lymph flow and cell output after UVB-exposure of human volunteers
(Yawalkar et al, 1998), and an increase in the number of LC in afferent lymph
draining the skin of UVB-irradiated sheep (Dandie et al, 2001).
In the current study, as reported previously by Moodycliffe et al (1992), the
number of DC in the DLN was increased in mice that had received a single dose of
UVB, providing evidence that UVB exposure results in migration of epidermal LC to
the DLN; in a previous study, a single UVA-I exposure also increased DC number in
the DLN (Duthie et al, 2000). In contrast, following a chronic 3 week UVB protocol,
the number ofDC in DLN was decreased compared to unirradiated mice. In the study
by Moodycliffe et al (1992), the increase in DC number in the DLN of irradiated
mice reached a maximum at 42 h after the exposure, and then decreased rapidly to
the levels found in unirradiated mice by around 60 h. This decrease maybe due to the
re-circulation of the DC; alternatively, the DC that have migrated from the UVB-
exposed skin may apoptose upon reaching the LN. In the present study, an attempt
was made to assess the level of apoptosis of DC from the DLN of irradiated mice
using annexin V, which binds to phophatidylserine, and early marker on apoptotic
cells. No difference in the level of apoptosis in DC in DLN cell populations from
unirradiated and irradiated mice was indicated; however a high level ofbinding was
seen in DLN cells that had been enriched for DC. Since annexin V binding is an early
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marker of apoptosis, it is likely that the in vitro manipulation of the cells resulted in a
large percentage of early apoptotic cells. Using a marker for cells in the later stages
of apoptosis and taking LN from mice at various stages during the chronic irradiation
protocol might have yielded more information on the levels of apoptosis ofDC in the
DLN ofUV-irradiated mice.
In vitro studies have demonstrated that UVB-irradiated LC only show increased
apoptosis following at least 2 days in culture (Rattis et al, 1998; Tang and Udey,
1992), leading to the suggestion that LC migrating from the skin apoptose once they
have reached the DLN. Similarly, following skin painting with an irritant, DC
accumulate in the DLN, but disappear rapidly after 2 days (Ruedl et al, 2000), an
effect attributed to the death of the DC, since no DC have been observed leaving LN
via the efferent lymphatics (Smith et al, 1970). This is in contrast to DC migrating
from the skin in unsensitised mice, which demonstrate a turnover of around 30 days
(Ruedl et al, 2000). Thus, while DC that migrate from the skin in nonnal, untreated
mice can remain in the DLN for some time, LC that have migrated from UVB-
irradiated skin, some ofwhich demonstrate DNA damage (Sontag et al, 1995;
Kolgen et al, 2002), are perhaps more likely to undergo apoptosis, decreasing the
overall DC numbers in the DLN of chronically irradiated mice.
Despite the decrease in DC numbers in the DLN of irradiated mice, no
difference in expression of the cell surface molecules la and CD86 was found on DC
from DLN ofUV-exposed mice, compared to DC from unirradiated mice. Therefore,
the DC that remain in the DLN following multiple UV exposures express normal
levels of at least two of the molecules involved in antigen presentation to, and
stimulation of, T cells. The decrease in both epidermal LC and DC in the DLN
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suggests that there is a lack of available antigen presenting cells in chronically UVB-
irradiated mice, which could either lead to less effective initiation of an immune
response, or make antigen presentation by other cells such as macrophages more
important in these mice.
3.3.3 - Effect of 3 week UV irradiation on the CH response
Exposure ofmice twice a week for 3 weeks to broad-band UVB (1000 J/m ),
narrow-band TL01 (10,000 J/m2) or UVA (10,000 J/m2) significantly suppressed the
CH response to oxazalone. In the chronic exposure study by El-Ghorr et al (1995) a
six-week exposure to 3000 J/m TL01, 3 times a week, failed to suppress the CH
response; the higher dose of TL01 used in the present study could account for the
suppression. A single dose of 5000 J/m2 UVB, 50,000 J/m2 TL01 or 500,000 J/m2
UVA-I is the minimum dose required to suppress the CH response in C3H/HeN mice
(El-Ghorr and Norval, 1999); use ofmultiple exposures in this study has reduced the
dose required for suppression.
Exposure to broad-band UVB or UVA over a 3 week period decreased the
number of epidermal LC, and suppressed the CH response to oxazalone, suggesting
that UV effects on LC may play a role in UV-induced suppression of CH. A
correlation between epidermal LC density and the induction of CH responses has
been shown (Toews et al, 1990); thus, a decrease in LC numbers by UV exposure
may be enough to suppress CH. In a human study however, susceptibility to UVB-
induced suppression of CH was not related to the number of epidermal LC (Skov et
al, 1998).
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Alcalay and Kripke (1990) demonstrated that DLN cells taken from mice
sensitised through UV-irradiated skin had reduced ability to initiate a CH response in
normal mice as compared with DLN cells taken from unirradiated, sensitised mice. It
is therefore possible that UV-induced immune suppression could result from altered
antigen presentation following irradiation by UV-damaged LC. The loss of epidermal
LC following UV-irradiation is accompanied by the infiltration of inflammatory cells
such as macrophages and neutrophils (Cooper et al, 1993). Hammerberg et al (1996)
showed that UV-induced tolerance and suppression ofCH could be reversed by in
vivo anti-CD 1 lb treatment; reversal of tolerance was associated with reduced
numbers of infiltrating monocyte/macrophage cells in the irradiated site. Using DLN
cells from fluorescein isothiocyanate (FITC)-sensitised mice, it has been shown that
DLN cells from irradiated mice induce significantly less proliferation ofFITC-
specific T cells in vitro; of the Ia+ dendritic cells, a significantly higher percentage of
the cells from UV-irradiated mice expressed macrophage markers, and fewer
contained the LC-specific Birbeck granules (Bucana et al, 1994). It is possible that
antigen presentation by cells other than LC following UV-irradiation may result in a
tolerogenic response.
The use ofmultiple doses ofUV in this study is perhaps more reflective of the
everyday sunlight exposure received by individuals; however the effects ofUV on
murine LC may not equate with the response of human epidermal cells. Following in
situ UVB exposure with doses that alter the morphology and stimulatory capacity of
mouse LC, no effect is seen on the morphology or stimulatory capacity of human
epidermal cells (Goettsch et al, 1998). Kremer et al (1997) showed that LC from
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UVB-irradiated human epidermal sheets retained their ability to stimulate the
proliferation of allogeneic T cells, despite having UV-induced DNA damage.
3.3.4 - IL-12 and UV-induced suppression of CH
• 2
Mice irradiated for 3 weeks with 1500 J/nL broad-band UVB showed
significantly suppressed CH responses; mice injected with rIL-12 after each
irradiation had even more suppressed CH responses. There was no difference in the
CH response of unirradiated mice receiving or not receiving rIL-12.
The suppression of CH responses following UV irradiation has been attributed
partly to changes in cytokine profiles in irradiated mice. Irradiation with UVB results
in increased epidermal IL-10 expression, whereas UVA irradiation increases the
levels of epidermal IL-12 and IFN-y (Shen et al, 1999). In unirradiated mice IFN-y,
IL-12 and IL-4 are detectable in spleen and DLN after sensitisation with oxazalone
(Garssen et al, 1999); UV exposure daily for 4 days prior to sensitisation decreases
the levels of both IFN-y and IL-12. Schwarz et al (1996) showed that injection of
rIL-12 prior to sensitisation abrogated the suppression of CH in mice that had
received 4 consecutive daily exposures to UV. Transfer of spleen and DLN cells
from UV-irradiated, sensitised mice to nai've mice suppressed the CH response when
these mice were challenged; no suppression was seen in mice that received lymphoid
cells from UV-irradiated, rIL-12 treated donors. Similarly, rIL-12 abrogated the
suppression of the DTH response to allogeneic spleen cells following a single dose
(15,000 J/m2) ofUVB (Schmitt et al, 1995). Schwarz et al (2002) showed that rIL-12
treatment repaired UVB-induced DNA damage; it is suggested that this prevents the
production of IL-10, which is thought to be released following DNA damage
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(Nishigori et al, 1996), and which has been shown to be important in UV-induced
immunosuppression (Beissert et al, 1996; Kang et al, 1994).
The suppression of the CH response despite injection of rIL-12 following UV
irradiation in this study was therefore unexpected. In the study by Schwarz et al
(1996) mice were exposed to 1000 J/m UV (FS-20 sunlamps) for 4 consecutive days
and mice were sensitised with DNFB one day after the final irradiation; rIL-12 was
injected 3 h prior to sensitisation. In a similar study (Miiller et al, 1995), mice
received 5 consecutive daily doses ofUV (100 J/m2); injection of 500 ng rIL-12 on
the day of the final UV-exposure abrogated UV-induced suppression ofCH to
DNFB. In the present study, rIL-12 was injected 4 h after each irradiation, and the
mice sensitised 3 days after the final UV exposure; the difference in timing of rIL-12
injection may account for the lack of an effect of rIL-12 on UV-induced suppression
of CH.
It is possible that the amount of rIL-12 injected was insufficient to overcome
the suppression induced by 3 weeks exposure to 1500 J/m2 broad-band UVB. In the
study by Schwarz et al, mice received 100 ng rIL-12 3 h prior to sensitisation; while
this was sufficient to overcome suppression induced by 4 exposures of 1000 J/m
UVB, injection of 50 ng rIL-12 was not. In the present study, mice received 50 ng of
rIL-12; this dose was chosen because it was injected after each irradiation. Higher
doses of IL-12 might have been effective in reversing the UV-induced suppression;
however, repeated injection of rIL-12 can have adverse effects such as weight loss
and splenomegaly (Ryffel, 1997). Additionally, daily injection of rIL-12 (500 ng per
mouse) has been shown to cause suppression of a DTH response to alloantigen
(Koblish et al, 1998). It is thought that immunosuppression due to high doses of IL-
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12 is caused by nitric oxide-induced T cell apoptosis (Lasarte et al, 1999). Repeated
injection of 50 ng rIL-12 had no effect on the CH response in unirradiated mice,
although suppression of CH in irradiated mice (40%) was higher (but not
significantly) in those treated concomitantly with rIL-12 (70%). It is possible that in
this protocol rIL-12 is enhancing UV-induced suppression through the action ofnitric
oxide; determination of apoptosis levels in the spleen or DLN, or treatment ofmice
with a nitric oxide synthase inhibitor, would perhaps have shown if this had a role in
the increased suppression seen in rIL-12 treated UV-irradiated mice.
Following a second challenge with oxazalone, the amount ofUV-induced
suppression was decreased from 40% to 22%; in single challenge experiments the
amount ofUV-induced suppression decreases as the concentration of the challenge
contact sensitiser is increased (Miyauchi and Horio, 1995). Previous studies by
Shimizu and Streilein (1994a, 1994b) demonstrated UVB-induced tolerance, such
that upon a second challenge with a contact sensitiser (14 days after the first
challenge), the CH response in irradiated mice remained significantly suppressed
compared with controls. It is possible that challenging the mice a second time in the
present study is causing the UVB-induced tolerance to be overcome; it would have
been interesting to see if further challenges would have further decreased the
suppression in UV-irradiated mice.
3.3.5. - Effect of UVB exposure on in vitro proliferation ofDLN cells
Despite the decrease in DC number in the DLN ofmice exposed to broad-band
UVB over a 3 week period, there was no change in the in vitro spontaneous
proliferation of the DLN cells. In a previous study, mice exposed to a single UVB
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2dose (1440 J/m ) showed an increased proliferative response to Con A (El-Ghorr and
Norval, 1997); however, in the present study, the ability ofDLN cells to proliferate in
response to Con A was not affected by 3 weeks exposure to UVB. These results are
in agreement with a study using human volunteers, who received whole body
irradiation with 0.8 MED UVB on 5 consecutive days. The irradiation had no effect
on the in vitro spontaneous or Con A stimulated proliferation of peripheral blood
leukocytes (Weichenthal et al, 2000).
In mice that had been challenged with oxazalone, the DLN cells from all
groups showed a very high spontaneous proliferation, probably due to the mice being
challenged twice. DLN cells from mice that had been previously sensitised with
oxazalone showed a lower spontaneous proliferation compared with unsensitised
mice. This is perhaps unexpected, however it is not known whether DLN cells from
mice that have been sensitised and are then challenged a single time show an
increased spontaneous proliferation compared with mice that have not been
previously sensitised. Here a second challenge with oxazalone resulted in a higher
proliferation in unsensitised mice compared with previously sensitised mice. It is
possible that the proliferation ofLN cells from previously sensitised mice had
reached a peak on or before the second challenge.
Proliferation ofDLN cells from mice that had received rIL-12 (irradiated and
unirradiated) was increased compared with controls, which is consistent with the role
of IL-12 as a mediator ofCH responses. As with LN cells removed from nai've mice
and stimulated in vitro, UVB exposure had no effect on proliferation of cells from
mice that had received a challenge in vivo. Challenge of the mice a single time might
have given more informative results, as it would have shown whether the increase in
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proliferation that is seen in mice that have been previously sensitised is affected by
prior exposure to UVB.
3.4 - Summary of Chapter 3
Following 3 weeks of broad-band or narrow-band UVB, or UVA exposure,
irradiated mice have decreased numbers of epidermal LC, and suppressed CH
responses; thus the immune systems of irradiated mice at the time of fibrosarcoma
cell injection are altered compared with unirradiated controls. Mice irradiated with a
single dose ofUVB have increased DC numbers in the LN draining the irradiated
skin, which is thought to be due to LC migration from the skin. Mice exposed to
UVB six times over a period of 3 weeks have decreased DC numbers in the skin
draining LN compared with control, unirradiated mice. This decrease suggests that
there is a lack of available APC in chronically UVB irradiated mice, which may play
a part in UVB-induced immunosuppression.
Injection of rIL-12 after a single UV exposure has been shown previously to
reverse UV-induced suppression, suggesting that induction of suppressor cells by UV
exposure is overcome by rIL-12 treatment. This study has demonstrated that in a
chronic protocol, rIL-12 did not reverse UVB-induced suppression, rather, the
suppression was greater in irradiated mice treated with rIL-12. Perhaps the use of low
doses of rIL-12 in a chronic UVB protocol increases UV-induced suppressor cell
activity, rather than abrogating it.
Exposure ofmice to UVB over a period of three weeks has no effect on the in
vitro spontaneous proliferation ofDLN cells from either unsensitised mice, or mice
that have been challenged twice with oxazalone. UVB exposure also had no effect on
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the in vitro proliferation ofDLN cells in response to mitogenic stimulation; thus, the
immunosuppression resulting from chronic UVB exposure is not related to an effect
on the proliferative ability of cells from LN draining the irradiated site.
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Chapter 4
Effect of UV irradiation with broad-band UVB, TL01 or UVA-I
on outgrowth of fibrosarcoma cells in vivo
4.1 - Introduction
Kripke and Fisher (1976) demonstrated that antigenic UV-induced skin tumours,
which are rejected upon transplantation into immunocompetent mice, grow
progressively when transplanted into mice that have been UV-irradiated for several
weeks prior to tumour implantation. Experiments using spleen cell transfers revealed
that the effect ofUV exposure was immunological. Since then, it has been shown that
UV radiation has numerous effects on the immune system, including alterations of
epidermal antigen presenting cell numbers (Duthie et al, 2000), changes in cytokine
expression (Shen et al, 1999), and suppression of CFI and DTH responses (El-Ghorr and
Norval, 1999).
A study using Skh-1 albino hairless mice demonstrated that the most effective
wavelength for induction of skin cancer was 293 nm, which lies within the UVB (290-
320 nm) range (de Gruijl et al, 1993). A shoulder of effectiveness at 10"4 of the
maximum resulted from exposure ofmice to wavelengths over 340 nm, suggesting a
possible role for UVA (320-400 nm) in the generation of skin cancer.
It is not known whether there is a most effective wavelength for the suppression
of anti-tumour immune responses. In the study by Kripke and Fisher (1976), the lamps
used emitted broad-band UV wavelengths. Using a UV-induced fibrosarcoma, De Fabo
and Kripke (1980) demonstrated that mice exposed to an FS40 sunlamp (87% of total
output lies between 255-340 nm) were rendered susceptible to enhanced outgrowth of
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subsequently implanted tumours. Increased tumour outgrowth in irradiated mice was
not affected by the removal of wavelengths below 275 nm; however, removal of
wavelengths below 315 nm abrogated the enhanced outgrowth of tumours in irradiated
mice. Chapter 2 and previous studies have demonstrated that both TL01 (311-313 nm)
and UVA (340 - 400 nm) exposure affects immune parameters in mice, including the
suppression of the CH response, and loss of LC from the epidermis. The immune
alteration that leads to increased tumour outgrowth in irradiated mice can be transferred
by spleen cells to unirradiated mice, suggesting that the UV-induced suppression of
anti-tumour immunity is systemic. Additionally Fisher and Kripke (1977) demonstrated
that when two mice, one irradiated and one unirradiated, were joined parabiotically,
subsequently implanted tumours grew progressively in both mice.
In the present study, using a moderately immunogenic fibrosarcoma (FSA) cell
line, the effect of exposure ofmice to the UVA and TL01 lamps on the growth of
subsequently injected FSA cells was compared with that of a lamp emitting broad-band
UVB (TL12, 280-320 nm). The systemic effects of broad-band UVB exposure on
enhanced tumour cell outgrowth in irradiated mice were assessed by injection of FSA
cells either into a non-irradiated skin site, or intravenously, which results in the
formation ofmeasurable colonies in the lung (Milas et al, 1974).
Previous studies have demonstrated that injection of exogenous IL-12 between
UV exposure and antigen application can overcome UV-induced suppression of CH and
DTH responses; IL-12 injection can also break UV-induced tolerance (Schwarz et al,
1996; Schmitt et al, 1995). As will be discussed in more detail in chapter 6, in vitro
incubation of tumour antigen pulsed epidennal cells with cA-UCA suppresses their
ability to induce and elicit anti-tumour responses upon injection into mice (Beissert et
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al, 1997); this suppression can be abrogated by incubation of the epidermal cells with
exogenous IL-12 (Beissert et al, 2001). In the present study, the effect of in vivo
administration of exogenous IL-12 on UVB-enhanced tumour outgrowth is examined.
4.2 - Results
4.2.1 - Growth of FSA cells after injection into the dorsal skin of C3H mice
In order to determine a suitable number of FSA cells to use when testing the
effects ofUV on FSA cell outgrowth, untreated mice were injected in four shaved
dorsal sites with varying numbers of FSA cells, as described in section 2.4.1. Figure 4.1
shows that following injection of 103 FSA cell in four dorsal sites, no palpable tumours
were apparent by 14 days post inoculation. Injection of 104 FSA cells resulted in the
appearance of palpable tumours at seven days, and by day 14 tumours were apparent in
around 30% of the inoculation sites; injection of 105 cells gave rise to tumours in all the
inoculation sites. It was therefore decided to use 7.5 x 104 FSA cells when assessing the
effect ofUV on tumour cell outgrowth, as injection with too few, or too many, FSA
cells can give rise to tolerance and the induction of suppressor cells (McBride and
Howie, 1986).
Figure 4.2 shows a mouse 10 days after injection of 7.5 x 104 FSA cells in 4
dorsal sites, where tumours were first apparent by day 4 post-inoculation. The majority
of tumours grew to approximately 4 mm diameter, at which point the growth rate
declined (around day 15). Some tumours continued to grow until they reached 10 mm
diameter, at which point the mice were killed for humane reasons; mice were also killed
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Figure 4.1. Incidence of tumours following injection of varying numbers of FSA cells.
Mice (4-6 per group) received four injections into shaved dorsal skin of 103 (O), 104 (A),
8.4x104 (□) or 105 (A) FSA cells per site. Tumour incidence is the percentage of FSA injected
sites where a palpable tumour formed.
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Figure 4.2. Growth of tumours following subcutaneous injection of FSA cells. Injection of
7.5 x 104 FSA cells in four dorsal sites gave rise to four visible tumours in this mouse, indicated
by the arrows, 10 days later.
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4.2.2 - Effect of broad-band UVB exposure on outgrowth of FSA cells
A dose of 1500 J/m2 broad-band UVB (TL12) represents one MED in C3H mice;
previous studies that demonstrate an increase in tumour growth following UVB
exposure have used doses much higher than 1 MED (De Fabo and Kripke, 1980; Kripke
and Fisher, 1976). Exposure ofmice twice a week for three weeks to 1000 J/m2 UVB
results in suppression of the CH response (section 3.2.3); therefore this dose was
initially used to determine whether prior exposure ofmice to sub-erythemal doses of
UVB caused increased tumour outgrowth. Mice were irradiated on their shaved dorsal
skin twice a week for three weeks; 7.5 x 104 FSA cells were injected 24 h after the final
irradiation (section 2.4.1). The size of the resulting tumours was no different to that of
the tumours in unirradiated controls (Figure 4.3). Increasing the dose ofUVB to 1200
J/m however, resulted in a significant (p<0.05) increase in the size of the tumours
(Figure 4.3). Following FSA cell injection, one group ofmice continued to receive 1200
J/m twice a week; continuation of the UVB exposure did not further increase the UV-
enhanced outgrowth of the tumours (Figure 4.3).
To determine whether the three week period ofUVB exposure was necessary to
enhance FSA cell outgrowth, mice were exposed to 1500 J/m UVB twice a week for
one, two or three weeks and 7.5 xlO4 FSA cells injected 24 h after the final irradiation.
In figure 4.4a, mice exposed to UVB twice a week for three weeks showed significantly
(p<0.05 compared to unirradiated controls) increased tumour outgrowth from day 13,
the first day ofmeasurement.
Exposure ofmice to UVB twice a week for only two weeks did not have a
consistent effect on tumour cell outgrowth. In the experiment represented by Figure
4.4a, mice irradiated for two weeks prior to FSA cell injection showed increased tumour
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Day post FSA cell injection
Figure 4.3. Growth of FSA cells in C3H mice following 3 weeks broad-band UVB (TL12)
exposure. Groups of mice (15-17) were irradiated twice a week for 3 weeks with 1000 (□) or
1200 (A) J/m2 TL-12. Control mice were not irradiated (•). FSA cells were injected 24 h after
the final UV exposure. One group continued to receive 1200 J/m2 TL12 twice a week following
FSA cell injection (A). * indicates a significant difference (p < 0.05) between the unirradiated
group and the groups irradiated with 1200 J/m2. Error bars show the SEM.
outgrowth compared to unirradiated controls, although this was to a lesser extent than
mice exposed to UVB for three weeks, and was not significantly more than unirradiated
controls. Whereas two weeks UVB exposure had no significant effect on tumour
outgrowth in Figure 4.4a, Figure 4.4b shows that two weeks exposure ofmice to 1500
J/m2 UVB prior to FSA cell injection resulted in a significant (p<0.05 on days 7 to 17)
decrease in the size of the resulting tumours compared with unirradiated controls.
Exposure ofmice to UVB for only one week had no effect on the outgrowth of
subsequently implanted FSA cells, as compared to unirradiated controls (Figure 4.4b). It
was therefore decided that the three week protocol was the most suitable for
experiments using the broad-band UVB source.
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Day post FSA cell injection
Figure 4.4. Growth of FSA cells following 1,2 or 3 weeks broad-band UVB (TL-12)
exposure. Groups of mice (8-9) were irradiated with 1500 J/m2 broad-band UVB twice a week
a) for 2 (□) or 3 (A) weeks prior to FSA cell injection or b) for 1 (x) or 2 (□) weeks prior to FSA
cell injection. Control mice were not irradiated (•). FSA cells were injected 24 h after the final UV
exposure. * and t indicate a significant difference (p<0.05 and p<0.005 respectively) between
the control group and the groups irradiated for 3 (chart a) or 2 (chart b) weeks prior to FSA cell
injection. Error bars show the SEM.
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4.2.3 - Effect of UVA-I and TL01 exposure on outgrowth of FSA cells
The majority of studies on UV-enhanced tumour outgrowth have used lamps
emitting wavelengths that are mostly within the UVB range. In the previous chapter,
exposure of mice for 3 weeks to either the UVA or the TL01 lamps caused suppression
of the CH response and loss of LC from the epidermis (section 3.2.3 and 3.2.1). To
determine whether the effects of exposure to these lamps on immune parameters
extended to suppression of the ability to control FSA cell outgrowth, mice were exposed
to either UVA-I (340-400 nm) or TL01 (311-313 nm) twice a week for three weeks
prior to FSA cell injection (section 2.1.4 and section 2.4.1).
Irradiation with 10,000 J/m2 UVA-I did not increase the size of the tumours in
irradiated mice compared with unirradiated controls (Figure 4.5); increasing the UVA-I
















Figure 4.5. Growth of FSA cells in C3H mice following UVA-I exposure. Groups of 9 mice
were irradiated twice a week for 3 weeks with 10,000 (□) or 500,000 (A) J/m2 UVA-I. Control
mice were not irradiated (•). FSA cells were injected 24 h after the final UV exposure. Error bars
show the SEM.
Day post FSA cell injection
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2Irradiation ofmice for 3 weeks with 14,000 J/m TL01 prior had no effect on the
outgrowth of subsequently injected tumour cells (Figure 4.6). Continuing the irradiation
protocol however, resulted in a significant increase in the size of the resulting tumours,
beginning on day 18 post-injection.
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Figure 4.6. Growth of FSA cells in C3H mice following narrow-band UVB (TL01) exposure.
Groups of 12 mice were irradiated twice a week for 3 weeks with 14,000 (□) J/m2 TL01. Control
mice were not irradiated (•). FSA cells were injected 24 h after the final UV exposure. One
group continued to receive 14,000 J/m2 TL01 twice a week following FSA cell injection (A). *
and f show a significant difference (p < 0.05 and p < 0.005 respectively) between the
unirradiated group and the group irradiated with TL01 before and after FSA cell injection. Error
bars show the SEM.
4.2.4 - IL-12 and UV-enhanced FSA cell outgrowth
The effect of exogenous IL-12 (rIL-12) on UVB-enhanced tumour outgrowth was
determined by irradiating mice twice a week for 3 weeks with 1500 J/m2 broad-band
UVB (section 2.1.4); rIL-12 was injected intraperitoneally 4 h after each irradiation
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(section 2.1.6). Control groups received UVB only or no treatment. FSA cells (7.5 x 104
per site) were injected 24 h after the final irradiation (section 2.4.1).
As seen previously in section 4.2.2, mice irradiated with 1500 J/m UVB showed
increased outgrowth of the injected FSA cells. In mice that received rIL-12 after each
injection, the size of the resulting tumours was significantly (p<0.05) increased
compared to unirradiated controls at all time points measured (Figure 4.7). The tumour
area on irradiated rIL-12 treated mice was also greater than that on irradiated mice that
had not received rIL-12 treatment; the difference between these two groups was
















Figure 4.7. Effect of exogenous IL-12 on UVB-induced enhancement of FSA cell
outgrowth. Groups of mice (11-12) were irradiated with 1500 J/m2 UVB twice a week for 3
weeks, and received rIL-12 4 h after each irradiation (□). Control groups received broad-band
UVB only (A), or were not irradiated or treated with rIL-12 prior to FSA cell injection (•). FSA
cells were injected in 4 dorsal sites 24 h after the final UV exposure. * indicates a significant
difference between the unirradiated control mice and the irradiated mice treated with rIL-12. A
indicates a significant difference between the irradiated mice and the mice that were treated
with rIL-12 after each irradiation. Error bars show the SEM.
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4.2.5 - Effect of UVB exposure on tumour outgrowth in unirradiated skin of
irradiated mice
The effect of 3 weeks exposure to broad-band UVB on the outgrowth of tumour
cells in an unirradiated skin site was assessed by irradiating mice twice a week for three
weeks on shaved dorsal skin with 1500 J/m2 UVB, and injecting 7.5 x 104 FSA cells in
4 sites in the ventral skin 24 h after the final exposure, as described in section 2.4.2.
Control groups received FSA cells in unirradiated dorsal skin. Whereas injection of
FSA cells into irradiated skin results in increased outgrowth of the resulting tumours,
irradiation ofmice had no effect on the growth of tumour cells injected into unirradiated
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Day post FSA cell injection
Figure 4.8. Effect of broad-band UVB exposure on outgrowth of FSA cells in a non-
irradiated site. Groups of 12 mice were irradiated twice a week for 3 weeks with 1500 J/m2
TL12. The ventral skin was shaved 24 h before the final UV exposure; FSA cells were injected
in 4 ventral sites (□) 24 h after the final UV exposure. Control mice were not irradiated (•). Error
bars show the SEM.
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4.2.6 - Effect of UVB exposure on formation of tumours in the lung
Injection of FSA cells intravenously into the tail vein ofmice, which results in the
formation of colonies in the lung that can be counted by eye, has been used as a model
of systemic spread of tumours (Kripke and Fidler, 1980; Milas et al, 1974). To assess
whether sub-erythemal UVB exposure affected the formation of tumours in a systemic
body site that is non-skin associated, mice were irradiated twice a week for 3 weeks
with 1500 J/m2 UVB. FSA cells (7.5x104 per mouse) were injected into the tail vein 24
h after the final UV exposure; two weeks later, mice were killed, their lungs removed
and the number of lung colonies counted after fixation (Figure 4.9, section 2.4.3).
Figure 4.9. Formation of lung tumours following intravenous injection of FSA cells. FSA
cells (7.5x105) were injected into the tail vein of an unirradiated mouse. The lungs were
removed 14 days later and stained with Bouin's fluid, such that the pale yellow tumours are
easily differentiated from the surrounding tissue.
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Table 4.1 shows the results of 4 separate experiments. The number of colonies produced
in the lungs varied greatly between mice within a single group. No consistent effect of
UV exposure was seen on the number of colonies formed in the lungs of irradiated
mice. In experiments 1 and 4, the number of lung colonies was decreased in irradiated
mice. However, in experiment 2, the number of lung colonies was increased in UV-
exposed mice; in experiment 3, the number of colonies formed in the lungs of irradiated
mice was unchanged from that in unirradiated controls.
Mean number of lung colonies per mouse (range)
Experiment Control UV
1 11 (1-31) 4 (0-9)
2 36 (7-108) 94 (7-200)
3 18 (0-105) 18 (3-72)
4 41 (6-168) 6 (1-20)
Table 4.1. Effect of broad-band UVB exposure on formation of lung colonies by FSA cells.
Groups of mice (6-14) were irradiated twice a week for 3 weeks with 1500 J/m2 broad-band UVB.
FSA cells were injected intravenously 24 h after the final UV exposure. The lungs were removed
14 days later and stained using Bouin's fluid. Numbers in brackets show the range.
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4.3 - Discussion
4.3.1 - Growth of FSA cells following injection into the skin of C3H mice
The tumour cells used in this study were from a fibrosarcoma induced by
methylcholanthrene treatment of C3H mice; FSA cells from this tumour are moderately
immunogenic. Immunisation of C3H mice with these cells results in development of
tumour-specific T helper activity (Howie and McBride, 1982); the intratumoral host cell
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populations have been well characterised (McBride et al, 1992) and consist mainly of
macrophages, with a small component ofCD4+ and CD8+ cells. The induction of an
immune response to the FSA cells is dependent on the number of cells injected, such that
if too few or too many are injected, tolerance occurs (McBride and Howie, 1986). In the
present study, mice received varying doses of FSA cells to ascertain the number of cells
that would produce tumours in at least 50% of the inoculation sites. No tumours were
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seen following injection of 10" cells per site, and injection of 10 cells resulted in
tumours in all inoculated sites. A dose of 7.5xl04 cells per site was chosen for use in all
further experiments, such that tumours would be induced without the use of a high dose
of cells that might overwhelm any enhancing effect ofUV exposure on tumour growth.
4.3.2 - Effect of broad-band UVB exposure on outgrowth of FSA cells
Previous studies have shown that antigenic UV-induced murine tumours,
including fibrosarcomas and melanomas, grow progressively upon transplantation into
UV-irradiated hosts. In the current study, irradiation of mice twice a week for three
weeks with 1200 J/m broad-band UVB (280-360 nm) resulted m enhanced outgrowth of
FSA cells injected into the UV-irradiated skin. There may be a minimal dose
requirement as 1000 J/m2 had no effect. A minimal dose requirement for UV-enhanced
outgrowth ofK1735 mouse melanoma cells was demonstrated by Romerdahl et al
(1988). Exposure ofmice twice a week for four weeks to 5640 J/m2 (FS40 sunlamps)
caused increased outgrowth of melanoma cells injected intrapinnally; however, doses of
2820 J/m2 and below had no effect. The decreased dose requirement in the present study
2 2
compared to that study (1200 J/m versus 5640 J/m ) could be due to a number of factors
such as the differences in UV source, tumour site, cell type and cell numbers used (105
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per site in that study, as opposed to 7.5xl04 here). Additionally, Romerdahl et al injected
the melanoma cells into the irradiated ears of unshaved mice; the larger surface area of
the shaved mice exposed to UVB in the present study could have reduced the actual dose
required for increased tumour cell outgrowth.
Donawho et al (1994) looked at the relationship between UV-induced erythema
and UV-enhanced tumour melanoma outgrowth, and found that doses sufficient to
cause erythema in C3H mice did not cause increase outgrowth of implanted tumours in
these mice. Increased tumour outgrowth in that study only occurred following multiple
exposures ofmice to UVB doses that were many times 1 MED. In the present study
however, enhanced outgrowth of FSA cells was seen following irradiation of C3H mice
with doses ofUVB that do not cause erythema in these mice.
In the study by Romerdahl et al (1988), irradiation ofmice twice a week
beginning immediately after melanoma cell injection caused increased outgrowth in
previously unirradiated mice. In the present study, continued exposure ofmice to 1200
J/m UVB after tumour injection did not further increase tumour outgrowth compared
with mice that were irradiated prior to, but not following, FSA cell injection. Thus, in
the FSA model, increased outgrowth of FSA cells in irradiated mice appears to depend
mostly on effects ofUV on mice prior to FSA injection.
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Exposure ofmice to a dose of 1500 J/m twice over a single week prior to FSA
cell injection had no effect on tumour outgrowth compared with unirradiated controls.
In one experiment, exposure ofmice to UVB for two weeks prior to FSA cell injection
caused increased tumour outgrowth, although to a lesser extent than seen following 3
weeks UVB exposure. However, when this experiment was repeated, exposure ofmice
to UVB for two weeks prior to FSA cell injection significantly decreased tumour
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growth compared with controls. Slight differences in the timing of the irradiation, the
length of time between the final irradiation and FSA cell injection and age of the mice
may have given these variable results. Exposure of nude mice to lower doses ofUVB
than those required for increased outgrowth ofmelanomas, for 4 weeks prior to
melanoma cell injection resulted in decreased incidence of melanomas compared to
control mice (Donawho and Kripke, 1991). It is possible that certain doses ofUV may
suppress the in vivo growth of tumour cells in a non-immunological, non-specific way,
or through activation of some immune parameters such as mast cell degranulation, and
release of histamine and prostaglandins.
4.3.3 - Effect ofUVA-I and TL01 exposure on outgrowth of FSA cells
In previous reports investigating the effects ofUVA radiation on immune
responses, a variety of sources and filters have been used, making it difficult to compare
one study with another. In the present study, wavelengths below 340 nm were excluded
by a Cation X screen. It was shown that prior exposure to the UVA-I lamp had no effect
on the growth of the FSA tumours. This supports the findings by Aubin et al (1991) that
prior exposure ofmice to UVA does not result in progressive growth of subsequently
implanted melanomas. In a previous study, exposure of BALB/c mice to FS40 Sunlamps
increased the growth of subsequently implanted UV-induced fibrosarcomas (De Fabo
and Kripke, 1980). Use of filters that removed 99% ofwavelengths below 275 nm, or
99% ofwavelengths below 315 nm, demonstrated that the most effective wavelengths
for UV-enhanced tumour outgrowth most probably lay within the UVB range. A study
by de Gruijl et al (1993) demonstrated that for induction of skin cancer in hairless mice,
the most effective wavelength was 293 nm, which lies within the UVB range; however,
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wavelengths within the UVA range were also effective, although to a much lesser extent.
In a model using the opossum Monodelphis domestica, exposure to UVA (over 320 nm)
3 times a week for 87 weeks gave rise to non-melanoma skin tumours in the UV-
irradiated sites in 50% of the animals (Ley, 2001).
It is possible that the dose ofUVA used was not high enough to cause
suppression of anti-tumour responses; alternatively it may be that, although UVA can
induce tumours, these wavelengths do not initiate the suppressive events required for
increased tumour cell outgrowth. The UV-induced tumours that are reported as highly
antigenic were all induced by exposure to wavelengths in the UVB range (Kripke,
1974); it is not known whether UVA-induced tumours demonstrate the same degree of
antigenicity.
The TL01 lamp has an output mainly within the UVB range, with a peak (51%) at
311 nm. Exposure ofmice to 14,000 J/m TL01 for 3 weeks prior to inoculation with
FSA cells had no effect on the outgrowth of the subsequent tumours; however, in mice
that continued to be irradiated after tumour cell injection, the resulting tumours were
significantly increased in size compared with those in unirradiated mice. It is not clear
whether this effect of the TL01 exposure was on the FSA cells themselves, or on the
host. Exposure ofmice to a wider range of doses ofTL01 prior to FSA cell injection
would have clarified whether the increased tumour outgrowth was due to an effect on the
mice.
Despite the ability of both the UVA and TL01 lamps to decrease LC numbers to a
similar extent as the broad-band UVB lamp as reported in Chapter 3, this does not
correlate with an effect on outgrowth of FSA cells in irradiated mice in the current study.
In a study by Grabbe et al (1991), epidermal LC that had been pulsed with tumour
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antigen (TA) prior to injection into mice, protected mice from growth of subsequently
implanted tumours. However, Cavanagh et al (1997) demonstrated that although TA-
pulsed LC could induce a DTH response to subsequently injected tumour cells, they did
not induce protection against the outgrowth of injected tumour cells.
Halliday et al (1991) showed that UV exposure ofmice before and after injection
of tumour cells significantly decreased the number of LC in the epidermis above and
adjacent to the tumour. However, whereas a non-immunogenic tumour attracted
numerous LC in and around the tumour, significantly less LC were present in and
around an immunogenic tumour, questioning the importance of LC in anti-tumour
immunity. In a study using FS40 sunlamps, exposure ofmice to doses that were
sufficient to reduce epidermal LC numbers did not cause enhanced melanoma outgrowth
(Donawho and Kripke, 1992).
It is possible that, as the tumours are injected subcutaneously, and therefore
below the epidermis, LC are not the most important APC for induction of immunity to
the tumours. Immunisation of mice with TA-pulsed dermal cells gave protection against
the growth of subcutaneously injected tumour cells; this effect was dependent upon Ia+
dermal cells (Campton et al, 2000). Other candidate APCs for induction of tumour
immunity are LN dendritic cells. As demonstrated in Chapter 3, the number of DC is
decreased in LN draining the irradiated skin of mice exposed to broad-band UVB for 3
weeks. It would be interesting to assess DC numbers in LN draining the irradiated skin
ofmice exposed to UVA-I, or TL01 for 3 weeks to demonstrate whether they correlated
with FSA cell outgrowth in irradiated mice.
Exposure to either the UVA or TL01 lamps for 3 weeks suppressed the CH
response to oxazalone in C3H mice, as noted in Chapter 3; however, this did not
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correlate with the ability to cause increased FSA cell outgrowth. The opposite effect was
seen by Donawho and Kripke (1992), such that a 4 week irradiation ofC3H mice with
FS40 sunlamps, which increased the outgrowth of implanted melanomas, did not result
in suppression of the CH response. Thus the CH assay, which is commonly used to
assess UV-induced immunosuppression, is perhaps not a good model for the effects of
UV on immune responses in skin cancer. Another useful model for UV-induced
immunosuppression is the DTH assay. However, it has been demonstrated that, although
treatment of C3H mice with plant poly/oligosaccharides overcomes UVB-induced
suppression ofDTH to alloantigen, this treatment does not prevent UVB-induced
suppression of the ability to reject highly antigenic tumour cells (Strickland et al, 2001).
Using models of cell-mediated immunity such as DTH and CH responses to investigate
the mechanisms ofUV-induced immunosuppression may not yield answers that are
relevant to suppression of tumour immunity. As will be described in the next chapter, no
DTH response to FSA cells could be detected in mice bearing FSA tumours; therefore
this could not be used as a model for detecting UV-induced suppression of anti-tumour
responses.
4.3.4 - IL-12 and UV-enhanced FSA cell outgrowth
In the present study, treatment with rIL-12 concomitantly with UVB exposure
failed to reverse the UVB-induced increase in FSA cell outgrowth. This was unexpected
for a number of reasons. First, as discussed in the previous chapter, injection of rIL-12
after UV treatment has been reported to reverse both UV-induced suppression of
hypersensitivity responses, and UV-induced tolerance (Schwarz et al, 1996; Schmitt et
al, 1995). Second, rIL-12 treatment has been shown to have anti-tumour effects in
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murine sarcoma, adenocarcinoma and melanoma models (Nastala et al, 1994; Brunda et
al, 1993). FSA cells that have been infected with a murine IL-12 expressing viral vector
prior to injection into mice, show significantly decreased tumour outgrowth compared
with uninfected FSA cells (Meko et al, 1996). Finally, cA-UCA induced suppression of
induction of anti-tumour immunity by TA-pulsed epidermal cells can be overcome by
treatment of the epidermal cells with exogenous IL-12 (Beissert et al, 2001).
The increase in tumour growth in mice treated with both rIL-12 and UVB seen in
the present study could be due to the fact that, unlike in previous studies, the rIL-12
treatment was given prior to FSA cell injection. The inclusion of a control, unirradiated
rIL-12 treated group would have given information on whether prior treatment with rlL-
12 alone affects tumour cell outgrowth. Despite not including this control group, it is
interesting that mice treated with rIL-12 after each UVB exposure did not show reversal
ofUVB-induced suppression of CH or increased FSA cell outgrowth. In the literature,
IL-12 is recognised as a stimulator of immune responses, which can overcome tolerance
in many different models. IL-12 failed to have an effect in one study using a mouse lung
carcinoma model, where the tumours increase the numbers of granulocyte-macrophage
progenitors; these granulocyte-macrophage progenitors cause immunosuppression in
tumour-bearing mice. In that study, rIL-12 treatment had little effect on the immune
suppression, and even increased the number of the granulocyte-macrophage progenitors
(Prechel et al, 1995). It could be speculated that in the present study, rIL-12 treatment
might increase the numbers ofmonocyte/ macrophages that infiltrate the UV-irradiated
skin to induce immune suppression and tolerance induction (Flammerberg et al, 1996).
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4.3.5 - Growth of FSA cells in unirradiated skin of UVB-irradiated mice
When two mice, one irradiated and one unirradiated, were joined parabiotically,
subsequently implanted tumours grew progressively in both mice (Fisher and Kripke,
1977), suggesting that the effect ofUV exposure on tumour outgrowth is systemic,
capable of acting at sites distant from the irradiated skin. In the present study, mice were
irradiated over a period of 3 weeks with 1500 J/m UVB, a dose sufficient to enhance
the outgrowth of FSA cells in the irradiated site. Following injection ofFSA cells into
the unirradiated ventral skin of irradiated mice, there was no increase in the outgrowth of
the subsequent tumours compared to those in unirradiated control mice. The dose of
UVB received by the mice may not have been high enough to have systemic effects; in
the study by Fisher and Kripke (1977) mice were irradiated for three months (10,000
J/m2, three times a week) prior to being joined to unirradiated mice.
Alternatively, the lack of a systemic effect ofUV exposure in the present study
could be related to the length of time between the final irradiation and injection of the
FSA cells. Mice sensitised with a contact sensitiser on irradiated skin immediately after
a four day sub-erythemal UV exposure have suppressed a CH response; however,
irradiated mice sensitised on unirradiated skin do not exhibit UV-induced suppression of
CH unless they are sensitised 3 days after the final irradiation (Shimizu and Streilein,
1994a). Mice irradiated for 12 h with a single UV dose showed increased outgrowth of
an implanted FSA tumour in irradiated skin, but only if the tumour was implanted at
least 48 h after irradiation. The results in section 4.2.2 demonstrated that for consistent
UVB-enhanced outgrowth of FSA cells in mice irradiated with 1500 J/m2 twice a week,
at least 3 weeks exposure is required. Two weeks exposure did not have a consistent
effect on outgrowth of FSA cells in the irradiated site, which could make the final
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exposure in this low-dose protocol, and therefore the timing of injection of FSA cells at
a distant, unirradiated site after this final exposure, quite critical for UV-enhanced
tumour outgrowth. On the other hand, it may be simply that the effect ofUV exposure
on FSA cell outgrowth in this study is a local one; UV-enhanced outgrowth of
melanomas in irradiated mice only occurs in the UV-exposed site, and is thought to be
due to suppression of effector cells in the irradiated skin (Romerdahl et al, 1988;
Donawho et al, 1996).
4.3.6 - Effect of UVB on formation of tumours in the lung
Injection of FSA cells intravenously into the tail vein results in the development
of tumours in the lung. This has been used as a model ofmetastasis formation of
fibrosarcomas; exposure ofmice to high doses (7800 J/m2) for 6 weeks prior to FSA cell
injection increases the number of lung colonies compared with unirradiated mice
(Kripke and Fidler, 1980). In the present study, the UVB protocol used did not have a
consistent effect on the number of lung colonies formed, such that numbers were
decreased, increased, or unchanged from those of unirradiated controls. Tail vein
injections are fairly time consuming, and during this time clumps tended to form within
the FSA cell suspension, probably due to the release ofDNA from dead cells. To
overcome this, DNase was added to the cell suspension (section 2.1.3). Additionally,
only a small volume of cells (lOOpl) was injected into the tail vein; small differences in
the actual volume received by the mice could have had affected the number of lung
tumours formed.
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4.4 - Summary of Chapter 4
Exposure ofmice to sub-erythemal doses (1200 J/m2) of broad-band UVB
induced enhanced outgrowth of FSA cells injected subcutaneously into the irradiated
skin. This effect was not seen following 1 or 2 weeks of exposure, but required an
irradiation protocol lasting at least 3 weeks. Continuing the broad-band UVB exposure
after FSA cell injection did not further increase the UV-enhanced tumour outgrowth
seen in mice irradiated prior to FSA cell injection. Therefore exposure to UVB reduces
the ability of the mice to control FSA cell outgrowth.
Despite the immunosuppressive effects of the UVA and TF01 lamps, exposure of
mice for 3 weeks to either of these wavebands had no effect on the outgrowth of
subsequently injected FSA cells. Thus UV-enhanced FSA cell outgrowth is not
correlated with loss of epidermal FC or suppression of CH. Continued exposure to TF01
after FSA cell injection resulted in a significant increase in the size of the outgrowing
tumours; perhaps the UV wavelengths emitted by this lamp act directly on the in vivo
FSA cells to stimulate growth, rather than affecting the ability of the mouse to control
tumour growth.
Injection of FSA cells into unirradiated skin ofUVB-irradiated mice did not
result in the enhanced tumour outgrowth seen following injection into irradiated skin. It
could be that the dose ofUVB used was not high enough; alternatively, UVB may only
act locally on irradiated skin to enhanced tumour growth.
Exogenous IF-12, which can stimulate anti-tumour immune responses, and
overcome UV-induced tolerance, was injected into mice after each irradiation of a 3
week UVB protocol. IF-12 treatment in this study did not reverse the UVB-enhanced
FSA cell outgrowth. Interestingly, IF-12 treatment further increased the enhanced FSA
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growth seen in irradiated mice; it may be that IL-12 potentiates the UV-induced
suppression of anti-tumour immune responses in this system.
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Chapter 5
Effect of broad-band UVB exposure prior to FSA cell injection on
immune responses in tumour-bearing mice
5.1 - Introduction
As described in Chapter 4, exposure ofmice to broad-band UVB over a 3 week
period caused increased outgrowth of subsequently injected FSA cells. Using 3 different
UV sources, it was demonstrated that enhanced tumour outgrowth was not related to
UV-induced reduction of epidermal LC numbers or suppression ofCH. It is possible
that UV exposure caused the release of substances in UV-irradiated skin that directly
stimulate the growth of the injected FSA cells; however, it is more likely that the UV
radiation increases tumour outgrowth by suppression of immune responses to the
tumour cells. Previous studies have shown that transfer of immune cells from irradiated
tumour-bearing mice to nai've mice results in increased outgrowth of implanted tumours
in the recipient mice (Fisher and Kripke, 1977), and that UV exposure only causes
increased outgrowth of antigenic tumours; outgrowth of non-antigenic tumours is not
affected by prior UV irradiation (Kripke and Fisher, 1976). In the current chapter, the
effect ofprior UVB exposure on immune responses in tumour-bearing mice is
investigated.
The FSA cells used in the present study are moderately immunogenic, therefore
initially an attempt was made to develop a way to measure anti-tumour responses in
mice that have been injected with live FSA cells. DTH responses of tumour-bearing
mice to FSA cells were compared with those ofnaive mice. Additionally, the in vitro
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proliferation of LN cells from tumour-bearing mice in response to FSA cell antigens
was tested.
In Chapter 4, the effect ofUVB on tumour outgrowth was demonstrated to be a
local one, as injection ofFSA cells into a site distant from the UVB-exposed skin of
irradiation ofmice had no effect on tumour outgrowth. Therefore, in the present chapter,
immune parameters of tumour-draining LN from irradiated mice bearing FSA tumours
were compared with those ofLN from unirradiated tumour-bearing mice, and control,
tumour-free mice.
The number of cells in the local LN draining the site of tumour cell injection was
counted in control and irradiated mice, at various time points following inoculation of
the FSA cells. The spontaneous proliferation of these DLN cells was also measured.
In a study of breast cancer patients, it was demonstrated that the
phytohaemagglutinin (PHA)- induced proliferation of peripheral blood mononuclear
cells from cancer patients was decreased compared with that of peripheral blood
mononuclear cells from healthy controls (Wiltschke et al, 1995). In the present study,
the proliferation of cells from LN draining the site of tumour injection in response to
Con A and PHA was measured; responses of cells from irradiated and unirradiated
tumour-bearing and tumour free mice were compared.
The expression ofMHC Class II, Thy 1.2, CD4 and CD8 by DLN cells from
irradiated and unirradiated tumour-bearing mice was also measured by flow cytometry
at various points during outgrowth of the FSA cells, to assess whether this was affected
by FSA cell injection.
The cytokine IL-10 has been shown to promote lung cancer growth by suppressing
T cell functions (Sharma et al, 1999) and there is also evidence that it is a mediator of
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UV-induced suppression (Kurimoto et al, 2000). The in vitro production of this
cytokine by DLN cells from tumour-bearing mice was measured to assess whether this
cytokine has a role in the increased outgrowth of tumour cells in irradiated mice.
Tumours arising from the FSA cells in this study have previously been shown to
have infiltrating host cells consisting mainly ofmacrophages, with a few CD4+ and
CD8+ cells (McBride et al, 1992). An attempt was made in the present study to assess
immunohistochemically whether prior UVB-exposure affected the infiltration of host
immune cells into the tumours that arose from injected FSA cells.
5.2 - Results
5.2.1 - Delayed-type hypersensitivity response to FSA cells by tumour-bearing
mice
To determine whether tumour-bearing mice were able to mount a DTH response to
FSA cells, mice received 7.5 x 104 FSA cells either in 4 dorsal sites or intravenously.
Control mice were injected with FIBSS only. Fourteen days later, mice were challenged
intrapinnally with irradiated FSA cells (105 per ear), and the ear swelling measured 24 h
later as described in section 2.2.2. No difference in ear swelling was seen in mice that
had had FSA cell injected dorsally compared with control mice that had not received
FSA cells prior to challenge (Figure 5.1). Mice that had received FSA cells
intravenously 14 days prior to challenge with FSA cells had slightly increased ear
swelling compared with mice that had not received FSA cells, however this increase
was not significant. The DTH response was therefore not a reliable measure of anti-
tumour immune responses in tumour-bearing mice.
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Control FSA s.c. FSA i.v.
Figure 5.1. Delayed type hypersensitivity response to FSA cells. Groups of 8 mice
were injected with 7.5 x104 FSA cells in four dorsal sites (FSA s.c.) or intravenously in
the tail vein (FSA i.v.). Control mice were injected subcutaneously in four dorsal sites
with HBSS (Control). All mice were challenged intrapinnally with irradiated FSA cells 14
days later (105 cells per ear). Error bars show the SEM.
5.2.2 - In vitro proliferation of LN cells in response to FSA cell antigens
The in vitro proliferation of immune cells from tumour bearing mice in response
to FSA cell antigens was compared with that of immune cells from tumour free controls.
A glycine extract of FSA cell tumour antigen (TA) was prepared as described in section
2.5.4. To determine whether there was an optimum TA concentration for immune cell
proliferation, live FSA cells were injected into 4 sites in the shaved dorsal skin, and
mice killed at day 22 post-FSA cell injection. The LN draining the tumour site and the
spleen were removed and disaggregated to give either LN or spleen cell suspensions
(section 2.5.1). The cells were then cultured for 96 h alone, or in the presence of varying



















Figure 5.2a, unstimulated proliferation of LN cells from tumour-bearing mice was
higher than that ofLN cells from naive, control mice. Proliferation of cells from both
groups was completely abrogated upon addition of 2000 pg/ml of FSA TA; however
this was due to an effect of the glycine extraction medium, which was toxic at the
highest concentration added, but otherwise had no effect on proliferation (section 2.5.4).
Cells from tumour bearing mice that were cultured in the presence of 20 p.g/ml ofTA
showed increased proliferation compared with unstimulated cells from the same mice,
with a SI of 2.2 (Figure 5.2a). The proliferation of LN cells from control mice was not
increased by addition ofTA at any of the concentrations tested, and the cpm of LN cells
from tumour-bearing mice was higher compared with that of controls following
incubation in 0.2-20 p,g/ml FSA TA.
Proliferation of spleen cells from the same mice is shown in Figure 5.2b. As seen
with the LN cells, unstimulated proliferation of spleen cells from tumour-bearing mice
was higher than that of spleen cells from control mice (not significant). Whereas the
increase in proliferation of LN cells in response to FSA TA stimulation was seen only in
cells from tumour-bearing mice, spleen cells from both tumour-bearing and tumour-free
mice showed increased proliferation in response to stimulation with 200 pg/ml and 0.2
pg/ml TA respectively (Figure 5.2b). Due to the low number of samples used, no
statistical tests could be done on these data.
The proliferation of LN cells in response to 20 pg/ml was assayed 2 more times at
varying incubation times (Table 5.1). As seen in Figure 5.2a, LN cells from tumour-
bearing mice showed increased unstimulated proliferation compared with cells from the
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Figure 5.2. Proliferation of immune cells in vitro in response to varying concentrations of
FSA extract. Cells from (a) LN draining the tumour site or (b) the spleen were cultured for 96 h
in medium alone (0), or with varying concentrations (0.2-2000 pg/ml) of a glycine extract of FSA
cells; 3H-Thymidine was added for the final 8 h of culture. The cells were pooled from two
tumour-bearing mice that had received 7.5 x 104 FSA cells in 4 dorsal sites (FSA) 20 days
previously, or from two untreated aged matched controls (Control). Error bars show the SEM of
3 replicate wells. Columns without SEM show the mean of 2 replicate wells. The SI is shown




















































Table5.1.ProliferationfDLNcellsinresponsetoFSAxtractf llowingv ryicu urtime .C lf mLdraihum ur sitewerecultu dfo48,7296r1 0hinthpr s ncef2pg/mloaglycinext a tFSAc lls;3H-T ymidinwad edf rth final8hofculture.Theellswetak nfromumour-bearingmict th dr c ived7.5x104FSAc llsd rsalsit(Tu our)20 dayspreviously,orfr muntreatedagematch dcontro s(Co l),ult redal neRPMI)wi hFSAx act(FSTA).R s ltsi cpmfro2separateex erimentsashow .Numb rinbr ckhowtSEM( f3-5r plicatewells).*indicat ssign ficant difference(p<0.05)betweenunstimulatedp oliferationfc lsfr tr la dtum ur-b aringmi ,indicat ss gnifica tdiff r ce (p<0.05)betweenunstimulatedc llsandincubatei hFSATA.$dic sgnificantdiffer nce(p<0.05)be weT - stimulatedproliferationfcellsfr montr latu ourbea i gic .
The level ofproliferation of cells incubated with FSA TA was significantly higher for
LN cells from tumour-bearing mice compared with LN cells from control mice, at all
time-points tested, except one. Proliferation of LN cells from tumour-bearing mice was
increased when the cells were cultured in the presence of 20 pg/ml FSA TA (Table 5.1),
compared with unstimulated cells from tumour-bearing mice, although not to the same
extent as the increase seen at 96 h in the previous experiment (Figure 5.2a). This
increase was only significant in 2 cases; additionally, LN cells from control mice also
showed significantly increased proliferation following stimulation with FSA TA in two
cases, compared with unstimulated cells from control mice. Thus the antigen-specific
FSA TA stimulated increase in proliferation of LN cells from tumour-bearing mice was
not reproducible, and was therefore considered an unreliable test of tumour-specific
responses in tumour-bearing mice.
In the following experiments, the effect ofUVB exposure ofmice prior to
injection ofFSA cells on cells of the LN (number, phenotype and in vitro proliferation)
draining the site of tumour cell injection was investigated. Mice were exposed twice a
week for 3 weeks to broad-band UVB (section 2.1.4), and FSA cells (7.5 x 104 per site)
injected into 4 dorsal sites (section 2.4.1). Control groups received FSA cells only, UVB
only, or no treatment. The mice (4 per group) were killed on days 9, 13 and 18 post-
injection of the FSA cells. These time points were chosen because following injection of
the FSA cells, at least 90 % of the mice are tumour bearing by day 9, and as the tumours
grow faster and often show signs of ulceration earlier in mice that have been exposed to
UVB, many of them require to be killed after 18 days. LN draining the site of tumour
injection were then removed and the LN for one group pooled; LN cell number,
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spontaneous and mitogen-induced proliferation of the LN cells, and cell surface marker
expression were then assessed.
5.2.3 - Cell numbers in LN draining the site of FSA cell injection
Following removal of the LN, the number of LN cells per ml was estimated by counting
with a haemocytometer as described in Section 2.5.1; the number of cells per LN was
then calculated for each group. The results of two separate experiments are shown in
Figures 5.3a and 5.3b. The number of cells/LN in unirradiated tumour-free mice
remained fairly constant over the course of a single experiment, from days 9 to 18.
In the first experiment, it can be seen that in tumour-free mice, 3 weeks exposure
to UVB had little effect on LN cell number compared with unirradiated control mice,
with only a slight increase in number on days 9 and 13 (Figure 5.3a); this group was not
included the second time the experiment was done. The results of both experiments
demonstrate that the number of cells/LN of unirradiated tumour-bearing mice was
around double that of tumour-free controls on day 9. LN cell numbers still remained
higher in tumour-bearing mice on day 13 but had decreased from day 9, and were further
decreased on day 18. In both experiments, mice that had been exposed to UVB prior to
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Figure 5.3. Effect of UVB exposure on DLN cell number in tumour-bearing mice.
Groups of 12 mice were irradiated twice a week for three weeks with 1500 J/m2 UVB,
and 7.5 x 104 FSA cells were injected in 4 dorsal sites 24 h after the final exposure
(UVR+FSA). Control groups received FSA cells but were not irradiated (FSA), were
irradiated but not injected with FSA cells (UVR), or were untreated (Control). On days
9, 13 and 18 post-FSA cell injection, 4 mice per group were killed and LN draining the
tumour-bearing skin were pooled for each group. Cell number was counted by eye
using a light microscope and the number of cells/LN calculated (a). This experiment
was repeated (b) without the inclusion of the irradiated, tumour-free group.
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5.2.4 - Spontaneous proliferation ofDLN cells
As seen in section 5.2.2, the spontaneous proliferation ofDLN cells taken from
tumour-bearing mice on day 20 post FSA cell injection was higher than in tumour-free
mice. To assess whether the increase in spontaneous proliferation of LN cells taken
from mice that had been injected with FSA cells was affected by UVB exposure of the
mice prior to FSA cell injection, LN cells taken from mice on days 9, 13 and 18 were
cultured for 24 h as described in section 2.5.2. The results of two separate experiments
are shown in Figures 5.4a and 5.4b. The spontaneous proliferation ofLN cells from
UVB exposed, tumour-free mice was unchanged from that of cells from unirradiated
tumour-free mice on days 9 and 13 and very slightly increased on day 18 (p<0.05)
(Figure 5.4a). The spontaneous proliferation of LN cells from tumour-bearing mice
(irradiated and unirradiated) was significantly higher than that of control tumour-free
mice at all time points in both experiments (Figures 5.4a and 5.4b). However, the
proliferation of LN cell from irradiated tumour-bearing mice was significantly
suppressed compared with that of LN from unirradiated tumour-bearing mice at all time
points, except for day 13 in experiment 2, when the level of spontaneous proliferation
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Figure 5.4. Effect of UVB exposure on spontaneous proliferation of DLN cells
from tumour-bearing mice. Mice were treated as described in Figure 5.3. On days 9,
13 and 18 post-FSA cell injection, 4 mice per group were killed and LN draining the
tumour-bearing skin were pooled for each group. Cells were cultured for 24 h in the
presence of 3H-Thymidine; the average for 5 replicate wells is shown (a). Error bars
show the SEM. This experiment was repeated without the inclusion of the irradiated,
tumour-free control group (b). * indicates a significant increase (p<0.05) compared with
the unirradiated tumour-free group, f indicates a significant decrease (p<0.05) of
irradiated tumour-bearing mice compared with unirradiated tumour-bearing mice.
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5.2.5 - Mitogen-stimulated proliferation ofDLN cells
In the previous section, DLN cells from unirradiated tumour-bearing mice had increased
levels of spontaneous proliferation compared with tumour-free controls; this increase
was not as high for DLN cells from mice that had been irradiated prior to FSA cell
injection. To assess whether the ability of these cells to proliferate in vitro in response to
mitogenic stimulation was also affected, DLN cells taken at days 9, 13 and 18 from
irradiated and unirradiated tumour-bearing mice were cultured for 48 h in the presence
of 2.5 pg/ml Con A or PHA as described in section 2.5.3.
The results of one experiment are shown in Table 5.2. DLN cells from tumour-
bearing mice showed significantly increased background proliferation compared to cells
from tumour-free mice on all days tested, with one exception (irradiated tumour-bearing
mice on day 13). In general, the level ofCon A-induced proliferation was also higher in
tumour bearing mice than in tumour-free controls. The overall level ofproliferation in
response to PHA was consistently lower than that to Con A; however, DLN cells from
tumour-bearing mice showed increased PHA-induced proliferation compared with those
from tumour-free mice. UVB exposure did not appear to consistently affect the mitogen-
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5.2.6 - IL-10 production by DLN cells
The release of IL-10 by DLN cells taken from mice on day 22 post FSA cell
injection and cultured in vitro was assessed as described in section 2.5.5. Following
culture for 24 h of unstimulated LN cells from untreated control mice, IL-10 was not
present in the culture supernatant in detectable amounts (more than 4 pg/ml) (Table 5.3).
After 48 h culture, IL-10 could be detected in the supernatant, and the level of IL-10 was
increased when cells had been cultured for 96 h.
Cells from tumour-bearing mice produced detectable levels of IL-10 after only 24
h culture, which continued to increase after 48 h and 96 h culture (Table 5.3). The level
of IL-10 in culture supernatants ofDLN cells after 24 h and 48 h was similar for both
UVB exposed and unirradiated mice; at 96 h, IL-10 levels were higher in the culture
supernatant from irradiated tumour-bearing mice, compared with unirradiated tumour
bearing mice.
Concentration of IL-10 in culture supernatant (pg/ml)
Culture time (h) Control FSA UVR+FSA
24 <4 97 73
48 64 271 209
96 986 1290 1771
Table 5.3. IL-10 production by cultured LN cells. LN were removed from irradiated
(UVR+FSA) or unirradiated (FSA) tumour-bearing mice, or from tumour-free controls
(Control), on day 22 post FSA cell injection. Cells were cultured for 24, 48 and 96 h
and the supernatants tested by ELISA for the presence of IL-10 protein. Values are
expressed as the mean of two replicate wells.
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5.2.7 - Phenotyping ofDLN cells
The percentages ofDLN cells expressing Thy 1.2, CD4, CD8 and MHC class II
were assessed by flow cytometry, as described in section 2.5.6. The levels for the total
cell population were measured because there are very few cells in the larger, granular
population, and the expression of a particular marker by the whole cell population was
similar to that by either the lymphocyte population or the larger, more granular cells.
The results of two separate experiments are shown in Tables 5.4-5.7; due to the
variability of the technique, the results for the two experiments could not be combined.
As the experiments were only done twice, the statistical significance of the trends could
not be evaluated.
Thy 1.2 was found on 55-78 % ofDLN cells from untreated mice (Table 5.4);
levels were similar for both irradiated and unirrradiated tumour-free mice. At all
timepoints after FSA cell injection, the percentage of Thy 1.2+ cells decreased in
unirradiated tumour-bearing mice, compared with untreated mice. Thy 1.2 expression by
DLN cells from UVB exposed tumour-bearing mice also decreased generally compared
with that in untreated mice, although not to the same extent as in unirradiated tumour-
bearing mice.
CD4 was found on 32-49 % ofDLN cells from untreated mice (Table 5.5); CD4
expression by DLN cells from UVB exposed tumour-free mice was slightly increased on
day 9, and slightly decreased on days 13 and 18, compared with unirradiated controls.
At all time points in both experiments, except one, the percentage of CD4+ cells was
decreased in the unirradiated tumour-bearing mice, compared with untreated mice
however, CD4 expression by DLN cells from irradiated tumour-bearing mice was not




Experiment Control FSA UVR UVR+FSA
9 1 55 46 60 50
2 77 71 ND 72
13 1 67 52 67 63
2 78 72 ND 76
18 1 56 50 56 59
2 73 70 ND 73
Table 5.4. Percentage of LN cells positive for Thy 1.2. LN were removed from
irradiated (UVR+FSA) or unirradiated (FSA) tumour-bearing mice, or from irradiated
(UVR) or unirradiated (Control) tumour-free controls on day 9, 13 and 18 post FSA cell




Experiment Control FSA UVR UVR+FSA
9 1 32 30 34 34
2 49 42 ND 45
13 1 43 35 39 39
2 48 43 ND 45
18 1 36 22 32 32
2 45 45 ND 45
Table 5.5. Percentage of LN cells positive for CD4. LN were removed from
irradiated (UVR+FSA) or unirradiated (FSA) tumour-bearing mice, or from irradiated
(UVR) or unirradiated (Control) tumour-free controls on day 9, 13 and 18 post FSA cell
injection. LN cells were stained for the presence of CD4, and analysed by flow
cytometry.
CD8 was found on 11-24 % ofDLN cells from untreated mice (Table 5.6); CD8
expression by DLN cells from irradiated tumour-free mice was slightly increased
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generally compared with unirradiated mice. Tumour-cell injection had little effect on
CD8+ cell numbers whether the mice had been irradiated or not.
Day post FSA
cell injection
Experiment Control FSA UVR UVR+FSA
9 1 18 16 21 16
2 23 22 ND 20
13 1 24 18 26 23
2 19 21 ND 19
18 1 11 13 11 13
2 24 20 ND 23
Table 5.6. Percentage of LN cells positive for CD8. LN were removed from
irradiated (UVR+FSA) or unirradiated (FSA) tumour-bearing mice, or from irradiated
(UVR) or unirradiated (Control) tumour-free controls on day 9, 13 and 18 post FSA cell
injection. LN cells were stained for the presence of CD8, and analysed by flow
cytometry.
MHC class II (la) was found on 5-19 % ofDLN cells from untreated mice (Table
5.7); MHC class II expression by DLN cells from irradiated tumour free mice was
similar to that of untreated controls. At all timepoints after FSA cell injection, the
number ofMHC class II+ DLN cells from unirradiated, tumour-bearing mice was
increased compared with tumour-free controls. In the first experiment, the percentage of
DLN cells expressing MHC class II from UVB exposed, tumour-bearing mice was not
increased until day 18 post-FSA cell injection. In the second experiment, the percentage
ofMHC class II+ DLN cells from irradiated tumour-bearing mice was slightly increased
on days 9 and 13, although not as much as that ofDLN cells from unirradiated tumour-
bearing mice. The histograms ofMHC class II expression by DLN cells from
129
unirradiated tumour-free and tumour-bearing mice, and irradiated tumour-bearing mice
(Experiment 1, day 13 post FSA cell injection) are shown (Figure 5.5). It can be seen
that the intensity ofMHC class II expression was increased on DFN cells from
unirradiated tumour-bearing mice, but not from irradiated tumour-bearing mice,
compared with DLN cells from control, tumour-free mice.
Day post FSA
cell injection
Experiment Control FSA UVR UVR+FSA
9 1 5 7 3 6
2 19 27 ND 24
13 1 7 13 7 7
2 18 25 ND 23
18 1 17 27 15 24
2 ND ND ND ND
Table 5.7. Percentage of LN cells positive for MHC class II. LN were removed from
irradiated (UVR+FSA) or unirradiated (FSA) tumour-bearing mice, or from irradiated
(UVR) or unirradiated (Control) tumour-free controls on day 9, 13 and 18 post FSA cell
injection. LN cells were stained for the presence of MHC class II, and analysed by flow
cytometry.
5.2.8 - Detection of tumour-infiltrating cells
Many tumours have an infiltrating population of immune cells, such as
macrophages and T cells (Zhang et al, 1998; Hakansson et al, 1997); tumours arising
from the FSA used in the present study have previously been shown to have mostly
infiltrating macrophages, with a few CD4+ and CD8+ cells (22%, 5% and 3%
respectively) (McBride et al, 1992). In the present study, an attempt was made to assess
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the prevalence of tumour-infiltrating cells, by flow cytometric analysis of the cells from
disaggregated tumours.
o
Figure 5.5. Expression of MHC class II by LN cells from control and tumour-
bearing mice. LN were removed on day 9, 13 and 18 post FSA cell injection, and the
LN cells were stained for the presence of MHC class II and analysed by flow
cytometry. The fluorescence intensity of the total cell population is shown for
unirradiated tumour-free controls (grey line), unirradiated tumour-bearing mice (blue
line) and irradiated tumour-bearing mice (orange line), on day 13 post-FSA cell
injection.
Mice were irradiated twice a week for 3 weeks prior to FSA cell injection. Tumours
were taken from these and unirradiated tumour-bearing control mice on day 18 and 24
post FSA cell injection. Tumours were disaggregated by incubation in Dispase as
described in section 2.6.1, and the expression of Thy 1.2, CD4, CD8 and CD1 lb
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analysed by flow cytometry. Following disaggregation of tumours in Dispase, cells
expressing Thy 1.2 (7-35 %), CD4 (7-24%) and CD1 lb (14-38%) could be detected,
however, no CD8+ cells were observed. An alternative method of enzymatic digestion
was tested to determine whether expression of the CD8 cell surface marker was affected
by digestion in Dispase. Mice were irradiated twice a week for 3 weeks prior to FSA
cell injection. Tumours were taken from these and unirradiated tumour-bearing control
mice on day 24 post FSA cell injection. Tumours from one mouse per group were
excised, cut into fragments and incubated for 1 h at 37°C in 3 ml PBS containing 0.1%
(w/v) collagenase (Sigma) and 20pg/ml DNAse. Single cell suspensions were prepared
by mechanical disaggregation through a nylon cell strainer, washed twice, counted, and
expression of cell surface markers determined by flow cytometry, as described in section
2.5.6. Cells expressing Thy 1.2 (10-13%), CD4 (20-21%) and CD1 lb (27-38%) could
be detected, however, no CD8+ cells were observed using this method of disaggregation.
It could be that only low numbers of CD8+ cells infiltrate the FSA tumours, such
that they were undetectable, alternatively it is possible that the enzymatic digestion of
the tumour tissue affected levels of expression of the CD8 molecule. It was also found
that disaggregation of tumours which were removed earlier than day 18 post FSA cell
injection generally resulted in a low cell recovery (around 2xl05 cells from 4 tumours),
due to the smaller size of the tumours. Therefore, an immunohistochemical technique
was developed in an attempt to visualise both infiltrating cells at earlier time points, and
any CD8+ cells.
The suitability of antibodies against CD4, CD8, Thy 1.2 and CD1 lb and MHC
class II for use in immunohistochemistry was first tested using spleen and LN sections
from normal mice, as outlined in section 2.6.2. After testing at a range of dilutions, only
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CD4 and CD8 antibodies were found to give positive staining; Figure 5.5 shows
examples of normal LN stained with antibodies to CD4 (Figure 5.6a) and CD8 (Figure
5.6b). These antibodies were then used at a range of dilutions on sections of a FSA
tumour taken from an otherwise untreated mouse, 22 days after tumour cell injection
(Figure 5.7). There was some background staining on the tumour sections, which could
not be eliminated (Figure 5.7b). Attempts to eliminate this staining, which were
unsuccessful, included increasing the concentration/length of the peroxidase blocking
step; titration of the secondary (biotinylated goat anti-rat IgG) antibody; raising the pH
to 9.0 to reduce avidin binding to any charged sites; and blocking of any endogenous
biotin prior to blocking in goat serum. Very few CD4+ cells (2-3 per section, not shown)
and CD8+ cells (2-3 per section, Figure 5.7a) were apparent.
Groups ofmice were then irradiated twice a week for 3 weeks prior to FSA cell
injection. Tumours were taken from these and unirradiated tumour-bearing control mice
on days 9, 13 and 18 post FSA cell injection. Tumour sections were then stained for the
presence ofCD4+ and CD8+ cells. In this experiment however, no positive-staining cells
could be seen on any tumour sections tested (results not shown).
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Figure 5.6. Immunohistochemical staining of LN sections. LN were taken from a
normal mouse. Frozen sections were incubated overnight with (a) anti-CD4 antibody
(1/2000 Dilution) or (b) anti-CD8 antibody (1/800 Dilution). A horseradish-peroxidase
conjugated secondary antibody was then added, and positive cells (brown) were
visualised using DAB. Sections were counterstained with haematoxylin, and show
positive staining T cells in the parafollicular cortex surrounding a germinal centre.
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Figure 5.7. Immunohistochemical staining of FSA tumour sections. Tumours were
taken from a normal mouse 22 days after FSA cell injection. Frozen sections were
incubated overnight with (a) anti-CD8 antibody (1/800 Dilution) or (b) isotype control
antibody. A horseradish-peroxidase conjugated secondary antibody was then added,
and positive cells (brown) were visualised using DAB. Sections were counterstained
with haematoxylin. a) shows a tumour-infiltrating cell staining positive for CD8 (far right
of picture); b) shows non-specific background staining on a tumour section.
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5.3 - Discussion
5.3.1 - Delayed-type hypersensitivity response to FSA cells
The FSA cells used in this study have previously been shown to be moderately
immunogenic, in that they show increased growth in immunosuppressed mice, and
decreased growth in mice that have been actively immunised with these cells (Suit and
Kastellan, 1970). In the present study an attempt was made to develop an assay for anti-
tumour responses in tumour-bearing mice, with the aim of investigating whether prior
UVB exposure affects protective responses to the injected FSA cells, leading to the
increased outgrowth of the cells in irradiated mice described in Chapter 4. A potential in
vivo assay was a DTF1 response to the FSA cells. Immunocompetent mice received FSA
cells either in 4 dorsal sites, leading to the formation of visible tumours, or
intravenously, which results in the formation of colonies in the lung. Injection of killed
FSA cells intrapinnally 14 days later failed to induce a DTH response in these mice.
Some previous studies investigating immune responses to tumours have
demonstrated DTH responses to si509a FSA cells (Grabbe et al, 1991; Campton et al,
2000). In the study by Grabbe et al, mice were immunised 3 times with tumour-antigen
pulsed epidermal cells, prior to challenge with killed tumour cells. In the study by
Campton et al, mice were immunised 3 times with killed cells prior to challenge with
tumour-antigen pulsed dendritic cells. The lack of a DTH response in the present study
could be due to the FSA cells in this study not sufficiently immunogenic to generate a
measurable response at the elicitation stage ofDTH. Alternatively, the nature of
exposure ofmice to the tumour antigens prior to the DTH assay may be important. Mice
receiving skin grafts that had been incubated in tumour-extract were unable to mount a
DTH response following challenge with whole tumour cells (Sluyter et al, 2001). In the
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present study, mice received a single dose of live FSA cells prior to challenge with
killed tumour cells; multiple exposure to tumour antigens prior to challenge may be
required for a measurable DTH response. Additionally, the mice in the current study had
developed tumours at the time of challenge, which may have affected the DTH
response. Spleen cells from mice bearing tumours from FSA cells similar to those used
in the present study contain a population of tumour-specific regulatory T cells (Howie
and McBride, 1982); perhaps the presence of suppressor T cells prevented the induction
of a DTH response in tumour-bearing mice. Using an immunisation protocol similar to
those used in previous studies would have demonstrated whether the lack of a DTH
response was due to the cells, or to the dose and number of injections of the FSA cells
prior to the hypersensitivity assay.
5.3.2 - In vitro proliferation of LN cells in response to FSA cell antigens
In an attempt to develop an in vitro assay for specific anti-tumour responses in
tumour bearing-mice, the in vitro proliferation of lymphoid cells from mice bearing FSA
tumours in response to a preparation ofFSA tumour antigens (TA) was tested. Cells
from LN draining the site ofFSA cell injection were cultured for 96 h in varying
concentrations of a glycine extract of TA. DLN cells from mice that had been injected
with FSA cells 20 days previously showed increased proliferation in response to TA,
whereas the proliferation ofDLN cells from naive, tumour-free mice was not increased
by the addition of TA. It appeared that the DLN of tumour-bearing mice contained
tumour antigen-specific cells that responded to the TA preparation.
When this experiment was repeated to test the TA concentration that caused the
largest increase in proliferation over a range of culture times, only a slight increase in
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proliferation ofDLN cells from tumour-bearing mice in response to TA was seen. A
slight increase in proliferation of DLN cells from naive controls in response to TA was
also found; thus the small increase in proliferation ofDLN cells did not appear to be due
to tumour antigen-specific cells in the draining lymph node. A similar pattern was seen
when spleen cells from tumour-bearing and control mice were cultured with TA.
The absence of an obvious tumour antigen-specific proliferative response by DLN
cells from tumour-bearing mice could be due to the nature of the tumour extract used.
The glycine extraction method was chosen because it has been used previously to
produce viral antigen preparations from virus-infected cells that are more sensitive and
effective than freeze/thaw preparations (Kettering et al, 1977). In the present study, a
freeze/thaw preparation ofTA was tested and found to have no effect on proliferation of
DLN cells from tumour-bearing mice (results not shown).
The lack ofDLN cell proliferation in response to the TA could result from the TA
preparation being only weakly immunogenic; it is unlikely that these tumour cells have
highly antigenic epitopes, as they are able to grow progressively in immunocompetent
mice. It is possible that there were few tumour-antigen specific immune cells in the LN.
Numerous previous studies have demonstrated the presence of tumour-specific cells in
tumour DLN (Ellis et al, 1975; Yoshizawa et al, 1992); and tumour-specific cells have
also been shown in the spleens ofmice bearing tumours generated from FSA cells
similar to those used in the present study (Howie and McBride, 1982). Alternatively, it
may be that there were cells present in the LN that would have regulated the
proliferation of any tumour antigen-specific cells in the present study; regulatory cells
are found in the spleens of tumour bearing mice (Howie and McBride, 1982) and in the
draining LN ofmelanoma patients (Hoon et al, 1987). Certainly no strong anti-tumour
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responses could be detected in tumour-bearing mice using either an in vivo DTH or an in
vitro proliferation assay in this study.
In Chapter 4, exposure ofmice to broad-band UVB for a 3 week period prior to
FSA cell injection resulted in increased tumour cell outgrowth in irradiated mice. This
effect ofUVB was a local one, such that increased growth only occurred if the cells
were injected into the irradiated skin ofUVB-exposed mice. In the current chapter, local
immune parameters of irradiated and unirradiated tumour-bearing mice were compared
with those ofnai've, tumour-free mice. Mice were irradiated for 3 weeks and then
received FSA cells in 4 dorsal sites; control groups received FSA cells without prior
irradiation, were irradiated but not injected with FSA cells, or were untreated. Draining
lymph nodes were taken on days 9, 13 and 18 post-FSA cell injection; the number of
cells per lymph node were estimated, the spontaneous and mitogen-induced proliferation
of the cells assessed, and the expression of cell surface markers by the DLN cells
measured by flow cytometry. The experiment was repeated without the inclusion of the
irradiated, tumour-free control group. During the second experiment, animals housed
within the same room as the experimental animals were found to be infected with an
intestinal parasite. Differences seen between the two experiments could have been partly
due to infection of some of the mice in the second experiment.
5.3.3 - Cell numbers of LN draining the site of FSA cell injection
Draining lymph nodes taken from unirradiated tumour-bearing mice had
approximately double the number of cells on day 9 post FSA cell injection, compared
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with tumour-free mice. The number ofDLN cells in tumour-bearing mice was decreased
on day 13, but remained higher than the number of cells in the DLN of tumour-free mice
throughout the experiment. This increase in LN cell numbers in tumour-bearing mice
may have resulted either from expansion of cells within the lymph nodes, or recruitment
of cells from other tissues, and is suggestive of an immune response in mice that have
received FSA cells.
The cellularity of LN from irradiated, tumour-bearing mice was also increased
compared with tumour-free mice; however, the DLN cell numbers of irradiated tumour-
bearing mice did not increase to the same extent as that of unirradiated mice that had
received FSA cells. The immune response to injected FSA cells in local LN may be
decreased in irradiated mice compared to that of unirradiated mice.
In the second experiment, the number of cells in the LN of tumour-free mice was
higher than the number in the first experiment. It is possible that parasitic infection of
the mice increased the LN cell numbers in the second experiment; use ofmice kept in a
pathogen-free environment would have helped to avoid changes in the immune status of
these mice.
5.3.4 - Spontaneous proliferation ofDLN cells
The spontaneous proliferation ofDLN cells taken from unirradiated tumour-
bearing mice was higher than that ofDLN cells from tumour-free mice on days 9, 13
and 18. Thus the increased cellularity of LN from tumour-bearing mice maybe due to
increased proliferation and therefore expansion of LN cell numbers. As an internal
control, it might have been informative to assess whether there was any change in
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proliferation of cells from LN not thought to be draining the tumours in tumour-bearing
mice.
LN cells from tumour-bearing mice that had been irradiated prior to FSA cell
injection generally had decreased spontaneous proliferation compared with LN cells
from unirradiated tumour-bearing mice; this may be the reason that the increase in LN
cell number following injection of FSA cells is less marked in UVB exposed mice. The
decreased proliferation ofLN cells from irradiated mice following FSA cell injection
suggests that there is suppression of a response to the FSA cells in the UVB exposed
mice. Other studies have demonstrated that mice irradiated prior to FSA cell injection
develop regulatory cells that control the response to skin cancers in irradiated mice.
Moodycliffe et al (2000) demonstrated that the spleens ofmice exposed to UV for three
time a week for 12-16 weeks contain natural killer T (NKT) cells that suppress tumour
immunity when transferred to syngeneic recipients. Beissert et al (1999) demonstrated
that alteration of the Thl/Th2 balance in favour ofThl responses in mice, by disruption
of the B7/CD23-CTLA-4 signalling pathway during photocarcinogenesis, reduced the
number of skin tumours that developed. In the present study, it is possible that the
development of regulatory T cells, and/or an alteration in Thl/Th2 responses in
irradiated mice may have resulted in suppression of the immune response to the FSA
cells.
It is possible that the increased proliferation of LN cells taken from tumour-
bearing mice was a response to an antigen in the growth medium, rather than a
reflection of in vivo proliferation of LN cells in response to the FSA cells. The FSA cells
were washed prior to injection into the mice; however the mice may have received a
small amount of a component of the growth medium, such as FCS. Previous studies
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have demonstrated that FCS components can stimulate immune responses in mice
(Slyuter et al, 2001; Porgador et al, 1996)). To avoid this, the use of normal mouse
serum in place of FCS in the medium for proliferations was assessed; however, all
concentrations (0.1% - 10%) of normal mouse serum tested were found to be toxic to
the cells incubated alone or with Con A (results not shown). The increased cellularity of
LN from tumour-bearing mice suggests that there is in vivo proliferation of the DLN
cells, therefore the increased in vitro proliferation is more likely due to this than a
reaction to the growth medium.
5.3.5 - Mitogen-stimulated proliferation of DLN cells
The proliferation ofLN cells from tumour-bearing mice in response to two
different mitogens, Con A) and PHA was generally higher than that of LN cells from
tumour-free mice. The unstimulated proliferation of LN cells from tunrour-bearing mice
was also increased compared with LN cells from tumour-free mice; the amount of
mitogen-stimulated proliferation mostly reflected the level of unstimulated proliferation.
Studies in human cancer patients have demonstrated altered mitogenic responses
of leucocytes in these patients. Peripheral blood mononuclear cells (PBMC) from breast
cancer patients had significantly decreased PHA-induced proliferation compared with
PBMC from healthy controls (Witschke et al, 1995); the degree to which the
proliferation decreased was dependent upon the tumour burden of these patients. In
another study, PBMC from the majority of patients with solid tumours (including breast
cancer, melanoma and basal cell carcinoma) responded normally to PHA or Con A.
PBMC from only two patients (with oesophageal carcinoma) showed decreased
proliferative responses (Miescher et al, 1986); however, tumour infiltrating lymphocytes
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taken from all the patients did not proliferate or showed significantly lower responses to
PHA and Con A. The stimulation index for the Con A response of LN from unirradiated
tumour bearing mice was approximately half the stimulation index for that of
unirradiated tumour-free mice at all time points. This may indicate a suppression of the
Con A response in tumour-bearing mice; however, it may simply be a consequence of
the higher background proliferation of LN cells taken from tumour-bearing mice.
In a study ofmelanoma patients, Hoon et al (1987) showed that cells from LN that
are near to a melanoma have a higher Con A-induced proliferation than cells from LN
further away. However, when the Con A expanded cells from LN close to melanomas
were inactivated and incubated with autologous peripheral blood lymphocytes, these LN
cells suppressed the PHA-induced stimulation of the blood lymphocytes to a greater
extent than cells from LN further away from the melanoma. The LN cells taken from
tumour-bearing mice in the present study that proliferated in response to Con A may
have been a mix of effector and suppressor type cells. It would have been interesting to
use the technique ofHoon et al (1987) to determine whether there was increased
suppressive activity by LN cells from irradiated tumour-bearing mice, compared with
unirradiated tumour-bearing mice.
5.3.6 - IL-10 production in vitro by DLN cells
Lymph node cells from both unirradiated and irradiated tumour-bearing mice
produced higher amounts of IL-10 following 24, 48 and 96 h culture compared with LN
cells from nai've, tumour-free controls. The amount of IL-10 detected in the culture
supernatant was slightly higher for LN cells from unirradiated tumour-bearing mice after
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24 and 48 h culture; however, after 96 h culture, more IL-10 was present in the culture
supernatant for LN cells from the irradiated mice.
The increased production of IL-10 by LN cells from tumour-bearing mice may
have been due to increased proliferation of LN cells from these mice, leading to
increased IL-10 release. Regulatory cells are found in the spleens ofmice with FSA
tumours (Howie and McBride, 1982); it is possible that there are also regulatory cells in
the LN of these mice, which might be the source of the IL-10 in the supernatants of
cultures of LN cells from tumour-bearing mice.
IL-10 is present in the sera of patients suffering from different types of cancer (De
Vita et al, 2000) and IL-10 transfected murine melanoma cells demonstrate increased
tumour outgrowth compared with non-transfected cells (Garcia-Hernandez et al, 2002).
IL-10 production by LN cells from tumour-bearing mice in the present study may help
to down-regulate anti-tumour responses in these mice. IL-10 has been shown to reduce
antigen-specific T cell proliferation in vitro (de Waal Malefyt et al, 1991); production of
IL-10 by LN cells from tumour-bearing mice may have contributed to the lack of an
anti-tumour antigen proliferative response of the LN cells described in section 5.2.2.
IL-10 is thought to be one of the mediators ofUVB-induced immunosuppression;
it is found in the skin of irradiated mice and is produced by murine keratinocytes after in
vitro UVB exposure (Enk and Katz, 1992). LN cells from irradiated tumour-bearing
mice showed increased IL-10 production compared with LN cells from unirradiated
tumour-bearing mice after 96 h culture. Perhaps the increased IL-10 production by LN
cells from irradiated tumour-bearing mice was due to an increased number of regulatory
type or Th2 cells in the LN of these mice.
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It may be that IL-10 production was an effect of culturing the cells in vitro;
measurement of IL-10 in the serum of these mice would perhaps have given more
information on the role of this cytokine in tumour outgrowth. Also, measurement of
other cytokines such as IFN-y, IL-12 and IL-4 would have established any differences in
the cytokine profiles of irradiated and unirradiated tumour-bearing mice, and indicated
whether a shift towards a Th2-type response occurred in irradiated mice.
5.3.7 - Phenotyping of DLN cells
In general, DLN cells from tumour-bearing mice had decreased numbers of cells
expressing the cell surface markers Thy 1.2 and CD4 compared with cells from naive
controls. There was no consistent change in CD8 expression over the course of the two
experiments. The significance of this decrease is not clear. It may be that CD4+ T cells
(which also express the pan T cell marker Thy 1.2) are recruited from the lymph nodes
to the site of FSA cell injection as part of the anti-tumour immune response.
LN cells expressing MHC class II from unirradiated tumour-bearing mice were
increased at all time points tested, compared with unirradiated tumour-free mice. This
increase may have been due to migration ofMHC class II antigen presenting cells from
the site of tumour cell injection to the LN, or recruitment from another site; alternatively
it could have resulted from an increase in MHC class II expression by resident LN cells.
In a guinea pig hepatocarcinoma model, administration of bacillus Calmette-Guerin into
the tumour lesions resulted in tumour regression; this was accompanied by an increase
in the number and MHC class II expression of draining LN cells (Steerenberg et al,
1991). Two-colour flow cytometry demonstrated that the increase in MHC class II
expression was due to an increase in the number of T cells expressing MHC class II. In
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the present study, injection of the FSA cells alone appears to have been sufficient to
cause an increase in cellularity and MHC class II expression in the tumour DLN,
perhaps due to their moderate immunogenicity. Use of two colour flow cytometry would
have given more information as to the nature of the cells expressing MHC class II in this
system.
MHC class II expression was also increased on LN cells from irradiated, tumour-
bearing mice, compared with tumour-free controls at most time points measured;
however, the increase was not as great as that ofLN cells from unirradiated tumour-
bearing mice. This suggests that the level of tumour-antigen presentation in irradiated
mice may not be as high as that in unirradiated mice, perhaps resulting in decreased anti-
tumour responses in irradiated mice, and increased tumour cell outgrowth.
5.3.8 - Detection of tumour-infiltrating cells
Enzymatic disaggregation of tumours taken from mice on days 18 and 24 post
FSA cell injection, followed by flow cytometric analysis of the tumour cell suspensions,
demonstrated the presence ofCDllb+, Thyl ,2+ and CD4+ infiltrating cells, indicating
that the host cells within a tumour include macrophages and CD4+ T cells. This is in
agreement with a previous assessment of cells infiltrating an FSA tumour (McBride et
al, 1992). No CD8+cells could be detected by flow cytometry; McBride et al (1992)
demonstrated that approximately 3% of cells within an FSA tumour were CD8+,
therefore it may be that in the present study there were too few cells present to detect. In
an immunohistochemical study of cells infiltrating a murine melanoma, it was found
that in mice irradiated for 3 weeks prior to melanoma cell injection, the number of
infiltrating CD8+ cells was decreased compared with unirradiated controls (Donawho et
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al, 1996). Therefore, in the present study, an immunohistochemical technique was used
in an attempt to determine whether CD8+ cell numbers were altered in the present
model.
Sections of a tumour taken from a normal mouse 22 days post FSA cell injection
had very few CD4+ and CD8+ cells visible after immunoperoxidase staining. The
majority of infiltrating cells in tumours induced by these FSA cells are macrophages,
with a few CD4+ and CD8+ cells present (McBride et al, 1992). Many tumours exhibit
infiltrating CD4+ and CD8+cells although some studies have shown that they are
functionally impaired (Van der Hove et al, 1997; Zhang et al, 1998).
In the present study, an attempt was made to compare the numbers ofCD4+ and
CD8+ cells in tumours taken from mice exposed to UVB over a period of 3 weeks prior
to FSA cell injection with those taken from unirradiated mice. In this experiment
however, the FSA cells used had been passaged once in an immunocompetent mouse,
cultured in vitro, then injected into the experimental mice. No visible staining ofCD4+
or CD8+ cells could be seen in tumours taken during this experiment. This could be due
to the fact that the tumours were taken earlier than 22 days; however it is likely that FSA
cells, which have already grown successfully in an immunocompetent mouse, are
perhaps less immunogenic than the origninal FSA cells. Unfortunately, this experiment
could not be repeated with the original cells due to time constraints.
5.4 - Summary of Chapter 5
Mice injected with live FSA cells failed to mount a measurable DTH response to
killed FSA cells injected 14 days later. Tumour DLN cells taken from tumour-bearing
mice and cultured in vitro in the presence ofFSA TA did not show antigen-specific
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proliferation. Lack of overt immune responses in tumour-bearing mice may be due to
the presence of regulatory cells which down regulate anti-tumour responses in these
mice.
LN cellularity was increased in tumour-bearing mice compared with tumour-free
mice; in vitro spontaneous proliferation of LN cells from tumour-bearing mice was also
increased compared with that ofLN cells from tumour-free mice. In mice that had been
exposed to UVB over a 3 week period prior to FSA cell injection, the number and
spontaneous proliferation of LN cells were also increased compared with tumour-free
mice; however, the increase in number or proliferation was not as high as that of LN
cells from unirradiated tumour-bearing mice. Proliferation of LN cells from tumour-
bearing mice in response to the mitogens Con A and PHA was generally increased,
probably reflecting the increased background proliferation of these cells.
IL-10 production was higher for LN cells from tumour-bearing mice compared
with LN cells from tumour-free mice, possibly due to the presence of regulatory cells, or
a Th2 cells, in the LN of tumour-bearing mice.
The number of cells expressing CD4 and Thy 1.2 in LN taken from unirradiated
tumour-bearing mice at days 9, 13 and 18 post-FSA cell injection was decreased
compared with tumour-free mice. LN cells taken from irradiated tumour-bearing mice
also showed a decrease in CD4 and CD8 expression, although to a lesser extent than LN
cells from unirradiated tumour-bearing mice. MHC class II expression by LN cells from
unirradiated tumour-bearing mice was increased compared with LN cells from tumour-
free mice; again the difference in MHC class II expression by LN cells from irradiated
tumour-bearing mice was less marked than that of LN cells from unirradiated tumour-
bearing mice.
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Taken together, these results are indicative of an immune response in tumour-
bearing mice, which may be regulated by the presence of regulatory cells in these mice.
Changes in immune parameters following FSA cell injection are less marked in mice
that have been exposed to UVB compared with unirradiated mice; it is possible that
UVB exposure results in an environment that allows increased numbers of regulatory
cells to be generated locally in these mice, resulting in enhanced tumour outgrowth.
Much of the work presented in this chapter was of a preliminary nature. Should
this work be continued in the future, I would recommend that the cytokine profiles of
the T cells from the DLN be assessed, to determine whether different subsets of T cells
are found in unirradiated and irradiated mice. I would also suggest that the proliferating
DLN cells from tumour-bearing mice be identified, to improve the understanding of the
importance of different immune cells in anti-tumour immune responses.
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Chapter 6
The effects of urocanic acid on FSA cell outgrowth in vivo and
lymphocyte proliferation in vitro
6.1 - Introduction
Exposure of skin to UVB causes photoisomerisation of Aa«,s-urocanic acid
(UCA), present in the stratum corneum, to cA-UCA (Anglin et al, 1961). Numerous
studies have demonstrated cA-UCA to be one of the mediators ofUV-induced
immunosuppression. For example, tape stripping ofmice to remove the stratum
corneum prior to UV exposure abrogated UV-induced suppression ofCH (De Fabo and
Noonan, 1983). Treatment ofmice with cA-UCA mimicked some of the suppressive
effects ofUV on DTH and CFI responses (Ross et al, 1986; Kurimoto and Streilein,
1992), and delayed rejection of skin and other allografts (Gruner et al, 1992a; Gruner et
al 1992b). Finally, injection ofmice with a monoclonal antibody specific for cA-UCA
prior to UVB exposure completely restored the DTH response to alloantigen in
irradiated mice (Moodycliffe et al, 1996).
Two previous studies have suggested a role for UCA in photocarcinogenesis.
Reeve et al (1989) demonstrated that topical application ofUCA prior to irradiation of
mice with solar-simulating UV during UV carcinogenesis increased both the number
and malignancy of the resultant tumours, compared with mice receiving only UV. More
recently, Beissert et al (1997) used tumour antigen-pulsed epidermal cells to immunise
mice against a SI905 spindle cell tumour. Mice that had received epidermal cells
incubated in cA-UCA prior to tumour antigen pulsing, were unable to reject
subsequently injected tumour cells; these mice also showed a significantly suppressed
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DTH response to the tumour cells. In the current chapter, the effect of in vivo cis-UCA
treatment on the outgrowth of subseqently injected FSA cells is assessed. Additionally,
a monoclonal antibody specific for cA-UCA is used to determine whether cA-UCA is a
critical mediator in the UVB-enhanced FSA cell outgrowth described in Chapter 4.
The mechanism for induction of suppression by cA-UCA remains to be
elucidated; however, numerous potential pathways have been suggested, including
degranulation ofmast cells and histamine release (Wille et al, 1999), effects on APC
(Noonan et al, 1988) and production of prostaglandin by epidermal cells (Hart et al,
1993). A study by Holan et al (1998) demonstrated that cA-UCA could act directly on T
cells in vitro to suppress proliferation, and enhance release of IL-10. An attempt is made
in the current chapter to reproduce some of the approaches of Holan et al.
6.2 - Results
6.2.1 - Effect of in vivo treatment with cA-UCA on FSA cell outgrowth
Treatment ofmice topically with a single dose of 0.1 pg -200 pg of cA-UCA prior
to infection of the mice with HSV suppresses the DTH response to the virus (Ross et al,
1986; Norval et al, 1989). In the present study, topical application of 100 pg cA-UCA
onto shaved dorsal skin twice a week for 3 weeks prior to FSA cell injection (section
2.7.1) had no effect on the outgrowth of FSA cells compared with controls (Figure 6.1a).
This experiment was repeated with similar results. Continuing topical cA-UCA
application after FSA cell injection also had no effect on FSA cell outgrowth (Figure
6.1a). To exclude the possibility that this was due to a lack of uptake of cA-UCA
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Figure 6.1. Growth of FSA cells following 3 weeks c/s-UCA treatment, a) Groups of shaved
mice (n=10) were treated twice a week for 3 weeks with 100 pg c/s-UCA topically (□). Control
mice were not treated (•). FSA cells were injected into the treated skin 24 h after the final c/s-
UCA application. One group continued to receive 100 pg c/s-UCA topically twice a week after
FSA cell injection (A); b) Groups of shaved mice (10-17) were injected intradermal^ twice a
week for 3 weeks with 100 pg c/s-UCA (□). Control mice were not treated (•). FSA cells were
injected into the treated skin 24 h after the final c/s-UCA application. There was no significant
difference between the cis-UCA and control groups at any time point.
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2.7.2); there was no significant difference in tumour size between these mice and
controls (Figure 6.1b).
6.2.2 - Effect of treatment with c/s-UCA on formation of tumours in the lung
To assess whether cA-UCA acted systemically to affect the formation of tumours
in the lung, mice were treated topically twice a week for 3 weeks with 100 pg cA-UCA
or 100 pg trans-UCA. FSA cells (7.5xl04 per mouse) were injected into the tail vein 24
h after the treatment; two weeks later, mice were killed, their lungs removed and the
number of lung colonies counted after fixation (described in section 2.4.3). Table 6.1
shows the results of three separate experiments. The number of colonies produced in the
lungs varied greatly between mice within a single group. No consistent effect of cis-
UCA treatment was seen on the number of lung colonies formed.
Mean number of lung colonies per mouse (range)
Experiment Control CA-UCA Trans-UCA
1 11 (1-31) 39 (17-65) ND
2 36 (7-108) 42 (6-76) 57 (3-159)
3 41 (6-168) 11(3-24) ND
Table 6.1. Effect of c/s-UCA treatment on formation of lung colonies by FSA cells. Groups
of mice (9-15) were treated topically twice a week for 3 weeks with 100 pg c/s- or trans-UCA.
FSA ceils were injected intravenously 24 h after the final UCA treatment. The lungs were
removed 14 days later and stained using Bouin's fluid. Numbers in brackets show the range.
ND: not done.
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In experiments 1 and 2, the number of lung colonies was increased in cA-UCA-treated
mice; in experiment 3, the number of lung colonies was decreased in cA-UCA treated
mice. In one experiment, the effect of trans-UCA treatment on formation of lung
tumours was assessed (Table 6.1). The number of lung colonies was increased in this
group compared with control mice; however this was not significant.
6.2.3 - Effect of cA-UCA-specific antibody on UVB-enhanced FSA cell outgrowth
Injection ofmice with 0.9 pg of a monoclonal antibody specific for cA-UCA prior to a
single UV exposure abrogated UV-induced suppression ofDTH to alloantigen
(Moodycliffe et al, 1996) and to HSV (El-Ghorr and Norval, 1995), and partially
reversed UV-induced suppression of CH to DNFB (Kondo et al, 1995). To assess the
role of cA-UCA in UVB-enhanced tumour cell outgrowth in the present study, mice
were irradiated twice a week for 3 weeks prior to FSA cell injection (as described in
section 2.1.4); cA-UCA antibody was injected intraperitoneally 2 h before each
irradiation (section 2.7.3). Injection of 0.5 pg cA-UCA antibody prior to each exposure
with 1200 J/m broad-band UVB slightly decreased tumour outgrowth in irradiated
mice, compared with UVB-exposed mice treated with control antibody; however this
difference was not significant (Figure 6.2).
Increasing the dose of cA-UCA antibody to 5 pg protein per mouse also had no
significant effect on tumour outgrowth in irradiated mice (results not shown). Injection
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Figure 6.2. Effect of c/'s-UCA specific antibody on UVB-enhanced FSA cell outgrowth.
Groups of 14 mice were irradiated twice a week for 3 weeks with 1200 J/m2 broad-band UVB;
two hours before each irradiation mice were injected i.p. with 0.5 gg cis-UCA antibody (A) or an
isotype control antibody (▲). Control mice received cis-UCA antibody (O) or isotype control
antibody (•) but were not irradiated. * shows a significant difference (p<0.05) between the
unirradiated groups and the irradiated groups.
6.2.4 - Effect of UCA isomers on in vitro proliferation of spleen cells
Holan et al (1998) demonstrated that pre-incubation of spleen cells from BALB/c
mice for 24 h in cis-, but not trans-UCA, suppressed their ability to proliferate in
response to stimulation with anti-CD3 antibody. In the present study, the effect ofUCA
isomers on anti-CD3 induced proliferation of spleen cells from C3H/HeN mice was
assessed, as described in Section 2.7.4. Initially, the effect of pre-incubation of spleen
cells with 200 pg/ml cis- or trans-UCA for 2 or 24 h prior to stimulation with anti-CD3








































Figure 6.3. The effect of incubation time on c/'s-UCA induced suppression of spleen cell
proliferation in response to CD3 antibody. Spleen cells from C3H/HeN mice were incubated
in medium alone, or in 200 pg/ml cis- or trans-UCA for (a) 2 h or (b) 24 h. Cells were then
washed twice and incubated for 72 h with or without 2 pg/ml CD3 antibody; 3H-Thymidine was
added for the final 8 h of culture. The average cpm for 6-7 replicate wells is shown; error bars
show the SEM. * indicates a significant decrease (p<0.05) in proliferation of UCA treated cells
compared with control cells.
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caused a significant decrease in the proliferative response of these cells, compared with
controls; the suppression was much greater in cells incubated for 24 h than 2 h in cis-
UCA. Incubation of the cells in trans-UCA however, had no effect on their proliferation
in response to anti-CD3 (Figure 6.3). The 24 h hour pre-incubation in UCA of spleen
cells followed by anti-CD3 induced proliferation was repeated on 4 separate occasions
(Table 6.2). CA-UCA incubation suppressed proliferation in 3 out of 4 experiments;
however incubation in trans-UCA also resulted in a decreased proliferative response in 2
out 4 experiments, although not to the same extent as cA-UCA incubation. In 3 out of 4
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The effect ofpre-incubation in a lower concentration ofUCA and in a mixture of
cis- and trans-UCA on proliferation of spleen cells was also tested. The results of a
representative experiment are shown in Figure 6.4. Incubation in 100 pg/ml cis- or
trans-UCA for 24 h prior to stimulation with anti-CD3 had no effect on the proliferative
response; however, pre-incubation in a mixture of 100 pg/ml cis- and 100 pig/in I trans-
UCA significantly suppressed the anti-CD3 induced proliferation of spleen cells. Pre¬
incubation in the two UCA isomers had no effect on the unstimulated proliferation of the
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Figure 6.4. Effect of combining c/'s-UCA and frans-UCA on proliferation of spleen cells in
response to CD3 antibody. Spleen cells from C3H/HeN mice were incubated in medium alone,
or in 100 pg/ml cis- or frans-UCA, or in 100 pg/ml cis- UCA + 100 pig/ml frans-UCA. Cells were
then washed twice and incubated for 72 h with or without 2 pg/ml CD3 antibody; 3H-Thymidine
was added for the final 8 h of culture. The average cpm for 4-5 replicate wells is shown; error
bars show the SEM. The experiment was repeated with similar results. * indicates a significant
decrease (p<0.05) in proliferation of UCA treated cells compared with control cells.
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Holan et a I (1998) demonstrated that incubation of BALB/c spleen cells in cis-
UCA during anti-CD3 stimulation induced IL-10 mRNA expression, that was not seen
in cultures incubated alone or with trans-UCA. In the present study, spleen cells from
C3H mice were stimulated for 20 h with anti-CD3 in the presence or absence of cis- or
trans-UCA, as described in section 2.7.4. The total RNA was then extracted, and used to
produce cDNA; this was amplified by PCR in the presence of primers for IL-10, or the
house-keeping gene (3-actin, (sections 2.7.5-2.7.8). As seen in Figure 6.5, IL-10 mRNA
was expressed to a similar level in unstimulated and CD3-simulated cells, regardless of
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Figure 6.5. IL-10 mRNA expression by spleen cells stimulated in the presence of UCA.
Spleen cells from C3H/HeN mice were incubated for 20 h alone (lane 2), or in 200 pg/ml cis-
UCA (lane 3); or were stimulated with anti-CD3 alone (lane 4) or in the presence of 200 pg/ml
c/s-UCA (lane 5) or 200 pg/ml trans-UCA (lane 6). Total RNA was isolated, reverse transcribed,
and amplified by PCR with 5' and 3' primers for IL-10 and actin. PCR products were run on an
agarose gel and visualised using ethidium bromide. Lane 1 shows RNA from anti-CD3-
stimulated cells amplified by PCR with the same primers, but without prior reverse transcription
to give cDNA. The intensity of the bands was measured and found to be similar for all samples.
This experiment was repeated with similar results.
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6.3 - Discussion
6.3.1 - Effect of in vivo treatment with cA-UCA on FSA cell outgrowth
The cA-isomer ofUCA, formed upon irradiation of trans-UCA, mediates at least
some of the suppressive effects ofUV. Treatment ofmice with cA-UCA has been shown
to suppress DTH responses to HSV (Norval et al, 1989), and prolong the survival of skin
allografts and prevent graft-versus-host disease (Gruner et al, 1992). Suppression ofCH
responses following cA-UCA treatment has also been demonstrated (Lauerma et al,
1995; Kurimoto and Streilein, 1992a).
In the present study, treatment ofmice topically with cA-UCA for 3 weeks prior
to FSA cell injection had no effect on tumour outgrowth, compared with untreated
controls. It is possible that the lack of effect was due to an uptake problem; however, this
is unlikely as a previous study has shown that radioactive cA-UCA applied to mouse
skin is readily internalised (Hug and Hunter, 1991). In the present study, injection of cis-
UCA intradermally prior to FSA cell injection also had no effect on tumour outgrowth.
Continuation of topical cA-UCA treatment after FSA cell injection failed to affect
tumour outgrowth. Therefore cA-UCA did not act directly on the tumour cells to alter
growth.
The lack of an effect of cA-UCA on tumour outgrowth in this study was in
contrast to the demonstration by Reeve et al (1989) that topical treatment ofmice with
UCA during UV carcinogenesis increased the number of resultant tumours. In that study,
the UCA was applied prior to each UV exposure, therefore it is possible that products
were formed from the photo-oxidation ofUCA by UVB; these products are thought to
have a role in UV-induced immune suppression (Kammeyer et al, 2001). Additionally,
in the study by Reeve et al (1989), UCA treatment may have caused an increase in
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induction of tumours, rather than promotion of tumour outgrowth by suppression of anti-
tumour immune responses.
Beissert et al (1997) also demonstrated a role for cA-UCA in tumour outgrowth.
EC that were pulsed with TA in vitro were used to immunise mice against tumour
challenge in vivo\ EC incubated in cis-, but not trans-UCA prior to TA pulsing failed to
induce anti-tumour immunity upon injection into mice. This effect of cA-UCA could be
abrogated by the addition of IL-12 to the EC during or after the cA-UCA incubation
(Beissert et al, 2001). As seen in chapter 4, IL-12 treatment in vivo did not reverse UVB-
enhanced tumour cell outgrowth in the current study. The conflicting results of the
studies by Beissert et al with the present one could be due to the different protocols
used; immunisation with tumour antigen-pulsed EC may well induce a stronger, or
different, immune response compared with that resulting from the injection of dividing
tumour cells. In vitro treatment of EC with cA-UCA is likely to affect the majority of
cells; in vivo treatment ofmice with cA-UCA may only affect some of the susceptible
cells, such that there remain cells that are unaffected and able to induce an immune
response in the usual way.
Immunosuppression following cA-UCA treatment has mostly been seen following
a single dose of cA-UCA prior to sensitisation. One study looking at the effect of chronic
treatment ofmice with cA-UCA demonstrated that intradermal injection of cA-UCA
three times a week for four weeks failed to suppress the DTH response to HSV or the
CH response to oxazalone (El-Ghorr and Norval, 1997b). It was suggested by the
authors that repeated exposure of mice to high doses of cA-UCA may result in
adaptation, or lead to the occupation of putative cA-UCA receptors, such that they
become unresponsive.
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As seen in Chapter 4, exposure ofmice to broad-band UVB, but not TL01, prior
to FSA cell injection resulted in increased outgrowth of the tumour cells. During chronic
irradiation ofmice with doses of 1000 J/m2 broad-band UVB, or 3000 J/m2 TL01 three
times each week, an increase in cA-UCA was seen after the first week, and a maximum
of 38 % and 35 % cA-UCA was reached with the broad-band UVB and TL01 lamps
respectively (El-Ghorr et al, 1995). Taking the results of that study and the present one
together, there does not appear to be a correlation between UCA conversion and
increased FSA cell outgrowth.
6.3.2 - Effect of treatment with cA-UCA on formation of tumours in the lung
Wavelengths within the UVB range do not penetrate past the upper layer of the
dermis; therefore it is likely that UV-induced systemic suppression is initiated through a
chromophore in the skin, such as cA-UCA. Subcutaneous injection of cA-UCA causes
systemic suppression ofCH responses (Hart et al, 1997). CA-UCA is found in the serum
of irradiated mice after UVB exposure (Moodycliffe et al, 1993) and in the urine after
whole body UVB exposure of human volunteers (Kammeyer et al, 1997).
In the present study, an attempt was made to assess any systemic effect of cA-
UCA on tumour outgrowth, by topical application of cA-UCA over a 3 week period
prior to intravenous FSA cell injection. No consistent effect of cA-UCA on the number
of lung tumours formed was apparent; however, the variability of the technique, as
discussed in Chapter 4, section 4.3.6, may have masked any changes in the cA-UCA
treated mice.
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6.3.3 - Effect of cA-UCA-specific antibody on UVB-enhanced FSA cell outgrowth
Injection of a monoclonal antibody specific for cA-UCA prior to UVB irradiation
ofmice prevents UV-induced suppression ofDTH to HSV or alloantigen, and UV-
induced reduction in epidermal LC (Moodycliffe et al, 1996; El-Ghorr and Norval,
1995). In the present study, injection of anti-cA-UCA antibody prior to each irradiation
did not reduce the enhanced outgrowth of FSA cells injected s.c after 3 weeks UVB
exposure. It is possible that the dose of antibody received by the mice in the present
study (0.5 pg) prior to each irradiation was not high enough to reverse the effects of
UV, however a high dose of antibody (5 pg/mouse prior to each irradiation) was tested
and found to be ineffective.
The results of this study are in contrast to the results of a study by Beissert et al
(2001), where mice were irradiated over a period of 6 months, resulting in induction of
skin tumours; one group received 0.1 pg cA-UCA specific antibody prior to each
irradiation. In that study, the probability of tumour induction in irradiated mice
receiving no antibody, or a control antibody was almost 100% at day 200 of the
experiment; treatment ofmice with anti-cA-UCA antibody reduced this probability to
around 50%. The cA-UCA specific antibody was initially raised in a BALB/c mouse;
therefore, it may be that multiple injections of the antibody into C3H mice in the present
study resulted in the production of anti-idiotypic antibodies, which reduced the
effectiveness of the anti-cA-UCA antibody. Beissert et al (2001) used BALB/c mice,
which could explain why the antibody was effective in that study.
It may be that cA-UCA has role in the early stages of tumour induction, but does
not have a role in UV-induced suppression of immune responses to injected tumour
cells. Injection of anti-cA-UCA antibody does not reverse all the effects ofUVB
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irradiation. In single dose experiments, it had no effect on UV-induced suppression of
CH, or DC accumulation in DLN (El-Ghorr and Norval, 1995); however, anti-cA-UCA
did prevent the induction of transferable suppressor cells in irradiated mice
(Moodycliffe et al, 1996). Thus cis-UCA is a mediator of only some aspects ofUV-
induced immunosuppression; the results of the present study do not show a role for cis-
UCA in suppression of anti-tumour responses in irradiated mice, suggesting that other
effects ofUVB exposure such as DNA damage, cytokine release, and antigen presenting
cell defects may be more important in UVB-enhanced tumour outgrowth.
6.3.4 - Effect of UCA isomers on in vitro proliferation of and IL-10 mRNA
expression by spleen cells
The mechanism of action of cA-UCA that results in immunosuppression is not
entirely clear. It has been suggested that cA-UCA suppresses CH responses through
induction ofTNFa (Kurimoto and Streilein, 1992), although this has been disputed
(Moodycliffe et al, 1994). CA-UCA may cause release of immunosuppressive cytokines
from keratinocytes. However, two in vitro studies have failed to find an effect of cis-
UCA on secretion/expression of a number of cytokines, including IL-10 and TNFa
(Redondo et al, 1996; Zak-Prelich et al, 2001). CA-UCA administration causes loss of
LC from the epidermis (Norval et al, 1990), though it is not known whether this is a
direct effect on the LC, or via an intermediate; Rattis et al (1995) failed to demonstrate
an effect of cA-UCA on the allostimulatory function of human LC in vitro. In an in vitro
study by Holan et al (1998), cA-UCA was shown to reduce proliferation of splenocytes
from BALB/c mice, as a result of IL-10 production by CD4+ T cells; it was suggested
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that the cA-UCA induced IL-10 may act on APC to affect the induction of an immune
response.
In the present study, an attempt was made to reproduce some of the work of Holan
et al, using splenocytes from C3H/HeN mice. Pre-incubation of spleen cells for 2 h in
200 pg/ml cis-, but not trans-UCA resulted in a decreased proliferative response to anti-
CD3 stimulation. This is in contrast to the finding ofHolan et al, that cells incubated in
cA-UCA for 12 h or less prior to stimulation showed no significant suppression of
proliferation. The shorter time period required for a significant response in the present
study could relate to the different mouse strain used. Streilein and Bergstresser (1988)
demonstrated that some mouse strains (such as C57BL/6 and C3H/HeN) are more
susceptible to UV-induced suppression of CH than others (BALB/c, C3H/HeJ), which
require exposure to high doses ofUV for immunosuppression to occur. Kurimoto and
Streilein (1992) demonstrated that for cA-UCA induced suppression of CH, injection of
low doses of cA-UCA was sufficient to cause suppression in UVB-susceptible mice,
while UVB-resistant mice required higher doses of cA-UCA for CH suppression. Thus,
spleen cells from the 'UVB-susceptible' strain C3H/HeN used in the present study may
be more susceptible to cA-UCA than spleen cells from the 'UVB-resistant' BALB/c
mice.
Alternatively, the shorter pre-incubation time required for suppression of the
proliferative response in the present study may be due to the different source of cis-
UCA used. The cA-UCA used by Holan et al was a mixture of 50-56 % cA-UCA and
44-50 % trans-UCA; it was produced by in vitro irradiation of trans-UCA. In the
current study, the cA-UCA was a 99% pure preparation; therefore, the use of 200 pg/ml
cA-UCA gave a cA-UCA concentration of approximately double that of Holan et al,
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which may have reduced the pre-incubation time required for suppression of the
proliferative response.
Incubation of spleen cells in cA-UCA for 24 h prior to stimulation resulted in a
more suppressed response compared with cells incubated for only 2 h. The suppressive
effect of 24 h pre-incubation in cA-UCA was generally seen upon repetition of the
experiment; however, it was often accompanied by a decrease in the background
proliferation of unstimulated cells, suggesting that the cA-UCA concentration used was
toxic to the cells. Pre-incubation in only 100 pg/ ml cA-UCA, which gave a similar
actual cA-UCA concentration to that used by Holan et al, had no effect on anti-CD3-
stimulated proliferation of spleen cells. Interestingly, pre-incubation of spleen cells in a
mixture of cis- and trans-UCA, which would have given similar concentrations of the
isomers as were present in the 'cA-UCA' cultures used by Holan et al, suppressed the
proliferative response without affecting the unstimulated cells. Thus it may be that for
suppression of spleen cell proliferation, both the presence of cis- and trans-UCA is
required. Using a combination ofboth isomers is perhaps more relevant to the in vivo
situation; following UVB exposure of mice, the percentage of cA-UCA in the skin
increases from 4.7 to approximately 30, and then gradually declines (Norval et al,
1988).
Proliferation of T cells in response to soluble CD3 antibody requires the presence
ofAPC (Tsoukas et al, 1985), therefore the decreased proliferation could have been due
to an effect ofUCA on the co-stimulatory capacity ofAPC. However, Holan et al
(1998) demonstrated that the decrease in proliferation of spleen cells incubated in cis-
UCA was due to IL-10 release by CD4+ T cells. Spleen cells incubated in cA-UCA also
showed increased expression of IL-10 mRNA compared with controls. In contrast, a
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study by Bi et al (1999) demonstrated that incubation of human lymphocytes in cis-
UCA during PHA stimulation suppressed IL-10 mRNA expression compared with
controls.
In the present study, an attempt was made to assess the effect of cA-UCA
incubation on IL-10 mRNA expression. Spleen cells cultured with or without anti-CD3,
in the presence or absence of cis- or trans-UCA all had similar detectable levels of IL-
10 mRNA. RNA extracted from spleen cells cultured with anti-CD3 was incubated with
IL-10 and actin primers to demonstrate that there was no contamination of the cDNA
mixture with genomic DNA. It is possible that the number of amplification cycles used
(40) was too many to detect a difference in yield. Use of a range of cycle numbers to
determine the optimum cycle number, or use of real-time PCR might have shown a
difference in IL-10 production in cA-UCA incubated spleen cells in this study.
6.4 - Summary of Chapter 6
Treatment ofmice with cA-UCA for a period of 3 weeks had no effect on the
outgrowth of FSA cells injected into the treated skin. In mice irradiated for 3 weeks
with broad-band UVB prior to injection of FSA cells into the irradiated skin,
intraperitoneal injection of a monoclonal antibody to cA-UCA prior to each irradiation
had no effect on the enhanced outgrowth of FSA cells seen in UVB-exposed mice.
Therefore, despite being a mediator of some aspects ofUVB-induced
immunosuppression, cA-UCA does not have an important role in UVB-enhanced
tumour outgrowth.
Pre-incubation of spleen cells in cA-UCA suppressed subsequent anti-CD3
induced proliferation, compared with cells incubated alone, or in trans-UCA; this
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suppression was dependent on the concentration of cis-UCA, and was not consistent.
Incubation of spleen cells in a mixture of cis and trans-UCA reduced the concentration
of cA-UCA needed for suppression, suggesting trans-UCA is required for cA-UCA
induced immunosuppression following UV exposure.
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Chapter 7
Final Discussion and Summary
UVR is mutagenic, and damages DNA leading to transformation of cells, which
can result in skin cancer. In 1974, Kripke demonstrated that UV-induced skin tumours
were antigenic, such that, when transplanted from the primary host to syngeneic
recipients, these tumours failed to grow, and regressed. This raised questions as to how
the tumours were able to develop in the primary host, and it was subsequently found
that UV exposure of the recipients prior to tumour transplantation prevented rejection of
the tumour, and allowed tumour outgrowth; this susceptibility to tumour outgrowth
could be transferred from irradiated mice to nai've mice using spleen and lymph node
cells (Fisher and Kripke, 1977).
Following this discovery, a large number of studies have investigated the
pathways involved in UV-induced immunosuppression, and a variety of effects ofUV
on immune parameters have been demonstrated, including alterations in number and
function ofAPC, changes in cytokine profiles, and development ofT regulatory cells
capable of transferring suppression to other animals. However the mechanisms involved
in suppression of immune responses to tumours by UV are still not entirely understood,
and in the present study, UV-enhanced tumour outgrowth was assessed in relation to
UV-induced immunosuppression. A FSA model was used, where FSA cells were
injected into the skin, resulting in tumour formation as early as 3 days post-injection.
This was a convenient method of assessing the effects ofUV on tumour growth.
However, tumour-bearing mice were killed when the tumours showed signs of
ulceration, usually at 3-4 weeks post-injection. In a photocarcinogenesis model, mice
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irradiated 3 times per week for 5 months did not show tumour development until 18
weeks from the start of the irradiation protocol (Beissert et al, 2001). Thus the 3-4
weeks of tumour growth in the present study was a very limited time span in terms of
tumour formation. During photocarcinogenesis, neoplastic cells undergo a series of
genetic mutations, which can promote their survival and growth; these aspects of
tumour growth would not have occurred in the present study, which used FSA cells
from a previously established tumour.
Using 3 different lamps, broad-band UVB, narrowband UVB (TL01) and UVA,
it was demonstrated that irradiation ofmice twice a week for 3 weeks with
suberythemal doses ofUVB or UVA suppressed the CH response to oxazalone, and
decreased the number of epidermal LC. As has been suggested in previous studies, these
results indicate that, in the skin of irradiated mice, the reduction in the number of
available APC to take up hapten may lead to a decrease in the ability to induce a CH
response.
It is thought that the loss of epidermal LC following UVB exposure is due to
migration of LC to the DLN. In this and previous studies (Moodycliffe et al, 1992;
Duthie et al, 2000) an increase in DC numbers in the DLN was observed after a single
UVB exposure, with a maximum increase at 42 h. However in the present study, it was
demonstrated that after a 3 week period of irradiation, the number ofDC in the DLN
was decreased compared with control mice. Increased levels of apoptosis in LN cells
from irradiated mice were not demonstrated. It may be that UV-damaged APC that
migrate to the DLN apoptose, resulting in decreased levels of available professional
APC in these mice. It has been demonstrated that after a single UVB exposure, very few
LC are apoptotic (Okamoto et al, 1999), however, the multiple UV exposures used in
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the present study may increase the level of apoptosis to significant levels. Following a
single UVB exposure, the epidermis is repopulated with B7 deficient LC from the hair
follicle (Gilliam et al, 1998). These phenotypically altered LC may be more susceptible
to UVB-induced apoptosis, after subsequent UV exposures.
Mice irradiated with the broad-band UVB lamp prior to FSA cell injection
showed increased outgrowth of subsequently injected FSA cells, however irradiation of
mice with the UVA-I (above 340 nm) or TL01 (311 nm) lamps prior to FSA cell
injection did not show increased tumour outgrowth. It may be that the wavelengths that
cause enhanced tumour outgrowth are the shorter UVB wavelengths (280-305 nm).
Although only the broad-band UVB lamp caused increased outgrowth of
injected FSA cells, both UVB and UVA lamps caused LC loss and suppression of CH.
Thus the reduction in LC numbers could not be used to predict the induction of
susceptibility to tumour cell injection. It is possible that UVB exposure had other effects
on the LC, such as alterations in production of cytokines, or expression of cell surface
molecules involved in induction of effector T cell responses. Sluyter and Halliday
(2000) demonstrated that mice were susceptible to tumour cell injection not at the time
of LC loss from the epidermis, but at the time inflammatory cells appeared in the
irradiated skin. Previous studies have demonstrated that CD1 lb+ macrophages that
migrate into UV exposed human skin produce IL-10 (Kang et al, 1994), and that UV-
induced suppression of CH in mice could be prevented by treatment with anti-CD 1 lb
antibody (Hammerberg et al, 1996). An attempt was made to assess the number of
CD1 lb+ macrophages in tumours from UVB-exposed and unirradiated mice, by flow
cytometry. However, there was no consistent difference in numbers ofCD1 lb+
expressing cells between control and irradiated mice. Irradiating mice using the UV
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protocol of the present study, and treatment with anti-CD 1 lb antibody, followed by
FSA cell injection, would have indicated whether these inflammatory macrophages
contribute to UV-enhanced tumour outgrowth.
Studies of the effect ofUV-exposure ofmice prior to injection of syngeneic
tumour cells have mainly used high doses ofUV, with each exposure well in excess of
a single MED (approximately 4-10 MED) (de Fabo and Kripke, 1980; Romerdahl et al,
1988). The present study demonstrated that exposure ofmice to a suberythemal dose
(1200 J/m2) of broad-band UVB twice a week for 3 weeks resulted in increase
outgrowth of subsequently injected FSA cells. Thus, even suberythemal doses ofUV
appear to result in suppression of immune responses to skin tumours in mice. Burning
of the skin following sun exposure is the most easily recognised indicator of sun
damage in humans; however, it may be that exposure to UV doses that are not sufficient
to cause sunburn can contribute to the pathogenesis of skin cancer. Use of a solar-
simulating UV source in place of the broad-band UVB source employed in the present
study would indicate the potential of sun exposure to suppress immune responses to
skin tumours.
The FSA cells have been shown previously to be moderately immunogenic in
C3H/HeN mice, and in the present study assessment of tumour-bearing mice
demonstrated increased DLN cell number, and increased in vitro spontaneous
proliferation of the DLN cells, compared with tumour-free mice. It is thought that both
CD4+ and CD8+ T cells are important in anti-tumour immune responses; assessing the
phenotype of the cells from the tumour-bearing mice that were proliferating in vitro
could have indicated whether a particular T cell subset was responding to tumour cell
injection. Flow cytometry ofDLN cells freshly isolated from tumour-bearing mice
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showed both increased numbers ofMHC class II+ cells, and increased levels ofMHC
class II expression compared with DLN cells from tumour-free controls. The MHC
class II positive cells are probably dendritic cells or other APC, suggesting that there is
increased antigen-presentation by DLN cells from tumour-bearing mice.
The increase in number, spontaneous proliferation and MHC class II expression
ofDLN cells seen in tumour-bearing mice was generally not as great in mice that had
been irradiated over a 3 week period prior to FSA cell injection. This indicated that the
immune response to the FSA cells was suppressed in mice that had been exposed to
UV, which may have allowed the increased tumour outgrowth observed in these mice.
A seasonality of presentation ofmelanoma, BCC and SCC has been demonstrated, with
a peak in the summer and autumn months (Swerdlow, 1985). It has been suggested that
this peak is due to increased UV exposure during the summer, which increases tumour
outgrowth (Romerdahl et al, 1988), possibly by suppressing immune responses to these
tumours.
Previous studies have demonstrated the presence of transferable regulatory cells
in the lymphoid organs of irradiated mice that can suppress immune responses to skin
tumours, leading to increased tumour outgrowth. Two different cell types have been
proposed to exert this regulatory effect; IL-4-producing NKT cells (Moodycliffe et al,
2000), and CTLA-4+ T cells that secrete high levels of IL-10 and IFNy (Beissert et al,
1999). In the present study, the percentage of CD4+ cells was similar in the DLN of
irradiated and unirradiated tumour-bearing mice. The conflicting results ofMoodycliffe
et al and Beissert et al could have been further investigated by isolation of any
regulatory cells that allow the increased outgrowth of FSA cells in the current study.
Measurement by ELISA of cytokines in supernatant following in vitro stimulation, or
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two-colour flow cytometry, could be used to detect any differences in cytokine
expression by DLN T cells from irradiated and unirradiated tumour-bearing mice. It is
important to determine the nature of the regulatory cells involved in UV-induced
suppression of anti-tumour immune responses so that the effects of these cells can be
prevented, to allow the host to develop a protective immune response.
IL-10 has been implicated as a mediator of UV-induced immunosuppression and
in one experiment, IL-10 production by DLN cells from irradiated and unirradiated
tumour-bearing mice was measured. It was found that DLN cells from unirradiated
tumour-bearing mice produced higher amounts of IL-10 after 48 h culture, while DLN
cells from irradiated tumour bearing mice had higher levels of IL-10 in the supernatant
after 96 h culture. In the present study, only limited data were acquired, therefore no
conclusions could be drawn as to the role of IL-10 in suppression of anti-tumour
immune responses. Won Byeon et al (1998) demonstrated that treatment ofmice
topically with Aloe barbadensis extracts after irradiation restored DTH responses and
suppressed IL-10 production in UV-exposed epidermis; however treatment ofmice with
Aloe barbadensis after each exposure during a 12 week irradiation protocol did not
prevent UV-enhanced outgrowth of tumour cells (Strickland et al, 2001). IL-12 is
thought to prevent UV-induced immunosuppression partially by restriction of IL-10
production by irradiated keratinocytes (Schmitt et al, 2000). However in the present
study IL-12 treatment failed to protect against UV-enhanced tumour outgrowth.
Treatment ofmice with anti-IL-10 antibody during a 3 week UV-exposure protocol,
followed by tumour cell injection, would indicate whether IL-10 is an important
mediator ofUV-induced suppression of anti-tumour responses.
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An attempt was made to determine the phenotype of host cells that infiltrated the
FSA tumours, but this was unsuccessful. Use of a mechanical method of tumour
disaggregation in conjunction with enzymatic digestion might aid the recovery of host
cells from the tumours, for flow cytometric analysis. It has been observed that the
majority of infiltrating cells in human skin tumours are T cells (Habets et al, 1988), with
significant numbers ofmacrophages also present. However the cell types that are most
important for tumour cell destruction are still not completely defined. Identifying any
differences in infiltrating cells present in tumours in mice irradiated prior to tumour cell
injection, which are less able to control tumour growth, compared with unirradiated
mice, could indicate which cells play an important role in tumour destruction.
Additionally, comparison of cytokines present in tumour sections from unirradiated and
irradiated mice, by immunohistochemistry or in situ hybridisation, could reveal the
cytokines that would be most effective in promoting anti-tumour responses.
Reeve et al (1989) demonstrated that topical application ofUCA during
photocarcinogenesis in mice increased tumour yield, and Beissert et al (2001) showed
that injection of a monoclonal antibody specific for cA-UCA during
photocarcinogenesis reduced the probability of tumour development. CA-UCA has a
number of immunosuppressive properties; therefore it is likely that the effects of cis-
UCA in those previous studies were related to a role in suppression of immune
responses to developing skin tumours. Thus, in the present study, it was expected that
cA-UCA would have a role in UV-enhanced outgrowth of tumour cells injected into
mice irradiated over a 3 week period. However, topical application of cA-UCA for 3
weeks had no effect on tumour outgrowth in mice, while injection of cA-UCA antibody
did not reverse UV-enhanced outgrowth of the FSA cells. It is possible that cA-UCA
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causes increased tumour development during photocarcinogenesis via a mechanism
other than immunosuppression. CA-UCA may affect the level ofDNA damage
sustained during photocarcinogenesis; it is possible that some metabolic products of cis-
UCA could increase DNA damage in irradiated mice. Alternatively, cA-UCA may act to
suppress immune responses to tumour cells in the early stages of development, but is
not involved in UV-induced suppression of immune responses to tumour cells that are
injected following 3 weeks UV exposure. The results of this study suggest that cA-UCA
is involved in the initiation stage of tumour development, and is not important in tumour
progression.
The results of the present study suggest that another photoreceptor may be
important for induction of suppression of immune responses to injected tumour cells.
DNA damage by UV has been reported as another mechanism by which UV-induced
immunosuppression is initiated. Treatment of xeroderma pigmentosum patients for one
year topically with T4 endonuclease V, to repair DNA damage, decreased the rate of
development of actinic keratoses and BCC (Yarosh et al, 2001). However, this effect
could have been due to a decreased induction of neoplastic cells, rather than preventing
the immunosuppressive effects of DNA damage. Immune responses in irradiated mice
have been restored by repairing DNA damage using endonucleases (Wolf et al, 1995).
This method could be employed to determine whether DNA damage has a role in the
UV-enhanced tumour outgrowth seen in the present study.
Studies in mice and humans imply that mast cells may be involved in
suppression of immune responses to BCC (Matheson and Reeve, 1991; Grimbaldeston
et al, 2000). CA-UCA is thought to mediate mast cell degranulation via sensory nerve
innervation. Keratinocyte-derived NGF is upregulated following UVB exposure, and
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may also cause mast cell degranulation via neuropeptide release by sensory nerves; this
mechanism appears to be independent of the action of cA-UCA (Townley et al, 2002).
Anti-NGF antibodies could be used to assess whether this mechanism has a role in UV-
enhanced tumour outgrowth.
Another possible mediator of UV-induced immunosuppression is platelet-
activating factor (PAF) which is produced by irradiated keratinocytes, and which
upregulates immunomodulatory cytokines, including PGE2. Treatment ofmice with
PAF suppressed DTH to Candida albicans, and injection of a PAF receptor antagonist
blocked UV-induced suppression ofDTH (Walterscheid et al, 2002). Walterscheid et al
proposed that PAF synthesis is induced during cellular repair ofUV-induced DNA
damage, causing immunosuppression. PAF-receptor antagonists can also reverse cis-
UCA induced suppression, and Walterscheid et al suggested that cA-UCA works in
concert with UV-induced DNA damage to amplify PAF synthesis. The results from the
present study indicate that cA-UCA is not the main photoreceptor for UV-induced
suppression of anti-tumour tumour responses, suggesting a role for DNA-damage,
possibly via PAF induction. CA-UCA may act to potentiate this effect in the long-term
photocarcinogenesis studies by Beissert et al (2001), and Reeve et al (1989), however
during the short-term UV exposure model used in the present study, the potentiating
effect of cA-UCA was too slight to measure. Figure 7.1 illustrates some of the pathways
involved in UV-induced immune suppression, demonstrating the possible role for cis-
UCA in potentiating the mechanisms by which immune suppression is initiated.
The immunogenicity ofmany UV-induced skin cancers offers the potential for
treatment of these cancers by manipulation of the immune system of the host.
Knowledge ofwhich cells are important for tumour destruction could guide the
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development ofmechanisms to induce an effective host response; comparison of
immune responses in irradiated and unirradiated tumour-bearing mice could indicate
which cells are important in the anti-tumour immune response. The demonstration of
UV-induced regulatory T cells offers a possible target for therapy of skin cancer
patients; understanding the nature and mechanism of action of these cells could lead to
prevention of their action, such that tumour-destructive immune responses are not
dampened by these regulatory cells.
Figure 7.1. Mechanisms involved in UV-induced immunosuppression. TCL = cytotoxic T lymphocyte.
Treg = regulatory T cell. Md> = macrophage. PG = prostaglandin. Ag = antigen.
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Immunogenic murine tumours that are normally rejected upon transplantation into syngeneic hosts grow
progressively if the hosts are UV-irradiated prior to tumour implantation. Using three sources of UV we
investigated the most effective waveband and dose for increased outgrowth of injected fibrosarcoma (FSA) cells in
mice, compared with unirradiated controls. The animals were exposed on their shaved dorsal skin twice a week for
3 weeks to either broad-band (XL 12) or narrow-band (TL01) UVB, or UVA-I radiation; FSA cells were then injected
subcutaneously into the UV-irradiated skin. Exposure to TL12 at doses higher than 1000 J m"2, but not TL01 or
UVA-I, caused increased outgrowth of the injected tumour cells. The effect of the UV irradiation seemed to be local
as injection of the FSA cells into the unirradiated ventral skin of mice irradiated with TL12 on the dorsal surface
did not result in increased outgrowth of the tumours. C/j-urocanic acid, a recognised initiator of UV-induced
immunosuppression, applied topically or intradermally for 3 weeks prior to FSA cell injection, had no effect on the
rate of tumour outgrowth. Similarly, injection of a monoclonal antibody with specificity for c/s-urocanic acid, prior
to each irradiation with TL12, did not reverse the increased growth of FSA cells injected into the UV-irradiated skin.
Thus wavelengths within the broad-band UVB range are the most effective for inducing increased outgrowth of FSA
cells; ctr-urocanic acid is not an important mediator in this UV-enhanced growth of tumours.
Introduction
Skin tumours, induced in mice by exposure to ultraviolet radi¬
ation (UVR) are mostly strongly antigenic, and do not grow
when transplanted into normal syngeneic hosts.1 However prior
exposure of the recipient mice to UVR twice a week for 4
weeks, results in progressive growth of subsequently trans¬
planted antigenic tumours.2 This effect on tumour outgrowth
can be transferred to unirradiated mice by spleen cells from
UV-irradiated mice, suggesting that UV exposure suppresses
the immune response to these immunogenic skin tumours.3 The
effect of different UV wavelengths on outgrowth of implanted
tumours was investigated by De Fabo and Kripke,4 using a
fibrosarcoma (FSA) tumour that does not grow progressively
upon transplantation into normal, syngeneic mice. Exposure of
mice to wavelengths between 255-340 nm prior to tumour
implantation resulted in progressive growth of the implanted
tumours; removal of wavelengths below 275 nm did not alter
this result. Mice exposed to wavelengths above 315 nm prior
to tumour implantation, were not susceptible to tumour
challenge; the most important waveband was therefore in the
range 275-315 nm.
A study using Skh-1 albino hairless mice demonstrated that
the most effective wavelength for induction of skin cancer was
293 nm, which lies within the UVB (290-320 nm) range.5 A
shoulder of effectiveness at 10 4 of the maximum resulted from
exposure of mice to wavelengths over 340 nm, suggesting a
possible role for UVA (320-400 nm) in the generation of skin
cancer.
There has been much investigation into the immuno¬
suppressive properties ofUV, especially UVB, which suppresses
both contact hypersensitivity (CH) and delayed type hyper¬
sensitivity (DTH); these have been used as models for UVB-
induced suppression of T-cell responses. Following UVB
exposure, there are changes in cytokine profiles (reviewed in ref.
6), alterations in the number7 and morphology8 of epidermal
antigen presenting cells (APCs), and induction of regulatory
1006 Photochem. Photobiol. Sci., 2002, 1, 1006-1011
cells in the spleen and lymph nodes.9,10 Wavelengths within the
UVB range do not penetrate past the upper layer of the dermis;
therefore it is thought that UV initiates suppression through
a photoreceptor in the skin. Two photoreceptors with major
roles in UV-induced immunosupppression are DNA11 and
urocanic acid.12 Urocanic acid (UCA), which is found in the
skin as the trans isomer, is converted by UVR to the cis isomer;
ct'i-UCA has been demonstrated to suppress both CH and
DTH responses, and to affect the function of APCs (reviewed
in ref. 13).
Interest in the effects of wavelengths in the UVA range on
immune responses has grown in recent years. Prior irradiation
of mice with UVA waveband has been shown to protect against
UVB-induced suppression of CH responses.14 On the other
hand, UVA exposure alone can suppress both CH and DTH
responses.15 The mechanism is likely to be different from that
occurring as a result of UVB exposure and is probably through
the production of reactive oxygen species."
In the present study mice were irradiated for a period of
3 weeks; cells from a moderately immunogenic fibrosarcoma
were then injected subcutaneously, and outgrowth of the
subsequent tumours measured. The effects of broad-band
(280-360 nm) and narrowband (311-313 nm) UVB, and UVA-I
(340^100 nm) on the outgrowth of the FSA cells were com¬




Female C3H/HeN (H-2k) mice aged 6-10 weeks were obtained
from the Medical Faculty Animal Area, University of
Edinburgh; they were housed in a room where ambient light
was regulated on a 12 hour light/dark cycle, and had free access
to food and water. Room lights were shielded such that any
contaminating UV wavelengths were filtered out. All experi-
DOI: 10.1039/b208247k
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ments were performed according to the ethical guidelines of the
University of Edinburgh and the Home Office.
Tumour cells
The fibrosarcoma (FSA) cell line was a gift from Professor
William McBride (University of California, Los Angeles). The
cells are moderately immunogenic and are derived from a fibro¬
sarcoma that was induced in C3H mice by methylcholanthrene
treatment.17 The tumours formed after subcutaneous injection
have been well characterised with respect to the immune
response generated, including the intratumoural host cell
population, consisting mainly of macrophages with a small
component of CD4 and CD8 positive cells.18 Cells were stored
in liquid N2, and, prior to injection into mice, were cultured in
RPMI (Gibco, BRL, Paisley, UK) supplemented with 100 i.u.
mf1 penicillin, 200 pg ml1 streptomycin, 2 mM L-glutamine,
100 pg mf1 gentamicin, 1.5 pg mf fungizone and 10%
heat-inactivated foetal calf serum; cells were passaged a
maximum of three times prior to injection into mice. Sub-
confluent monolayers were harvested using a 0.1% trypsin/
0.04% versene solution and the number of viable cells deter¬
mined by trypan blue exclusion. For injection into mice, cells
were washed and resuspended in Hanks' balanced salt solution
(Gibco, BRL), supplemented with 20 pg ml ' deoxyribo-
nuclease I (Sigma, Poole, Dorset, UK). Mice were anaesthetised
with halothane 24 h after the final irradiation and 7.5 x 104
FSA cells in 100 pi HBSS were injected subcutaneously into 4
sites in the dorsal skin. In one experiment the FSA cells
were injected subcutaneously in the ventral skin. Mice were
monitored daily for the appearance of tumours; once the
tumours were of measurable size, two bisecting diameters were
measured twice a week, until the tumours reached 10 mm in
diameter, or showed signs of ulceration, at which point the
experiment was terminated. The total tumour area for one
mouse was calculated by multiplying together the bisecting
diameters for each tumour, and summing the product for each
of the four tumours; the mean value for each group was then
calculated.
UV sources and exposure
Three UV sources were used: a bank of two Philips TL12
lamps, which emitted a broad spectrum of UVB radiation
between 280 and 360 nm with a peak at about 305 nm and
produced an irradiance of 150 J m 2 min 1 at a distance of
20 cm from the source; a Philips TL01 lamp which emitted
narrow-band UVB radiation between 311 and 313 nm and pro¬
duced an irradiance of 120 J m 2 min 1 at a distance of 20 cm
from the source; and a Dr Honle Light Tower source which
emitted broad-band UVA radiation in the range 315-400 nm
and produced an irradiance of 2020 J m 2 min 1 at a distance of
44 cm from the source. The output of the sources was deter¬
mined using a filtered photodiode meter, which was calibrated
against measurements made with a UV-visible spectroradiom-
eter (model 742, Optronic Laboratories) across the spectral
range 250-450 nm. The UVA source emitted 0.5% of its output
in the UVB range. Cation X (2,7-dimethyl-diaza-(3,6)-cyclo-
heptadiene-(l,6)-perchlorate), a gift from Dr Frank de Gruijl
(University of Leiden), was used at 0.1 mg mL1 though a 1 cm
light path. At this concentration the transmission of wave¬
lengths below 340 nm was 0.0009% of the total output, and the
source was considered to emit UVA-L
Groups of 9-17 mice were irradiated twice a week for 3 weeks
and FSA cells were injected subcutaneously 24 h after the final
exposure; in some cases the UV exposure continued following
FSA cell injection. Mice were shaved on the back at least 24 h
before the first irradiation and again 24 h before the final irradi¬
ation. Control mice were shaved but not irradiated. Mice were
placed in a Perspex box for the irradiation with no more than 4
mice per box to avoid shielding by littermates.
Crs-urocanic acid
CA-UCA was prepared by irradiation of trans-UCA (Sigma,
UK), followed by purification by thin-layer chromatography
to give a greater than 99% pure preparation, as described
previously.19 For topical application, cA-UCA was dissolved in
ethanol (2 mg ml ') and 50 pi applied to shaved dorsal skin. For
intradermal injection, cw-UCA was dissolved in sterile PBS
(1 mg ml ') and 100 pi injected into shaved dorsal skin. Mice
received 100 pg cw-UCA twice a week for 3 weeks prior to FSA
injection.
A monoclonal antibody with specificity for cw-UCA20 was
diluted in PBS and 300 pi (0.5 pg protein per mouse) injected
intraperitoneally 2 h prior to each irradiation with the TL12
source (1200 J m 2). Control mice received an isotype control
antibody (IgGl; anti-Border disease virus) at the same protein
concentration and times. Unirradiated controls received either
cw-UCA antibody or control antibody.
Statistics
Statistical significance between groups was determined using
the two-tailed student's t-test for unpaired data. A probability
of less than (p <) 0.05 of no difference between the groups was
considered significant.
Results
Following injection of the FSA cells, palpable tumours (1 mm
diameter) appeared around day 4. The majority of tumours
formed grew to approximately 4 mm diameter, at which point
growth rate declined (around day 15). Some tumours continued
to grow until they reached 10 mm diameter, at which point the
mice were killed for humane reasons; mice were also killed
when tumours (usually the largest) showed signs of ulceration
(around day 24).
Broad-band UVB exposure enhances tumour outgrowth
A dose of 1500 J m 2 broad-band UVB (TL12) represents 1
minimal erythemal dose (MED) for C3H mice, and a single
dose of 1000 J m 2 broad-band UVB (TL12) has been shown to
suppress both the CH and DTH responses in these mice.15 This
dose was therefore chosen and mice were initially irradiated
twice a week for 3 weeks with 1000 J m~2 TL12. Such an
exposure for 3 weeks prior to FSA cell injection had no effect
on the outgrowth of the tumours compared with unirradiated
controls (Fig. la); however, increasing the dose of UVB to
1200 J m 2 resulted in a significant increase in the size of the
tumours. Continuing to irradiate the mice with 1200 J m 2 after
injection of FSA did not further increase the UV-enhanced
outgrowth of the tumours. The experiment was repeated with
similar results.
Fig. lb demonstrates that the effect of UVB on tumour out¬
growth was a local one. Exposure of mice to 1500 J m~2 over a
period of 3 weeks, a dose that increased the outgrowth of FSA
cells injected into UV-irradiated dorsal skin, had no effect on
the outgrowth of FSA cells implanted into unirradiated ventral
skin.
UVA-I and narrow-band TL0I exposure do not enhance tumour
outgrowth
In a previous study, it was demonstrated that a single dose of
1000 J m 2 UVA-I suppressed the DTH response in C3H mice,
while a dose of 500,000 J m 2 (1 MED) was required for sup¬
pression of CH.15 The same study demonstrated that a single
dose of 10,000 J m"2 TL01 (1 MED) suppressed the DTH
response in these mice. Doses exceeding those necessary to
suppress the hypersensitivity responses were therefore chosen.
Fig. 2 shows that exposure of mice twice a week for 3 weeks to
10,000 or 500,000 J nU2 UVA-I radiation prior to FSA cell
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Fig. 1 Growth of FSA cells in C3H mice following broadband UVB
(TL12) exposure, (a) Groups of 17 mice were irradiated twice a week for
3 weeks with 0 (•), 1000 (□) or 1200 (A) J m 2 TL-12. FSA cells were
injected 24 h after the final UV exposure. One group continued to
receive 1200Jm 2 TL12 twice a week following FSA cell injection (A).*
shows a significant difference (p < 0.05) between the unirradiated group
and the groups irradiated with 1200 J m~2. (b) Groups of 12 mice were
irradiated twice a week for 3 weeks with 1500 J m 2 TL12. The ventral
skin was shaved 24 h before the final UV exposure; FSA cells were
injected in 4 ventral sites (□) or 4 dorsal sites (A) 24 h after the final UV
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Fig. 2 Growth of FSA cells in C3H mice following UVA-I exposure.
Groups of 9 mice were irradiated twice a week for 3 weeks with 0 (•),
10,000 (□) or 500,000 (A) J m '2 UVA-I. FSA cells were injected 24 h
after the final UV exposure.
injection had no effect on the size of the resulting tumours,
compared with unirradiated controls. Irradiation of mice for 3
weeks with 10,000 (data not shown) or 14,000 J mT2 TL01 had
no effect on the outgrowth of subsequently injected FSA cells
(Fig. 3). Continuing the irradiation protocol following tumour
cell injection however, resulted in a significant increase in the
size of the resulting tumours, beginning on day 18 post-
injection.
Gs-UCA does not enhance tumour outgrowth
Reeve et al21 demonstrated that topical application of UCA
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Fig. 3 Growth of FSA cells in C3H mice following narrow-band UVB
(TL01) exposure. Groups of 12 mice were irradiated twice a week for
3 weeks with 0 (•) or 14,000 (□) J m 2 TL01. FSA cells were injected
24 h after the final UV exposure. One group continued to receive 14,000
J itT2 TL01 twice a week following FSA cell injection (A).* and t show
a significant difference (p < 0.05 and p < 0.005 respectively) between the
unirradiated group and the group irradiated with TL01 before and after
FSA cell injection.
and state of malignancy of the resulting tumours. Topical
application of cis-UCA also suppressed the DTH response to
herpes simplex virus in C3H mice,18 while injection of a mono¬
clonal antibody to cA-UCA prior to UV-irradiation reversed
the UV-induced suppression of DTH to alloantigen.22 We
therefore investigated whether cA-UCA was a mediator in
UV-enhanced tumour outgrowth.
Topical application of 100 pg cA-UCA onto shaved dorsal
skin for 3 weeks prior to FSA cell injection had no effect on the
outgrowth of FSA cells compared with mice that received the
vehicle only (Fig. 4a). This experiment was repeated with similar
results. To exclude the possibility that this was due to a lack of
uptake of cA-UCA through the skin, cA-UCA was injected
intradermally twice a week for 3 weeks; there was no significant
difference in tumour size between these mice and controls (Fig.
4a).
Injection of 0.5 pg cA-UCA antibody prior to each exposure
with 1200 J m~2 TL12 had no effect on the increase in tumour
size seen following UV exposure (Fig. 4b); increasing the dose
of cA-UCA antibody to 5 pg protein per mouse gave a similar
result (data not shown). Injection of cA-UCA antibody also
had no effect on the outgrowth of tumours in unirradiated mice
(Fig. 4b).
Discussion
Many UV-induced tumours in mice are rejected upon trans¬
plantation into normal syngeneic hosts; however, these
tumours can grow progressively if transplanted into hosts
whose immune systems have been suppressed by UVR or
another method. These immunogenic properties are not
restricted to murine UV-induced skin tumours; an increase in
skin cancers on the sun-exposed skin of patients taking
immunosuppressive drugs has been observed,23,24 suggesting
that many potential cancer cells are destroyed by individuals
with an intact immune system. Although the nature of the
immune response to skin cancers is not well understood (for
review see ref. 25), there is evidence that UV-enhanced out¬
growth of implanted skin tumours is accompanied by induction
of suppressor T cells in the spleen and lymph nodes.26
In the current study, irradiation of mice twice a week for
3 weeks with 1200 J m 2 broad-band UVB (280-360 nm)
resulted in enhanced outgrowth of FSA cells injected into the
UV irradiated dorsal skin. There may be a minimal dose
requirement as 1000 J m 2 had no effect. The enhanced out¬
growth was not seen when FSA cells were injected into the
unirradiated ventral skin of irradiated mice; the effect of the
broad-band UVB was therefore a local one. This result is in
1008 Photochem. Photobioi Sci., 2002, 1, 1006-1011
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Fig. 4 Effect of cis-UCA on growth of FSA cells in C3H mice,
(a) Groups of 10 mice were treated topically twice a week for 3 weeks
with cA-UCA (□) or vehicle only (•); alternatively mice were injected
subcutaneously with cA-UCA (A). FSA cells were injected 24 h after
the final treatment, (b) Groups of 14 mice were irradiated twice a week
for 3 weeks with 1200 J m 2 broad-band UVB (TL12); two hours before
each irradiation mice were injected i.p. with cA-UCA antibody (A) or
an isotype control antibody (□). Control mice received cA-UCA
antibody (•) but were not irradiated.* shows a significant difference
(p < 0.05) between the unirradiated group and the irradiated groups.
agreement with the results of Romerdahl et al. ,27 where
unshaven mice were irradiated with one ear covered; sub¬
sequently injected melanoma cells showed increased outgrowth
in the UV-exposed ear but not in the ear that had been covered.
Previous studies have indicated that the effect of UVR is sys¬
temic, as the suppression of immune responses to implanted4
or primary UV-induced28 tumours can be transferred from
irradiated to unirradiated mice by spleen and lymphoid cells.
In an experiment by Fisher and Kripke,26 where 2 mice, one
UV-irradiated and the other unirradiated, were joined para-
biotically, implanted tumours grew progressively in both mice.
In that study, the mice were irradiated for at least 3 months
prior to the parabiosis, and each dose was 10,000 J m 2 (FS40
Sunlamps); the lower dose of UV used in the present study
might not have been sufficient to cause systemic suppression of
anti-tumour responses.
In previous reports investigating the effects of UVA radiation
on immune responses, a variety of sources and filters have been
used, making it difficult to compare one study with another. We
chose to exclude wavelengths below 340 nm by a Cation X
screen. It was shown that prior exposure to the UVA-I lamp
had no effect on the size of the FSA tumours. This supports the
findings by Aubin el al.,29 that prior exposure of mice to UVA
does not result in progressive growth of subsequently implanted
melanomas. In a previous study4 exposure of BALB/c mice to
FS40 Sunlamps, with 87% of their output between 255-340 nm
with a main peak at 313 nm, increased the growth of sub¬
sequently implanted UV-induced fibrosarcomas. Use of filters
that removed 99% of wavelengths below 275 nm, or 99% of
wavelengths below 315 nm, demonstrated that the most
effective wavelengths for UV-enhanced tumour outgrowth most
probably lay within the UVB range. A study by de Gruijl et al.3
demonstrated that for induction of skin cancer in hairless mice,
the most effective wavelength was 293nm, which lies within the
UVB range; however, wavelengths within the UVA range were
also effective, although to a much lesser extent. In a model
using the opossum Monodelphis domestica, exposure to UVA
(over 320 nm) 3 times a week for 87 weeks gave rise to non-
melanoma skin tumours in the UV-irradiated sites in 50% of
the animals.30
It is possible that the dose ofUVA used was not high enough
to cause suppression of anti-tumour responses; alternatively it
may be that, although UVA can induce tumours, these wave¬
lengths do not initiate the suppressive events leading to
increased tumour cell outgrowth. The UV-induced tumours
that are reported as highly antigenic were all induced by
exposure to wavelengths in the UVB range;1 it is not known
whether UVA-induced tumours demonstrate the same degree
of antigenicity.
The TL01 lamp has an output mainly within the UVB range,
with a peak (51%) at 311 nm. Exposure of mice to 14,000 J m"2
TL01 for 3 weeks prior to inoculation with FSA cells had no
effect on the outgrowth of the subsequent tumours; however, in
mice that continued to be irradiated after tumour cell injection,
the resulting tumours were significantly increased in size
compared with those in unirradiated mice. It is not clear
whether this effect of the TL01 exposure was on the FSA cells
themselves, or on the host. A single dose of 10,000 J m 2 TL01
(1 MED) is sufficient to cause suppression of the DTH
response in these mice; however a dose of 50,000 J m~2 is neces¬
sary to suppress the CH response.15 Although the mice received
a total of 84,000 J m 2 TL01 prior to FSA cell injection, it may
be that higher or continuing doses are required to induce
increased outgrowth of inoculated tumour cells.
In this study, cA-UCA was not found to have a major role in
UV-induced suppression of immune responses to FSA cells.
Two previous studies have suggested that cA-UCA may be
important in the pathogenesis of skin cancer. Topical appli¬
cation of UCA prior to irradiation with solar-simulating UV
during UV carcinogenesis increased both the number and
malignancy of the resultant tumours, compared with mice
receiving only UV.20 More recently, Beissert et al.32 used tumour
antigen-pulsed epidermal cells to immunise mice against a
SI905 spindle cell tumour. Mice that had received epidermal
cells, incubated in cA-UCA prior to antigen pulsing, were
unable to reject subsequently injected tumour cells; these mice
also showed a significantly suppressed DTH response to the
tumour cells. This inhibition by cA-UCA of tumour antigen
presentation by epidermal cells was completely reversed by
addition of IL-12 before, during or after incubation of the cells
with cA-UCA.32
The apparently conflicting results of these studies with the
present one could be due to the very different protocols and
endpoints. Our results showed that an antibody to cA-UCA did
not counteract the UV-enhanced tumour growth, nor did
treatment of mice with cA-UCA increase the growth of sub¬
sequently injected FSA cells. The increase in carcinogenesis
seen by Reeve et a!.20 may be caused by an increase in induction
of tumours by UCA, rather than promotion by suppression of
anti-tumour immune responses. As the UCA was applied prior
to each irradiation, it is possible that products were formed
from the photo-oxidation of UCA, which is induced by UVB,
but not UVA, radiation; these photo-oxidation products are
thought to have a role in UV-induced immune suppression.33
The amount of cA-UCA present in the skin following the
3 week irradiation protocol was not analysed in the present
study. Previous measurements had shown that, after exposure
to a single dose of 1000 J nT2 TL12, or 10,000 J m~2 TL01, the
irradiated skin contained approximately 42% cA-UCA, com¬
pared to 1.7% in unirradiated skin.15 A single dose of 500,000 J
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m 2 UVA-I resulted in only 17% formation of cw-UCA. During
chronic irradiation of mice with doses of 1000 J m 2 TL12, or
3000 J nT2 TL01 three times each week, an increase in cfs-UCA
was seen after the first week, and a maximum of 35% and
38% ds-UCA was reached with the TL01 and TL12 lamps
after 1 and 2 weeks respectively.34 When these percentages were
compared with suppression of hypersensitivity responses, no
correlation could be established.
Moodycliffe et al.22 reported that injection of a monoclonal
antibody specific for ris-UCA prior to UV-irradiation of mice
completely reversed the UV-induced suppression of the DTH
response to allogeneic spleen cells, although it had no effect on
UVB-induced suppression of the CH response to oxazalone. In
another report, the antibody to ew-UCA reversed the DTH
response to herpes simplex virus, but again had no effect on the
CH response to oxazalone.35 Since UV-induced suppression
appears to have different pathways for different antigens, the
present study shows that UCA is not an important photo¬
receptor in the cascade of immune response reduction during
outgrowth of tumour cells.
In conclusion, we have shown that irradiation of mice with
the broad-band UVB lamp was the most effective in increasing
the outgrowth of injected FSA cells; this effect was a local one,
as FSA cells injected into an unirradiated site of irradiated mice
did not show increased growth. Despite the carcinogenic and
immunosuppressive properties of UVA, irradiation of mice
with UVA-I did not cause increased growth of subsequently
injected tumour cells. Although cA-UCA may be important
in the early stages of UV-induced carcinogenesis, it was not a
critical mediator of UV-induced suppression of immune
responses to injected tumour cells.
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Immune suppression following UVB irradiation is partly attributed to the effects of the exposure on antigen-
presenting cells. Following a single UVB irradiation, there is a decrease in epidermal Langerhans cell numbers; this is
accompanied by an increase in the number of dendritic cells (DC) in lymph nodes draining the irradiated site. We
investigated whether a similar effect occurred following multiple UVB exposures. Mice were irradiated on their ears
and shaved dorsal skin twice a week for 3 weeks. After the final exposure, the number of ATPase+ Langerhans cells in
epidermal sheets prepared from the ears was found to be decreased by 33% compared to unirradiated controls. The
number of DC in the draining lymph nodes (DLN) did not increase as might have been expected; rather, a significant
decrease of approximately 30% in DC numbers in the DLN of UVB-irradiated mice compared with unirradiated
controls occurred. This decrease in antigen-presenting cells in both the epidermis and the DLN may be an important
contributing factor to the immune suppression that follows multiple UVB exposures.
Introduction
Exposure to ultraviolet radiation (UVR) causes suppression of
T-cell responses, such as the contact hypersensitivity (CH)
response, in both mice and humans.1,2 During contact sensitisa-
tion, hapten-bearing Langerhans cells (LC), normally resident
in the epidermis, migrate to the draining lymph nodes (DLN) to
induce an immune response.' There is evidence that UVR-
induced suppression of immune responses may be due, at least
partly, to effects on antigen-presenting cells of the skin. LC are
both decreased in number and altered morphologically follow¬
ing UV irradiation.4 UV exposure of human skin results in
increased numbers of LC in suction blister fluid, indicating that
UV-induced migration takes place.5 In another study, UV
irradiation [1 minimal erythemal dose (MED)] of the skin of
human volunteers increased the lymph flow and cell output in
an afferent lymph vessel.6 Moodycliffe et all demonstrated that
the number of dendritic cells (DC) in the skin DLN of unsensi-
tised mice increased as a result of irradiation with 1 MED
UVB, with a peak at 42 h after the exposure. Taken together,
these studies suggest that, following a single dose of UV, some
LC migrate from the epidermis through the afferent lymph and
accumulate in the DLN. How this change relates to the immune
suppression that follows UV exposure is unclear. One con¬
sequence could be a decrease in the numbers of LC in the skin
available to take up antigen. Alternatively, some LC migrating
from UV-irradiated skin show DNA damage5 which might lead
to altered antigen presentation by these cells. In vitro UV
exposure of LC affects the expression of co-stimulatory mole¬
cules such as CD86 (B7.2) and intercellular adhesion molecule-
l;8'9 a decrease in these molecules could result in a tolerogenic,
rather than an immunogenic, signal being generated. Finally, it
has been demonstrated that following UV irradiation, there is
an influx of inflammatory cells, including macrophages, into
the skin;10 presentation of antigen by these cells gives rise to a
suppressive, rather than an active, immune response."
Although the effects of a single, frequently erythemogenic,
UV exposure on immune responses are useful for examining the
complex processes involved in UV-induced immune suppres¬
sion, multiple exposures over a period of weeks are perhaps
more relevant to the sunlight exposure naturally received by
humans. Such a chronic protocol can also remove the need to
use high doses of UV. Whereas a single dose of 1250 J m~2 was
not sufficient to reduce epidermal LC numbers in C3H mice,12
the numbers were decreased following exposure 3 times weekly
to a dose of 500 J m~2 for 1-3 weeks." In the latter study,
tanning of the UV exposed mice was seen after 3 weeks
exposure, and it is not known at present whether such an adap¬
tive response could affect the induction of suppression.
The purpose of the present study was to assess whether a 3
week UV protocol had similar effects to an acute UV exposure
on the migration of LC in unsensitised mice. Following
exposure of C3H mice to UVB for 3 weeks, the numbers of
both epidermal LC and DC in LN draining the skin were
counted. The expression of co-stimulatory molecules on the
DC was also assessed. The in vivo CH response and the ability
of LN cells to undergo spontaneous proliferation in vitro were
tested as measures of immune function.
Materials and methods
Mice
Female C3H/HeN (H-2k) mice aged 6-10 weeks were obtained
from the Medical Faculty Animal Area, University of Edin¬
burgh; they were housed in a room where ambient light was
regulated on a 12 h light/dark cycle and had free access to food
and water. Room lights were shielded such that any contamin¬
ating UV wavelengths were filtered out. All experiments were
performed according to the ethical guidelines of the University
of Edinburgh and the Home Office.
UV exposure
Mice were irradiated under a bank of two Philips TL12 lamps,
which emit a broad spectrum of UVB radiation between 280
and 360 nm, with a peak at about 305 nm, and produced an
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irradiance of 150 J mirT1 rrT2 at a distance of 20 cm from the
source. The output of the lamps was determined using a filtered
photodiode meter, which was calibrated against measurements
made with a UV-visible spectroradiometer (Optronic Labora¬
tories model 724) across the spectral range 250^150 nm. The
backs of the mice were shaved at least 24 h before the first
irradiation, and the mice irradiated with 1500 J m~2 twice a
week (Tuesday and Friday) for 3 weeks. Mice were placed in a
Perspex box for the irradiation, with no more than 4 mice per
box to avoid shielding by littermates. Control mice were shaved
but not irradiated.
Epidermal Langerhans cells
UVB-irradiated and unirradiated control mice were killed by
cervical dislocation 24 h after the final irradiation, and their
ears removed and split. The dorsal side was floated in 0.76%
tetrasodium ethyleneamine tetraacetic acid for 2 h at 37 °C, and
the epidermal sheets removed. The number of LC in the epi¬
dermal sheets was determined by staining for adenine triphos¬
phatase (ATPase), using adenine diphosphate (ADP) as a sub¬
strate.14 Following staining, the sheets were rinsed in tap water
and mounted onto a glass slide under a cover slip in 50% gly¬
cerol. The number of ATPase4" cells in 10 fields per epidermal
sheet was counted (1 field = 0.1 mm2), with 4 sheets per group.
Lymphoproliferation of draining lymph node cells and dendritic
cell enrichment
Mice were killed by cervical dislocation 42 h after the final UV
irradiation or were unirradiated (8 mice per group). Their
auricular, axillary and inguinal LN were collected and pooled
in RPMI medium (Gibco BRL, Paisley, UK) containing 10%
foetal bovine serum (Gibco BRL) and 10 mM Hepes buffer
(Sigma, Poole, UK). Single cell suspensions were prepared by
mechanical disaggregation through a nylon cell strainer (Fred
Baker Scientific, Runcorn, UK) and washed once. Viable cells
were counted by Trypan Blue exclusion. For the lymphoprolif¬
eration assay, cells were resuspended to 2 x 106 cells ml-1 and
200 pi of this seeded into wells of a 96-well round-bottom cul¬
ture plate (Iwaki, Asahi Techno Glass, Tokyo, Japan) (5 repli¬
cates per group). Cells were radioactively pulsed by adding 0.7
pCi 3H-methyl thymidine (Amersham Life Science, Amersham,
UK) per well and incubated for 24 h at 37 °C in a humid atmos¬
phere of 5% C02 in air. Cells were harvested onto filter mats
and 3H-thymidine incorporation measured in counts per minute
using a scintillation counter (Canberra Packard, Zurich, Swit¬
zerland). The mean count of the 5 replicates for each group was
calculated.
The LN cell suspensions were enriched for DC using the
method of Macatonia et al.'s Briefly, 4 x 107 LN cells in 8 ml
medium were underlaid with 2 ml metrizamide (14.5%, Sigma,
UK). Following 15 min centrifugation at 600g, the interface
layer was collected, washed and resuspended in a minimal
amount of medium. The number of DC was assessed by mor¬
phological examination by light microscopy; at least 5 counts
for each group were made and the mean number of DC per LN
was calculated.
Phenotyping of DC by flow cytometry
DC-enriched LN cell suspensions were prepared as above and 4
x 10s cells incubated on ice for 45 min with an isotype control
antibody (rat anti-human CD8, Serotec, Oxford, UK) or
monoclonal antibodies recognising la or CD86 (rat anti-mouse,
Serotec). The cells were washed once with 1 ml RPMI-Hepes,
resuspended in RPMI-Hepes and incubated with an affinity-
purified F(ab')2 goat anti-rat IgG-FITC conjugate (100 pi of 1 :
100 dilution; Serotec) for 45 min on ice. Cells were washed
again, resuspended in 1 ml phosphate-buffered saline and ana¬
lysed using a Coulter XL flow cytometer. Cells were identified
first using forward scatter and side angle light scatter to quanti¬
fy their size and granularity. Gates were placed around the
entire cell population and around cells with low forward and
side angle scatter (lymphocytes) and around the larger cells. The
events within each region were displayed on histograms of log
fluorescence intensity (.x-axis) against cell count (y-axis). Iso¬
type controls were routinely set at 1% and a minimum of 20000
events was accumulated in the region around the entire cell
population.
Annexin V binding of DC-enriched LN cell populations was
determined by incubation of the cells for 3 min at room temper¬
ature with FITC-conjugated annexin V (Boehringer, Ingelheim,
Germany) diluted 1 : 500 in Hanks' balanced salt solution con¬
taining 5 pM CaCl2. Cells were analysed immediately by flow
cytometry, as described above.
Measurement of CH response
The CH response to oxazalone was measured in irradiated and
unirradiated mice by a standard technique, as outlined pre¬
viously.16 Six mice per group received a sensitising dose of 50 pi
1% oxazalone in an acetone-olive oil (4:1) vehicle on their
shaved backs, 3 days after the final UV exposure. An unirradi¬
ated negative control group received 50 pi of the vehicle alone.
Eight days after the sensitisation step, ear thicknesses were
measured and all the mice were challenged with 25 pi per ear of
0.25% oxazalone on the dorsal surface. Ear swelling was meas¬
ured 24 h later and the mean ear increase for each mouse was
calculated, followed by the mean increase for each group of
mice.
Statistics
Statistical significance between groups was determined using
the two-tailed student's t-test for unpaired data. A probability
of less than (p <) 0.05 of no difference between the groups was
considered significant.
Results
Exposure to UVB for 3 weeks reduces epidermal LC numbers
It has been reported that a single exposure to 5000 J m~2 UVB
(TL-12) reduces the number of LC in the epidermis by around
28%.12 This depletion was demonstrated to be dose dependent,
with a dose of 1250 J m~2 being insufficient to cause a signifi¬
cant drop in LC numbers. To determine the effect of multiple
UV doses over a period of 3 weeks on epidermal LC numbers,
mice were irradiated twice a week for 3 weeks with 1500 J m~2
broad-band UVB. The ears were removed 24 h after the final
irradiation and the frequency of LC in the epidermis deter¬
mined by counting the number of ATPase4 cells with dendritic
morphology. Fig. 1 shows that the number of epidermal LC
decreased by approximately 33%, a significant difference com¬
pared to the unirradiated control mice.
Exposure to UVB for 3 weeks decreases the number of DC in the
DLN
Moodycliffe et al? demonstrated that a single exposure of the
ears of C3H mice to 1440 J nU2 broad-band UVB induced an
increase in the number of DC in the auricular LN, which was
maximal at around 42 h following the irradiation. In the present
study, mice were shaved and exposed to a single dose of 1500 J
m~2 UVB. This resulted in an increase in the number of DC in
the LN draining the irradiated dorsal surface from 4575 to 6595
per LN. To determine whether the same effect was seen in mice
following multiple UV exposures, mice were exposed to 1500 J
m~2 UVB twice a week for 3 weeks and LN draining both the
ears and back were pooled and enriched for DC. The results of
4 separate experiments are shown in Table 1. The number of
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Fig. 1 Effect of 3 weeks UVB exposure on epidermal LC numbers.
Mice (2 per group) were irradiated twice a week for 3 weeks and their
ears removed 24 h after the final UV exposure. Control mice were not
irradiated. The epidermal sheets were removed, fixed and stained using
ADP-lead; the number of ATPase+ DC was counted in 40 fields of 1
mm2 each. Results are expressed as the mean of 40 fields, error bars
show the SEM. The asterisk indicates a significant (p < 0.05) difference
between the irradiated and unirradiated groups.
Table 1 Effect of UVB irradiation on DC numbers in LN draining the
ears and shaved backs of mice. Mice (8 per group) were irradiated twice
a week for 3 weeks and their LN removed 42 h after the final UV
exposure. Control mice were not irradiated. Numbers in parentheses
are the SEM
DC count per lymph node





















° Shows a significant difference (p < 0.05) between the control and the
irradiated groups.
DC in the LN from irradiated mice was consistently less than
the number in the LN from control mice. The mean for each
group was calculated and a t-test showed that exposure of mice
to UV for 3 weeks significantly (p < 0.05) decreased the number
of DC in the DLN.
To assess whether the decrease in DC numbers in the LN of
irradiated mice was due to increased cell death, the level of
annexin V binding by the DC-enriched cell populations was
measured. DC from control and irradiated mice demonstrated
similar levels of annexin V binding (Fig. 2), with an average
(from two experiments) of 72% positive cells for control DC
and 74% for DC from irradiated mice.
Exposure to UVB for 3 weeks has no effect on DC surface
molecules
Lappin et al." demonstrated that, in mice that were contact
sensitised, prior exposure to a single dose of UVB had no effect
on the expression of several cell surface molecules on DC
enriched from DLN, compared with unirradiated mice. We
assessed whether chronic UV exposure affected the expression
of cell surface markers involved in antigen presentation in
unsensitised mice. DLN cells from unirradiated mice and from
mice that had been irradiated over a 3 week period were
enriched for DC, and the expression of la and CD86 deter¬
mined by flow cytometry. No difference was seen in the expres¬
sion of either la [Fig. 3(a)] or CD86 [Fig. 3(b)] between mice
exposed to multiple doses of UV and unirradiated controls.
This experiment was repeated twice with similar results.
Exposure to UVB for 3 weeks has no effect on the spontaneous








Fig. 2 Effect of 3 weeks UVB exposure on annexin V binding to DC.
Mice (8 per group) were irradiated twice a week for 3 weeks and their
LN removed 42 h after the final exposure. Control mice were not
irradiated. Following DC enrichment of DLN cells, the enriched
populations were stained with FITC-conjugated annexin V. The
fluorescence intensity of the gated DC population is shown for control
(continuous black line) and irradiated mice (grey line). The fluorescence
intensity of DC from unirradiated mice stained with a control antibody
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Fig. 3 Effect of 3 weeks UVB exposure on expression of cell surface
markers on DC. Mice (8 per group) were irradiated twice a week for 3
weeks and their LN removed 42 h after the final exposure. Control mice
were not irradiated. Following DC enrichment of DLN cells, the
enriched populations were stained for the presence of la (a) and CD86
(b), and analysed by flow cytometry. The fluorescence intensity of the
gated DC population is shown for control (continuous black line) and
irradiated mice (grey line). The fluorescence intensity of DC from
unirradiated mice stained with a control antibody is also shown (dotted
black line).
LN cells that are removed from normal mice have a low spon¬
taneous proliferation in vitro; application of a contact sensitiser
to the skin results in increased proliferation of cells from LN
draining the skin.18 To assess whether UV irradiation had any
effect on the spontaneous proliferation of DLN cells, mice were
irradiated twice a week for 3 weeks and their LN removed 42 h
after the final irradiation. No difference was seen in the spon¬
taneous proliferation of cells from UV-irradiated mice com¬
pared with unirradiated controls (Fig. 4). This experiment was
repeated 3 times with similar results. In one experiment, pro¬
liferation of LN cells stimulated with the mitogen concanavalin















Fig. 4 Effect of 3 weeks UVB exposure on the spontaneous
proliferation of DLN cells. Mice (8 per group) were irradiated twice a
week for 3 weeks and LN draining the irradiated sites removed 42 h
after the final exposure. Control mice were not irradiated. The level of
proliferation was assessed using JH-thymidine incorporation. Error
bars show the SEM.
A (2.5 pg ml"' for 42 h)19 was measured; the stimulation index
(proliferation in response to concanavalin A divided by pro¬
liferation without the mitogen) was 37 for both control and
irradiated mice.
Exposure to UVB for 3 weeks suppresses the CH response
Suppression of the CH response following multiple UVB
exposures has been demonstrated previously." To assess the
effect of the UV exposure protocol used in the present study on
the ability of mice to mount an immune response, the CH
response to oxazalone was measured. As shown in Fig. 5, mice
irradiated with multiple UVB doses showed a significantly sup¬
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Fig. 5 Effect of 3 weeks UVB exposure on CH response to oxazalone.
Irradiated (UVB) or unirradiated (POS) mice (4-6 per group) were
sensitised with oxazalone on the dorsal skin 3 days after the final UVB
exposure, and challenged 8 days later on the ears. Unirradiated negative
control mice (NEG) were challenged but not sensitised. Error bars
show the SEM. The asterisk indicates a significant (p < 0.05) difference
between the irradiated and unirradiated groups.
Discussion
The results of this study show that, following a 3 week UVB
radiation protocol, the number of epidermal LC decreased and
this decrease was accompanied by a decrease in DC numbers in
the DLN, in contrast to the increase that occurred following a
single UV exposure.
The effect of chronic UVB exposure on epidermal LC num¬
bers has been reported previously." The 3 week UV protocol
used in the current study also led to local suppression of the
contact hypersensitivity response to oxazalone. A correlation
between UV-induced LC depletion and down-regulation of
contact hypersensitivity responses has been demonstrated pre¬
viously,1 suggesting a role for LC in UV-induced immune sup¬
pression. The decrease in epidermal LC numbers following UV
irradiation could be due to apoptosis of these cells, resulting
from UV-induced DNA damage. In vitro irradiation of human
LC with low dose UVB resulted in increased apoptotic cell
death.8 Following ex vivo UVB exposure of human skin
biopsies, the number of LC in the epidermis decreased com¬
pared to unirradiated controls. This decrease could not be attri¬
buted to migration however, as the number of LC found in the
culture medium decreased following UV irradiation of the
skin.20 On the other hand, a number of studies have provided
evidence that the decrease in LC numbers following UV
exposure is due to the migration of LC from the skin, rather
than through the induction of apoptosis. Experiments involv¬
ing cannulation of draining afferent lymph vessels have demon¬
strated an increase in lymph flow and cell output after exposure
of human volunteers to UVR,6 and an increase in the number
of LC in afferent lymph draining the skin of UV-irradiated
sheep.21 In another human study, suction blisters were raised in
skin and the number of LC detected in the blister fluid
increased following UVB exposure.5 Of these, 20-30% showed
evidence of UV-induced DNA damage, indicating that they
were derived from the UV-exposed epidermis; additionally,
very few apoptotic LC were observed in the epidermis and der¬
mis of the irradiated skin. Following a single UV rradiation,
mouse cells staining positive for cyclobutane pyrimidine dimers
(a specific marker for the commonest form of UV-induced
DNA damage) were present in DLN; at least some of these cells
had characteristic DC markers, suggesting that they were LC
that had migrated from the irradiated skin.22
In the current study, as reported previously by Moodycliffe et
al.,7 the number of DC in the DLN increased in mice that had
received a single dose of UVR, confirming that exposure to UV
causes migration of DC. By contrast, following a chronic 3
week UV protocol, the number of DC in DLN decreased com¬
pared to unirradiated mice. In the study by Moodycliffe et al.,7
the increase in DC numbers in the DLN of irradiated mice
reached a maximum at 42 h after the exposure, and then
decreased rapidly to the levels found in unirradiated mice by
around 60 h. This decrease may be due to the re-circulation of
the DC; alternatively, the DC that have migrated from the UV-
exposed skin may apoptose upon reaching the LN. In vitro stud¬
ies have demonstrated that UVB-irradiated LC only show
increased apoptosis following at least 2 days in culture,8,9 lead¬
ing to the suggestion that LC migrating from the skin apoptose
once they have reached the DLN. Similarly, following skin
painting with an irritant, DC accumulate in the DLN, but dis¬
appear rapidly after 2 days,23 an effect attributed to the death of
the DC, since no DC have been observed leaving LN via the
efferent lymphatics.24 This is in contrast to DC migrating from
the skin in unsensitised mice, which demonstrate a turnover of
around 30 days.23 The death of DC in sensitised mice could
result from interaction with antigen-specific T cells, as splenic
DC showed increased apoptosis when cultured in vitro with
antigen-specific T cells.25 No increase in the spontaneous pro¬
liferation of cells from the DLN of irradiated mice was seen in
the present study, indicating that the DC did not stimulate anti¬
gen-specific T cells upon arrival; this is to be expected, since the
mice were not sensitised. No difference in the level of cell death
in DC isolated from unirradiated and irradiated mice was indi¬
cated using the marker annexin V; however, a high level of stain¬
ing was seen in both groups, possibly as a consequence of the in
vitro manipulation of the cells. It may be that the decrease in
both epidermal LC and LN DC numbers in irradiated mice
resulted from cell death that occurred earlier in the UVB proto¬
col; alternatively some of the migrating LC could have died in
the draining lymphatics.
Despite the decrease in DC numbers in the DLN of irradi¬
ated mice, no difference in expression of the cell surface mole-
4 Photochem. Photobiol. Sci., 2003, 2, 1-6
cules la and CD86 was found on DC from DLN of UV-
exposed mice, compared to DC from unirradiated mice. There¬
fore, the DC that remain in the DLN following multiple UV
exposures express normal levels of at least two of the molecules
involved in antigen presentation to, and stimulation of, T cells.
However this finding does not rule out the possibility that UVB
may affect the expression of other DC surface molecules such
as CD80, CD40 and CD 11c, which were not assessed in the
present study.
Although we have shown that, following exposure of mice to
UV over a 3 week period, the number of LC in the epidermis
decreased, there was no evidence that the LC had migrated to
the DLN, since the number of DC in the DLN of chronically
UV-irradiated mice was significantly decreased compared to
unirradiated mice. The ultimate fate of these cells remains to be
determined. As seen previously, multiple exposures to UV sup¬
press the contact hypersensitivity response13 and result in
enhanced outgrowth of implanted tumours in UV-irradiated
mice.26 The decrease in both epidermal LC and DC in the DLN
suggests that there is a lack of available antigen-presenting cells
in chronically UV-irradiated mice, which could either lead to
less effective initiation of an immune response, or make antigen
presentation by other cells, such as macrophages, more import¬
ant in these mice.
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